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Abstract 
Retroviruses must integrate their genome into the host DNA as a necessary step 
of their replication cycle. Normally, retroviruses integrate into somatic cells and 
are transmitted, from infected to uninfected hosts, as “exogenous” retroviruses. 
On rare occasions, they can infect germ line cells and become part of the host 
genome as “endogenous” retroviruses (ERVs), which are transmitted vertically to 
the offspring and inherited as Mendelian genes. During evolution, most ERVs 
have accumulated mutations that rendered them defective and unable to 
produce infectious viral particles. Some ERVs, however, have maintained intact 
open reading frames for some of their genes, and have been co-opted by the 
host as they fulfil  important biological functions. Sheep betaretroviruses 
represent a unique model to study the complex evolutionary interplay between 
host and pathogen in natural settings. In infected sheep, the exogenous and 
pathogenic Jaagsiekte sheep retrovirus (JSRV) co-exists with the highly related 
endogenous JSRVs (enJSRVs). The sheep genome harbours at least twenty-seven 
enJSRV loci and, most likely, the process of endogenization is still occurring. 
During evolution, one of these enJSRV loci, enJS56A1, has acquired a defective 
and transdominant Gag polyprotein that blocks the late replication steps of 
related retroviruses, by a mechanism known as JSRV late restriction (JLR). 
Interestingly, enJSRV-26, a provirus that integrated in the sheep germ line less 
than two hundred years ago, possesses the unique ability to escape JLR. In this 
thesis, the molecular basis of JLR escape was investigated. The main 
determinant  of  JLR  escape  was identified in the signal peptide of enJSRV-26 
envelope protein (SP26). A single amino acid substitution in SP26 was found to 
be responsible for altering its intracellular localization as well as its function as 
a  post-transcriptional regulator of viral gene expression. Interestingly, 
interference assays demonstrated that enJSRV-26 relies on the presence of the 
functional signal peptide of enJS56A1 envelope protein (SP56) in order to escape 
JLR. In addition, the ratio between enJSRV-26 and enJS56A1 Gag polyproteins 
was found to be critical to elude JLR. Finally, sequence analyses revealed that 
the domestic sheep has acquired, by genome amplification, several copies of the 
enJS56A1 provirus, reinforcing the hypothesis that this locus has provided an 
evolutionary advantage to the host. This study unveils critical aspects of JLR 
that were previously unknown,  and provides new insights on the molecular 3 
mechanisms governing the interplay between endogenous and exogenous sheep 
betaretroviruses. 4 
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1.1 Historic perspectives 
The dawn of retrovirology dates back to the beginning of the 20th century, 
when Henri Vallée and Henri Carré showed that equine anaemia was transmitted 
by a «filterable agent» (Vallée and Carré, 1904), now known as equine 
infectious anaemia virus (EIAV). Few years later, Vilhelm Ellermann and Oluf 
Bang reported that chicken leucosis  was transmitted by cell-free filtrates 
(Ellermann and Bang, 1908), and Peyton Rous obtained similar results while 
studying a solid tumour (sarcoma) of chicken in 1911 (Rous, 1911). We now 
know that the etiological agent discovered by Ellerman and Bang was the avian 
leucosis virus (ALV), while the virus isolated by Rous bears today his name (i.e., 
Rous sarcoma virus, RSV) (Vogt PK, 1997). 
For many years, the scientific community did not show great interest for 
retroviruses, due to their apparent irrelevance to mammals. Moreover, the lack 
of reliable cell cultures and biochemical techniques rendered the study of 
“filterable agents”  quite inaccurate, costly and time-consuming. These 
attitudes began to  shift when John Bittner (Bittner, 1936) and Ludwik Gross 
(Gross, 1951) expanded the retroviral paradigm to mammalian hosts, by 
demonstrating that retroviruses can cause neoplastic disease in mice. 
Furthermore, the development of quantitative assays to measure viral 
infectivity by Howard Temin and Harry Rubin (Temin and Rubin, 1958) greatly 
facilitated virological studies. 
In 1970, Howard Temin and David Baltimore independently discovered the 
reverse transcriptase (Baltimore, 1970; Temin and Mizutani, 1970), for which 
they were awarded the Nobel Prize in 1975. This finding gave the field its first 
real molecular tool for the sensitive detection of retroviruses, that were named 
after this discovery “retraviruses” (for reverse transcriptase containing viruses) 
(Dalton et al., 1974). It was only later, and for reasons of linguistic fluidity, that 
they gained their actual name. 
The discovery of the reverse transcriptase was also critical to validate the «DNA 
provirus hypothesis» formulated by Howard Temin in 1960s, which postulated 
that retroviruses integrate into the DNA of somatic cells (Temin, 1964). 
However, the notion that retroviruses could also integrate into the host germ Chapter 1                                                                                                                                          21 
line, and be inherited as Mendelian genes, was still regarded as bizarre. In the 
late  1960s and early 1970s, ALV, murine leukaemia  virus (MLV) and murine 
mammary tumour virus (MMTV) were found endogenous in the genome of their 
hosts (Huebner and Todaro, 1969; Payne and Chubb, 1968; Varmus et al., 1972; 
Weiss and Payne, 1971), while the first description of human endogenous 
retroviruses (HERVs) was reported in 1970s (Kalter et al., 1973). Today, we 
know that retroviral genome invasions have occurred throughout the evolution 
of vertebrates (Jern and Coffin, 2008) and continue to the present day (Arnaud 
et al., 2007a; Tarlinton et al., 2006). 
The realization that retroviruses were involved in oncogenesis in chickens, mice, 
cats (Jarrett et al., 1964a; Jarrett et al., 1964b) and non-human primates 
(Kawakami et al., 1972; Theilen et al., 1971) led to postulate that they might 
have been generally involved in tumorigenesis. This, in turn, generated 
extensive efforts to identify analogous human viruses that resulted in the 
isolation of human T-cell leukaemia virus (HTLV) and human immunodeficiency 
virus (HIV) in 1980s (Barré-Sinoussi et al., 1983; Poiesz et al., 1980). These 
discoveries galvanized widespread interest in retroviruses, and provided broader 
insights into several aspects of cellular and molecular biology, including gene 
regulation, cell growth and immune response. 
Over the past decades, scientists have been attracted by retroviruses as 
important pathogens in humans and animals, and powerful models to study many 
aspects of both normal and cancer cells. Despite the extraordinary productivity 
of retrovirology in recent years, questions seem larger and more numerous than 
ever. The major outlines of the retroviral replication cycle are firmly drawn, but 
mechanisms of key events, such as viral persistence, are just now coming into 
view. Important human pathogens have been identified among retroviruses, but 
strategies for prevention and cure are still desperately needed, and have 
assumed a greater urgency because of the acquired immunodeficiency syndrome 
(AIDS) pandemic. 
1.2 Retroviral taxonomy 
Retroviruses belong to the unique family of Retroviridae, which uses the virally 
encoded reverse transcriptase (RT) to replicate viral genomic RNA (vRNA) into a Chapter 1                                                                                                                                          22 
double-stranded DNA intermediate (cDNA). Retroviruses have been shown to 
infect many vertebrates species, including fish, birds, reptiles and mammals, 
and cause a wide variety of diseases, such as cancers (leukaemias, mammary 
carcinomas), immunodeficiencies and arthritis (Vogt PK, 1997). An interesting 
exception is represented by members of the genus Spumavirus, which can 
persistently infect wild non-human primates, felines, bovines, equines and small 
ruminants, with no apparent pathological consequences (Murray et al., 2008). 
Retroviruses were originally classified into four groups, named A-type through D-
type, according to the morphology and the position of the nucleocapsid core 
observed by electron microscopy. A-type viruses were defined as non-enveloped 
cytoplasmic particles, with an electron-lucent centre and one or two concentric 
electron-dense rings, thereby overall resembling a doughnut. This term is now 
used to refer to immature particles, such as intracytoplasmic particles formed 
by some retrotransposons (intracisternal A-type particles, IAPs). B-type viruses, 
such as Jaagsiekte sheep retrovirus (JSRV) and MMTV, display a round and 
eccentrically positioned core. Conversely, C-type viruses contain a central and 
spherical inner core, with ALV being the prototype. Finally, D-type viruses, 
including Mason-Pfizer monkey virus (M-PMV), have a bar-shaped core (Vogt VM, 
1997). Recently, retroviruses have been re-classified by the International 
Committee on Taxonomy of Viruses into two subfamilies, the Orthoretrovirinae 
and Spumaretrovirinae
2
Table 1│ Classification of Retroviruses. 
, and seven genera (Table 1). 
Subfamily  Genus  Prototype virus  Genome  Morphology 
Orthoretrovirinae 
Alpharetrovirus  Avian leucosis virus 
(ALV)  Simple  C-type 
Betaretrovirus  Mouse mammary 
tumour virus (MMTV)  Simple  B-type 
D-type 
Gammaretrovirus  Murine leukaemia virus 
(MLV)  Simple  C-type 
Deltaretrovirus  Bovine leukaemia virus 
(BLV)  Complex  C-type 
Epsilonretrovirus  Walleye dermal 
sarcoma virus (WDSV)  Simple  C-type 
Lentivirus 
Human 
immunodeficiency virus 
1 (HIV-1) 
Complex  C-type 
Spumaretrovirinae  Spumavirus  Human foamy virus 
(HFV)  Complex  D-type 
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All retroviruses share a similar genetic organization consisting of four open 
reading frames, including gag,  pro,  pol  and  env. These genes are normally 
translated as polyprotein precursors, and subsequently processed by viral or 
cellular proteases to yield, respectively, internal structural proteins, enzymes, 
and envelope glycoproteins. Some retroviruses, such as JSRV and M-PMV, contain 
only the four open reading frames mentioned above and are therefore termed 
“simple” retroviruses. Conversely, other retroviruses express several genes that 
encode regulatory and accessory proteins, required for  efficient viral 
replication, nuclear export, transmission and evasion from innate and acquired 
immunity. These retroviruses that include, among others, lentiviruses and foamy 
viruses (FVs), are thus referred to as “complex” retroviruses (Vogt PK, 1997). 
1.3 Exogenous and endogenous retroviruses 
Normally, retroviruses infect host somatic cells, passing horizontally from an 
infected to an uninfected organism as exogenous retroviruses. Occasionally, 
retroviruses can infect germ cells, thus leading to integrated proviruses 
(“endogenous retroviruses”, ERVs), which are transmitted vertically to the 
offspring and inherited as Mendelian genes (Jern and Coffin, 2008). Until 
recently, it was believed that only simple retroviruses could become endogenous 
in their host (Weiss, 2006). However, the recent identification of endogenous 
lentiviruses in the genome of European rabbits (termed RELIK, for rabbit 
endogenous lentivirus type K) (Katzourakis et al., 2007) and gray mouse lemurs 
(Gifford et al., 2008), together with the identification of  endogenous 
retroviruses related to spumaviruses (HERV) (Kalter et al., 1973; Ono et al., 
1986) and deltaviruses (HTLV type I-related endogenous sequences, HRES) (Perl 
et al., 1989) in humans, has extended this paradigm to all the members of the 
Retroviridae family. 
Currently, there is no standardised nomenclature for ERVs. HERVs have been 
classified on the basis of cellular tRNA usage. For example, members of HERV-K 
group possess a primer binding site (pbs) complementary to a lysine
3
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-tRNA 
(Larsson et al., 1989). However, this method of classification does not faithfully 
represent phylogenetic relatedness, as often HERVs belonging to the same group 
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phylogenetic analysis of the Pol polyprotein has proved to be a more useful 
criterion to classify ERVs, which have been thus divided into three groups: class 
I, II and III ERVs. Class I ERVs are related to gammaretroviruses, class II to 
betaretroviruses and class III to alpharetroviruses (Jern et al., 2005). 
ERVs share the same genetic structure and organization of their exogenous 
counterparts. In general, “modern” ERVs exist both as endogenous and 
exogenous viruses. On the other hand, “ancient” ERVs do not possess any 
exogenous counterpart, leading to the hypothesis that the process of 
endogenization is one of the steps that contributes to the extinction of 
horizontally transmitted infectious retroviruses (Denner, 2010). 
The exact mechanisms underlying the expansion of ERVs within the host genome 
(i.e., the copy number variation) and  the host population remain still poorly 
understood. From a genetic point of view, ERVs are “retrotransposons” with long 
terminal repeats (LTRs) at each end of their genome. ERVs, together with DNA 
transposons, long interspersed nucleotide elements (LINEs) and short 
interspersed nucleotide elements (SINEs), belong to the group of transposable 
elements, firstly discovered in 1950 by Barbara McClintock (McClintock, 1950) 
(Fig. 1). Chapter 1                                                                                                                                          25 
 
Figure  1│  Schematic representation of transposable elements.  A/B, A-  and B-box Pol III 
promoter; An, poly(A); C, zinc knuckle domain; DR, direct repeat; EN, endonuclease; IN, integrase; 
ITR, inverted terminal repeat; LM, left monomer; LTR, long terminal repeat; RT, reverse 
transcriptase; TSD, target site duplication. Figure adapted from (Goodier and Kazazian, 2008). 
By definition, retrotransposons move from one genomic location to another one 
in a “copy and paste” manner, which involves reverse transcription of an RNA 
intermediate and insertion of its cDNA copy at the new genomic site (Goodier 
and Kazazian, 2008). It is therefore possible that ERVs may amplify and then 
“jump” from one locus to another one  within a host germ cell. This 
“intracellular spread” is the mechanism adopted by murine IAPs, which originally 
derived from retroviruses but lack the env gene, and are therefore unable to 
give rise to infectious particles (Maksakova et al., 2006). Alternatively, ERVs may 
form viral particles that can essentially act as exogenous retroviruses and re-
infect the host germ line, spreading in this way across the host population and, 
occasionally, across species. Most ERVs have amplified probably using both 
mechanisms, giving rise to infectious viral particles that can infect the host 
genome and, perhaps, the germ line of the host population, but rarely crossing 
the species barrier (Jern and Coffin, 2008). Chapter 1                                                                                                                                          26 
 
Figure 2│ DNA recombination events involving ERVs. See text for details. Boxes indicate LTR, 
while  black and coloured  lines represent proviral and cellular sequences,  respectively.  Figure 
adapted from (Stoye, 2001). 
ERVs display a significant tendency to recombine, through different mechanisms. 
Homologous recombination between the flanking LTRs of a provirus results in the 
excision of proviral DNA, with consequent formation of “solo LTR” (Fig. 2A). For 
most ERVs, this relic structure represents  the only remnant of their cognate 
ancestral proviruses embedded in the host genome. Usually, solo LTRs form soon 
after proviral integration, probably due to the higher recombination rate 
between identical flanking LTRs that have not accumulated mutations (Belshaw 
et al., 2007). Similarly, homologous recombination between two proviruses 
located on the same chromosome leads to significant deletions of both proviral 
and genetic sequence, with consequent rearrangements of the latter (Fig. 2B). 
Recombination between the 3' and 5' LTRs of allelic proviruses leads to a tandem 
provirus sharing, in the middle, a single LTR on one chromatid, and a solo LTR on 
the other (Fig. 2C). Homologous recombination between proviruses located on 
the same chromosomes or on different ones can also give rise to nonreciprocal 
exchange  without loss of proviral sequences. This process known as “gene 
conversion” leads to the exchange of all or part of one proviral sequence to that 
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1.4 Genetic organization of the retroviral genomic RNA 
Retroviruses are enveloped viruses that package two copies of positive single-
stranded RNA molecules,  consisting of four open reading frames flanked by 
repeated (R) and unique (U) sequences that form the untranslated regions 
(UTRs). The retroviral genome contains also a polypurine tract (PPT), located 
just upstream of the 3'UTR, that serves as a primer for the synthesis of the plus-
strand DNA during reverse transcription (see paragraph 1.6.2). The open reading 
frames are always organised in the same order: gag, pro, pol and env. Complex 
retroviruses possess also other genes, located downstream of pol and/or env, 
that encode for accessory and regulatory proteins, critical for viral replication 
and to counteract host defences  (e.g., HIV-1 Tat, Vif, Vpr and Vpu; HTLV Tax 
and FV Tas) (Bannert et al., 2010) (Fig. 3). 
 
Figure 3│ Genetic organization of a typical retrovirus. The proviral DNA (top) is characterized 
by the presence of a long terminal repeat (LTR) sequence at each end of the genome, abutting 
cellular sequences (in purple). Accessory genes are usually  located as shown. The primary 
transcript (middle) is a single-stranded RNA molecule that serves both as viral  genomic RNA 
(vRNA) and mRNA for Gag, Pro and Pol proteins. The Env protein, on the other hand, is generated 
by a double splicing event (bottom). AAA, poly(A) tail; PA, polyadenylation signal; pbs, primer-
binding site; PPT, polypurine tract; R, repeat sequence; SA, splice acceptor site; SD splice donor 
site;  U3,  3'  unique  sequence;  U5,  5'  unique  sequence;  UTR,  untranslated  region;  ψ  (Psi), 
packaging signal. Figure adapted from (Gifford and Tristem, 2003). 
In retroviruses, the unspliced RNA serves both as a template for viral proteins 
translation and source of vRNA that is packaged into assembling virions. As such, 
both RNA species share identical genetic organization (D'Souza and Summers, 
2005). In addition, as they are both transcribed by the host RNA polymerase II, 
they undergo the same post-translational modifications as those of eukaryotic Chapter 1                                                                                                                                          28 
mRNAs, including the 5' cap structure and poly(A) tail
4
Both 5'UTR and 3'UTR harbour cis-acting RNA motifs that are involved in several 
aspects of the retroviral replication cycle. The 5'UTR contains (i) a poly-
adenylation stem loop, which is responsible for the addition of the 3' poly (A) 
tail, (ii) the pbs, where the cellular tRNA is recruited for the initiation of the 
reverse transcription, (iii) a dimerization initiation site (DIS), which is involved in 
the formation of the kissing-loop complex between two vRNAs during packaging, 
(iv) a major splice donor (SD), used for the production of viral subgenomic 
mRNAs, and finally (v) a core packaging signal (Psi, Ψ), which selects and directs 
the vRNA to the viral assembly machinery. Conversely, the 3'UTR is 
characterized by the presence of RNA motifs that control the termination of 
transcription, including an upstream enhancer element (USE), essential for 
efficient polyadenylation, and a poly(A) signal site (Balvay et al., 2007; Bannert 
et al., 2010). 
 (Balvay et al., 2007) (Fig. 
3). 
1.5 Virion structure and viral proteins 
Retroviral virions contain two copies of single-stranded vRNA molecules, the Gag 
polyprotein, the viral enzymes encoded by pro  and  pol, cellular RNAs and 
cellular proteins, such as cyclophilin A (CypA) and apolipoprotein B mRNA-
editing catalytic enzyme 3 (APOBEC3) (Onafuwa-Nuga et al., 2006; Strebel et 
al., 2009). 
Upon release, retroviral particles display an “immature” morphology, 
characterized by an electron-lucent centre, doughnut-shaped. The proteolytic 
cleavage of the Gag and Gag-Pol polyprotein precursors initiates a series of 
structural rearrangements that ultimately lead to a “mature” virion, containing 
an electron-dense core. This process is mediated by  the viral protease (PR) 
encoded by pro, during a process referred to as “maturation” (Swanstrom and 
Wills, 1997). 
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Gag is the internal structural protein of all retroviruses, which shapes viral 
capsid and associates with the vRNA to form viral core. In orthoretroviruses, the 
Gag polyprotein is processed into at least three mature proteins: nucleocapsid 
(NC), capsid (CA) and matrix (MA) (Fig. 4). In addition, some retroviruses, such 
as HIV-1 and RSV, possess spacer peptides between MA and CA, and CA and NC, 
which have been proposed to influence some steps of viral assembly and particle 
release. In spumaviruses, by contrast, Gag is not processed in the canonical NC, 
CA and MA domains, and thus, after release, the extracellular virions retain an 
“immature” morphology (Bannert et al., 2010). 
 
Figure  4│  Schematic cartoon of a typical retroviral  virion.  CA, capsid; IN, integrase; MA, 
matrix; NC, nucleocapsid; PR, protease; RT, reverse transcriptase; SU, surface; TM, 
transmembrane. Figure adapted from (Vogt VM, 1997). 
The viral membrane derives from the host cell membrane and is decorated with 
glycoprotein spikes, encoded by the env gene, that mediate the attachment and 
entry into target cells. Env is the only viral protein localized on the surface of 
infected cells and viral particles, and is the main determinant of viral tropism. 
Soon after translation from a spliced transcript, the Env precursor protein 
undergoes co- and post-translational modifications in the endoplasmic reticulum 
(ER) and Golgi complex, including processing and glycosylation. The proteolytical 
cleavage is mediated by cellular proteases, and gives rise to two functionally 
distinct proteins: the surface (SU), which contains the receptor binding domain, 
and transmembrane (TM), which mediates the early events of fusion between 
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Finally, pro and pol encode, respectively, the protease (PR), and the reverse 
transcriptase (RT) and integrase (IN) enzymes (Fig. 4). As mentioned above, PR is 
responsible for the proteolytical cleavage of Gag, Gag-Pro and Gag-Pro-Pol 
polyprotein precursors. In this process, PR firstly cleaves itself out and then 
processes the remaining viral polyproteins. RT and IN are respectively involved 
in the reverse transcription and integration of vRNA into the host chromosomes. 
In orthoretroviruses, Pro and Pol proteins are synthesized by RNA frameshifting 
or termination codon read-through from the Gag-Pro and/or Gag-Pro-Pol 
polyprotein precursors. The first process depends on the presence of “slippery” 
(i.e., repeated) sequences and stable RNA secondary structures (RNA 
pseudoknots) that cause a change in the reading frame. Termination codon read-
through is due to the misreading of a stop codon that results in the translation of 
the downstream gene. By contrast, in spumaviruses, Pro is translated as a Pro-
Pol mRNA that is proteolytically cleaved into the IN enzyme and the RT-PR 
polyprotein (Bannert et al., 2010; Dunn et al., 2002). 
1.6 Retroviral replication cycle 
Retroviruses replicate through a complex cycle that includes a double-stranded 
DNA intermediate and can be divided into two overall phases, referred to as 
“early” and “late” steps (Freed, 2001) (Fig.  5). Although some events occur 
simultaneously, for simplicity they will be described here as ordered step-wise 
processes, including: 
I.  Cell entry 
II.  Uncoating and reverse transcription 
III.  Nuclear entry and integration 
IV.  Transcription, processing and nuclear export 
V.  Translation of viral proteins 
VI.  Genome packaging, assembly and budding 
VII.  Release and maturation Chapter 1                                                                                                                                          31 
 
Figure 5│ Schematic representation of the replication cycle of a typical orthoretrovirus. See 
text for details. CA, capsid; cDNA, complementary  DNA;  DLS,  dimer-linkage structure;  IN, 
integrase; MA, matrix; NC, nucleocapsid; PIC, pre-integration complex; RT, reverse transcriptase; 
RTC, reverse transcription complex; vRNA, viral genomic RNA (unspliced). Figure adapted from 
(D'Souza and Summers, 2005). 
1.6.1 Cell entry 
Retroviral entry is a multistep process that involves an initial attachment of the 
viral particle to the host cell, followed by receptor binding and membrane fusion 
(Fig. 5). Free extracellular virions attach to host target cells “brushing” the cell 
surface till they snag-on their cognate receptor. The initial attachment of viral 
particles can be facilitated by nonspecific interactions with surface proteins of 
the host cell membrane; however, viruses are taken-up into target cells only 
after binding to specific receptors on the cell surface (Mothes and Uchil, 2010) 
that determine viral tropism (Hunter, 1997). Engagement of the cellular 
receptor triggers conformational changes in the viral Env glycoprotein, which 
drives the fusion between viral and cellular membrane (Melikyan, 2008) (Fig. 5). 
In some retroviruses, such as HIV-1, membranes fusion is activated only upon the 
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al., 2000), MMTV (Redmond et al., 1984; Ross et al., 2002) and JSRV (Bertrand et 
al., 2008; Côté  et al., 2008), require the presence of a cellular  receptor 
followed by exposure to low pH in order to enter target cells. In particular, for 
JSRV it has been recently proposed that the binding to its entry receptor Hyal2
5
1.6.2 Uncoating and reverse transcription 
 
(Rai et al., 2001; Spencer et al., 2003) activates the SU domain of Env which, in 
turn, dissociates from the TM and inserts into the plasma membrane. 
Subsequently, a low PH triggers conformational changes in the TM that lead to 
membranes fusion (Côté et al., 2009). 
Upon membranes fusion, the viral core is propelled into the target cell, exposing 
to the cytoplasm the vRNA, the NC protein and viral enzymes. At some point 
after fusion and before integration into the host chromosomal DNA, viral capsids 
disassemble through a process referred to as “uncoating” and vRNA is reverse 
transcribed into cDNA (Fig.  5). The process of retroviral uncoating is poorly 
understood. It is believed that it depends on specific cellular factors and 
adenosine triphosphate (ATP) molecules (Narayan and Young, 2004), which re-
organize the core leading to the formation of a reverse transcription complex 
(RTC), where synthesis of viral cDNA takes place (Basu et al., 2008; Telesnitsky 
and Goff, 1997). 
In orthoretroviruses, the temporal sequence of the events immediately following 
viral entry is still a matter of debate and, at present, three main models have 
been proposed. The first one postulates that viral capsids uncoat gradually after 
viral entry and remain intact at least for the initiation of reverse transcription. 
Support for this model comes from the observation that mutant HIV capsids with 
altered stability are impaired in reverse transcription (Forshey  et al., 2002). 
Conversely, the second model suggests that uncoating occurs at the nuclear pore 
upon completion of reverse transcription. In support of this hypothesis, there are 
studies showing that, in absence of viral cDNA, HIV-1 cannot translocate to the 
nucleus to start the process of integration into the host genome (Arhel et al., 
2007). In addition, it seems that reverse transcription can efficiently occur only 
in intact viral capsids, as they ensure the correct stoichiometry between vRNA 
and viral enzymes that would otherwise dissociate in the cytoplasm. Finally, a 
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recent study supports a third model, whereby uncoating occurs as the reverse 
transcribing viral genome is transported towards the nucleus, suggesting that 
there may be an interplay between these two events  (Hulme et al., 2011). 
Interestingly,  spumaviruses  display a “biphasic DNA synthesis” (Delelis et al., 
2003), whereby early reverse transcription occurs during transport towards the 
nucleus, while late  reverse transcription can take place before viral budding 
from infected cells, thus causing  frequent intracellular re-integrations 
(Rethwilm, 2010). 
During reverse transcription, the single-stranded positive vRNA molecule is 
converted into double-stranded viral cDNA by the retroviral RT enzyme. This is 
an RNA/DNA-dependent DNA polymerase with an associated RNase H activity 
that specifically degrades the RNA component of RNA/DNA hybrids. In MLV and 
MMTV, the RT enzyme functions as a monomeric polypeptide and couples both 
polymerase and RNase H activities; the lentiviral enzyme, by contrast, is an 
obligate dimer (Engelman, 2010; Herschhorn and Hizi, 2010). Reverse 
transcription is controlled  by the NC domain of Gag, which  drives critical 
structural rearrangements of the vRNA due to its nucleic acid condensing and 
chaperoning activities (Muriaux and Darlix, 2010). 
Reverse transcription (Fig. 6) begins with the annealing of a cellular tRNA to 
complementary sequences in the viral pbs.  Extension of the nascent minus-
strand to the 5' end of the vRNA yields to the minus-strand strong-stop DNA, 
which includes the R and U5 sequences (Fig. 6A). This step is followed by a first 
strand transfer that allows annealing of the minus-strand strong-stop DNA to the 
3' end of the vRNA (Fig. 6B). Subsequently, minus-strand DNA synthesis resumes 
and it is accompanied by RNase H degradation of the RNA template (Fig. 6C). 
The PPT resists RNA digestion and serves as a primer for the plus-strand DNA 
synthesis towards the 5' end of the minus-strand DNA. The plus-strand DNA is 
extended until the RT encounters the tRNA primer to form the plus-strand 
strong-stop DNA (Fig. 6D). At this point, the RNase H removes the tRNA and the 
PPT and a second strand transfer occurs, resulting in the annealing of the pbs of 
both DNA strands (Fig. 6E). These DNA strands are then further extended, 
yielding to a linear double-stranded DNA that contains a copy of U3-R-U5 
sequence at each end, known as LTRs (Herschhorn and Hizi, 2010) (Fig. 6F). Chapter 1                                                                                                                                          34 
 
Figure 6│ Reverse transcription. See text for details. Dashed line represents degraded vRNA by 
RNase H, while white and blue dots stand for primers for cDNA synthesis. In brackets, symbols (-) 
and (+) indicate  the polarity of nucleic acid molecules. cDNA, complementary DNA; LTR, long 
terminal repeat; pbs, primer-binding site; PPT, polypurine tract; R, repeat sequence; U3, 3' unique 
sequence; U5, 5' unique sequence; vRNA, viral RNA. In black, vRNA template; in red, minus-
strand cDNA; in green, plus-strand cDNA. Figure adapted from (Sarafianos et al., 2001). 
Lentiviruses and spumaviruses contain an additional PPT, known as the central 
PPT (cPPT), which functions as a second origin of plus-strand DNA synthesis. As a 
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synthesized viral genome, referred to as “central DNA flap”, which may be 
involved in nuclear entry (Engelman, 2010; Stevenson, 2000; Zennou et al., 
2000). 
1.6.3 Nuclear entry and integration 
Once in the cytoplasm, the RTC starts to move towards the nucleus maturing 
into a pre-integration complex (PIC) (Fig.  5). This is a large nucleoprotein 
complex that contains the newly synthesized viral cDNA associated with viral and 
cellular proteins (Suzuki and Craigie, 2007). One of the key components of the 
PIC is the viral IN enzyme, which accomplishes the integration of the viral cDNA 
into the host chromosome by processing its 3' ends and mediating DNA strand 
transfer. During the 3' processing, IN hydrolyses each cDNA adjacent to the 
conserved CA/GT sequence. This reaction occurs in the cytoplasm and generates 
3'-OH groups at the recessed 3' ends  that  are subsequently used by IN to 
hydrolyse the host target DNA backbone once it gains access to the nucleus (Li et 
al., 2011). In spumaviruses, by contrast, the 3' processing is catalyzed by the 
viral RT enzyme (Juretzek et al., 2004). 
Retroviruses, with the exception of lentiviruses, display marked preferences for 
infecting dividing cells  versus  growth-arrested cells that are nonetheless 
metabolically active. Lentiviral PICs are actively transported into the nuclei of 
non-dividing primary cells and growth-arrested cell lines (Lewis et al., 1992; 
Weinberg et al., 1991). The molecular mechanism underlying this process is still 
poorly understood. Several reports demonstrate that viral (MA, Vpr, IN, CA) and 
cellular components (the lens-epithelium-derived growth factor LEDGF/p75, 
members of the importin-α protein family, tRNA species), as well as viral cDNA 
structures (i.e., DNA flap), may exert karyophilic activities and promote nuclear 
import. However, the contribution of each component to this process has not 
always been conclusively defined (Arhel et al., 2007; Riviere et al., 2010; Suzuki 
and Craigie, 2007). Other retroviruses, such as MLV (Harel et al., 1981) and JSRV 
(Murgia et al., 2011), by contrast, require cells to be actively cycling, in order to 
take advantage of the nuclear membrane dissolution during cell division, thus 
gaining access to the nucleus. Finally, spumaviruses RTCs display high affinity for 
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infected cell is stimulated to divide; upon cell activation, viral disassembly takes 
place and infection proceeds (Bieniasz et al., 1995; Lehmann-Che et al., 2007). 
Following entry into the nucleus, IN engages the viral cDNA as a tetramer and 
inserts the recessed 3' ends of the molecule into the host genome. Subsequently, 
cellular enzymes fill-in the resulting single-stranded gaps and 5' overhangs, 
which initially flank integrated viral cDNA, to finally give rise to a stably 
integrated provirus (Cherepanov et al., 2011). 
Retroviral integration occurs basically in a random fashion throughout the whole 
genome. However, different retroviruses show predilection for different  host 
DNA sites. Lentiviruses, for instance, preferentially integrate into transcription 
units of active genes (Schroder et al., 2002), while MLV and spumaviruses target 
primarily CpG
6
1.6.4 Transcription, processing and nuclear export 
 islands (Lewinski et al., 2006; Trobridge et al., 2006). 
In the proviral phase, retroviruses rely almost entirely on the cellular machinery 
for gene expression. For this reason, besides encoding for a limited number of 
proteins, retroviral genomes also contain cis-acting sequences, in the viral LTRs, 
to maximize gene expression by host cell machinery. In particular, the U3 region 
of the 5'LTR contains cis-acting control elements that regulate transcriptional 
initiation by the cellular RNA polymerase II (Rabson and Graves, 1997). Complex 
retroviruses,  such as HIV, HTLV and spumaviruses,  encode their own 
transcriptional activators (Tat, Tax and Tas, respectively) that enhance viral 
expression by acting in concert with cellular factors (Nicot et al., 2005; Purcell 
and Martin, 1993). The U3, R, and U5 regions of the 3'LTR, on the other hand, 
include  cis-acting control elements involved in the post-transcriptional 
processing that occurs at the 3' end of viral RNA transcripts (Rabson and Graves, 
1997). 
Retroviral transcription generates two mRNAs species, one that undergoes RNA 
splicing (single or multiple) and the other that remains unspliced and can be 
translated and/or packaged as vRNA into assembling virions (Fig.  3). In 
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orthoretroviruses, Gag, Gag-Pro and Gag-Pro-Pol polyprotein precursors derive 
from unspliced transcripts (Goff, 2007), whereas in spumaviruses Pol is 
synthesized from a separate mRNA  (Enssle et al., 1996). The Env precursor 
derives from a single RNA splicing event that joins sequences upstream of the 
donor splice site in the 5'UTR and downstream of the acceptor splice site in pol, 
to eliminate gag, pro and pol genes (Swanstrom and Wills, 1997) (Fig. 3). Finally, 
complex retroviruses such as HIV-1, MMTV and HTLV, possess a third class of 
mRNAs that is generated by multiple splicing events and encode regulatory and 
accessory proteins (Bolinger and Boris-Lawrie, 2009). 
Retroviral RNA splicing depends on cellular factors, which normally retain intron-
containing transcripts  in the nucleus. To overcome nuclear sequestration, 
retroviruses have evolved two elegant strategies to export their intron-
containing mRNAs in the cytoplasm: the Crm1
7 and Tap
8
All known lentiviruses, as well as the human oncoretrovirus HTLV, employ the 
cellular protein Crm1 to export their unspliced and incompletely spliced RNAs in 
the cytoplasm of infected cells (Pollard and Malim, 1998). Crm1 is a member of 
the karyopherin β family of transport receptors that normally mediates nuclear 
export of small nuclear RNAs (snRNAs), ribosomal RNAs (rRNAs) and a small 
subset of cellular mRNAs (Weis, 2003). The Crm1 pathway is typified by the Rev 
transactivator protein of HIV-1, which is translated from the fully spliced viral 
mRNA and is thereby constitutively exported in the cytoplasm. Rev selectively 
 pathways (Cochrane et 
al., 2006) (Fig. 5). Simple retroviruses, such as M-PMV (Bray et al., 1994) and 
RSV (Ogert et al., 1996), recruit the Tap pathway, which is normally used for 
nuclear export of cellular mRNAs. Other viruses, such as influenza, hepatitis B 
and herpes simplex, were shown to employ the same nuclear export mechanism 
(Fontoura et al., 2005). This pathway involves a constitutive transport element 
(CTE) located in the 3'UTR of the viral RNA that interacts specifically with the 
cellular heterodimer Tap/p15 and mediates nuclear export (Li et al., 2006; 
Wiegand et al., 2002). 
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interacts with a cis-acting RNA stem-loop structure, the Rev-responsive element 
(RRE), located at the 3' end of unspliced and incompletely spliced viral 
transcripts  (Felber et al., 1989; Malim et al., 1989). Multiple domains are 
required for Rev to function, including an arginine-rich motif (ARM) and a 
leucine-rich sequence, situated, respectively, at the N-terminal and C-terminal 
portions of the protein. The ARM domain contains a nuclear/nucleolar 
localization signal (NLS/NoLS) and binds to the major groove of the RRE. The 
leucine-rich domain harbours a nuclear export signal (NES) that binds to the 
cellular protein Crm1, in a Ran-GTP manner
9
Interestingly, recent studies indicate that some retroviruses employ other export 
pathways to circumvent the nuclear retention of their unspliced transcripts that 
seem to share common features to both Crm1 and Tap mechanisms. Along this 
line, it has been recently reported that spumaviruses utilize a Crm1-dependent 
pathway that does not require any trans-acting viral regulatory protein, but 
putative CTE-like RNA secondary structures that respond to cellular HuR proteins 
(Bodem et al., 2011). Another study suggests that export of unspliced 
spumaviruses RNAs may rely on an additional and complementary mechanism 
based on Gag-RNA interactions (Renault et al., 2011). In MLV infected cells, by 
contrast, nuclear export of unspliced vRNAs depends on the presence of CTE-like 
stem-loop structures within the ψ sequence (Basyuk et al., 2005). Finally, MMTV 
(Byun et al., 2010) and JSRV (Caporale et al., 2009; Hofacre et al., 2009; Nitta 
et al., 2009) recruit a Crm1-dependent pathway that functions in presence of 
the signal peptide (SP) of their Env glycoproteins. 
. Upon interaction with components 
of the nuclear pore, the Rev-RRE/Crm1/Ran-GTP complex reaches the 
cytoplasm, where Ran-GTP is converted into Ran-GDP and the ternary complex 
disassembles (Askjaer et al., 1998; Fornerod et al., 1997). Subsequently, the NLS 
interacts with the transport mediator importin β  and Rev enters the nucleus 
again (Fontoura et al., 2005). 
1.6.4.1  Retroviral signal peptides and export of viral unspliced RNAs 
In eukaryotes, SPs target proteins to the ER membrane, which is the entry site 
into the secretory pathways, and mediate insertion into the translocon for 
transport through the lipid bilayer (Paetzel et al., 2002). SPs are generally 
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located at the N-terminal protein extension, but they can also lie within the 
peptide or at its C-terminal end (Kutay et al., 1995). Despite a great diversity in 
terms of sequences, the function of SPs  has been maintained throughout 
evolution, as evidenced by the fact that they can be interchanged between 
different proteins, and even between proteins of different organisms, without 
being affected (Gierasch, 1989; Izard and Kendall, 1994). 
Although SPs are extremely heterogeneous in terms of length and amino acid 
charge, they share a number of conserved features that are essential for protein 
export. These include a core region of seven to fifteen hydrophobic residues (h), 
required for targeting and membrane insertion, a central region (c) of two to 
nine small and polar residues, which determines the site of SP cleavage, and a 
polar region (n), usually positively charged. The n-region contributes most to the 
variation in the overall length of SPs, which can range from fifteen to up to fifty 
amino acid residues (von Heijne, 1985; von Heijne, 1986; von Heijne, 1990). 
Upon insertion into the ER membrane in a loop-like configuration, SPs can be 
cleaved-off by signal peptidases (SPases) on the membrane lumen. A number of 
features of the SP sequence influences the outcome of SPase cleavage, such as 
the steric hindrance and charge of amino acid residues located within the 
cleavage site, as well as the length of the h-region and properties of the n-
region. After being cleaved and released from the rest of the protein, SPs can 
undergo proteasomal degradation or be further processed by signal peptide 
peptidases (SPPase) (Paetzel et al., 2002). 
New studies revealed that SPs display additional and important functions beyond 
membrane targeting. Along this line, it has been shown that eukaryotic SPs can 
exert important roles in cellular processes, such as signal-transduction pathways 
(e.g., targeting of calmodulin by the pre-prolactin SP) and cellular immune 
response (e.g., activation of natural killer cells by SP fragments of major 
histocompatibility complex class I molecules) (Paetzel et al., 2002). However, 
most examples of post-targeting functions come from viral SPs, including FVs 
where it has been proposed that it plays a key role during viral budding and 
particle release and may also determine viral infectivity (Cartellieri et al., 2005; 
Lindemann et al., 2001; Shaw et al., 2003; Stanke et al., 2005; Wilk et al., 
2001). Conversely, in MMTV (Byun et al., 2010) and JSRV (Caporale et al., 2009; Chapter 1                                                                                                                                          40 
Hofacre et al., 2009; Nitta et al., 2009), SPs are involved in  the export of 
unspliced viral RNAs. 
1.6.4.2  MMTV and the export of unspliced viral RNAs 
Besides the four basic retroviral genes, MMTV encodes also a regulatory protein 
(Rem) that derives from a double splicing event of the viral mRNA (Indik et al., 
2005; Mertz et al., 2005). At the N-terminus, both Rem and Env contain a SP 
sequence (MMTV SP) that exhibits HIV Rev-like activity. MMTV SP possesses 
several Rev-like motifs that are important to exert its function, including NLS, 
ARM and NES domains and the Rem-responsive element (RmRE) located at the 3' 
end of the full-length viral RNAs (Byun et al., 2010). Upon targeting Rem and Env 
to the ER, MMTV SP is cleaved-off by the SPase, retrotranslocates to the 
cytoplasm and enters the nucleus (Byun et al., 2010; Dultz et al., 2008). Here, it 
binds to the full-length viral RNAs through the RmRE (Mertz et al., 2009) and 
export them to the cytoplasm (Byun et al., 2010). 
1.6.4.3  JSRV and the export of unspliced viral RNAs 
Recent results obtained by Marco Caporale and colleagues in our laboratory 
shown that the N-terminal portion of JSRV Env glycoprotein contains a SP 
sequence (JSE-SP) with a HIV Rev-like activity (Fig. 7). Similarly to Rev, JSE-SP 
function depends on multiple domains, including NLS/NoLS, ARM and NES. 
Following cleavage from the Env polyprotein at the ER membrane, JSE-SP enters 
the nucleus, where is targeted to the nucleolus by the NLS/NoLS domain. 
Evidences suggest that nuclear export is achieved through the binding of the 
ARM domain of JSE-SP to the signal peptide responsive element (SPRE), a stem-
loop RNA secondary structure located at the 3' end of viral unspliced RNAs. JSE-
SP acts as a post-transcriptional regulator of viral gene expression, as it 
enhances Gag synthesis and viral particle release (Caporale et al., 2009). 
Experiments conducted by Hofacre, Nitta and colleagues confirmed the presence 
of a trans  acting factor, which  was termed Rej (for regulator of JSRV 
expression), located at the N-terminus of JSRV Env glycoprotein and that 
specifically interacts with its  responsive element Rej-RE (for Rej-responsive 
element) (Hofacre et al., 2009; Nitta et al., 2009). Chapter 1                                                                                                                                          41 
 
Figure  7│  Model of JSE-SP trafficking.  See text for details. ER, endoplasmic reticulum; SP, 
signal peptide; SPRE, signal peptide-responsive element. 
1.6.5 Translation of viral proteins 
Following nuclear export, retroviral proteins are translated on cellular ribosomes 
by the host cell translational machinery in a cap-dependent mechanism. 
However, in order to optimize synthesis of viral mRNAs throughout the 
replication cycle, retroviruses have evolved alternative initiation strategies 
(Bolinger and Boris-Lawrie, 2009). Some retroviruses, such as lentiviruses 
(Berkhout et al., 2011; Herbreteau et al., 2005; Ohlmann et al., 2000), RSV 
(Deffaud and Darlix, 2000b) and MLV (Berlioz and Darlix, 1995; Deffaud and 
Darlix, 2000a; Vagner et al., 1995), make use of internal ribosome entry site 
(IRES) elements (on both 5'UTR and coding regions) to regulate viral expression. 
IRES are defined as RNA domains where ribosomes are recruited in a cap-
independent manner, thus allowing mRNAs translation even during stress 
conditions that normally inhibit the host cell translation machinery (e.g., 
hypoxia, apoptosis, angiogenesis). Additional mechanisms include viral proteins 
that directly bind to secondary structures of the vRNA (e.g., HIV-1 Tat/TAR and 
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(e.g., cleavage of eukaryotic initiation translation factor by retroviral 
proteases), thus overall favouring translation of viral transcripts (Balvay et al., 
2007). 
A second important strategy adopted by retroviruses to increase efficiency of 
viral translation is to synthesize different proteins from a single unspliced RNA 
molecule. For example, in orthoretroviruses, Pro and Pol are produced from the 
same Gag-Pro and/or Gag-Pro-Pol polyprotein precursors by RNA frameshifting 
(e.g., HIV-1, RSV and HTLV) or termination codon read-through (e.g., MLV and 
Feline leukaemia virus, FeLV) (Swanstrom and Wills, 1997). 
1.6.6 Genome packaging, assembly and budding 
Retroviral assembly is a multistep process finely orchestrated by the Gag 
polyprotein, whose various domains play distinct roles during viral 
morphogenesis.  Within the context of the unprocessed polyprotein, MA is 
primarily required for Gag membrane targeting and attachment, CA represents 
the driving force for the assembly of immature particles, while NC mediates the 
packaging of  vRNAs into forming virions  (D'Souza and Summers, 2005).  In 
spumaviruses, by contrast, the Gag polyprotein is not processed in the canonical 
MA, CA and NC domains, and it seems that both Gag and Pol proteins take part 
to viral assembly (Lindemann and Rethwilm, 2011). 
The process starts with the encapsidation of vRNAs into assembling particles. A 
unique feature of the vRNA is that it dimerizes with nearby vRNA molecules via 
“kissing” interactions
10
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  between palindromic stem loops, leading to the 
formation of a dimer-linkage structure (DLS) (Muriaux and Darlix, 2010). 
Retroviral dimeric vRNAs are selectively recruited, from the large pool of 
cellular RNA molecules, by high affinity interactions between the NC domain of 
Gag and the ψ sequence located within the 5'UTR and the 5' end of gag (Johnson 
and Telesnitsky, 2010) (Fig. 3). Subsequent steps in retroviral assembly include 
the oligomerization of a few thousand Gag molecules, through their interaction 
(I) domains around the nucleating core formed by Gag-RNA complex. This 
process is driven by the CA and NC domains of the Gag polyprotein (D'Souza and 
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Retroviruses have been shown to recruit Gag molecules to two different sites for 
productive viral assembly: 
i.  Betaretroviruses (B-type and D-type retroviruses) assemble in the 
cytoplasm,  by forming intracytoplasmic “A-type” particles  that  are 
subsequently transported to the plasma membrane, where Env is 
incorporated during budding (Swanstrom and Wills, 1997). This is also the 
mechanism adopted by spumaviruses (Yu et al., 2006). 
ii.  Alpharetroviruses, gammaretroviruses and lentiviruses (C-type 
retroviruses), on the other hand, recruit Gag polyproteins at the plasma 
membrane, where formation of immature viral particle occurs (Swanstrom 
and Wills, 1997). 
Interestingly, a single amino acid substitution in the MA domain of Gag 
transforms M-PMV (i.e., the prototype of D-type retroviruses) to a C-type 
retrovirus (Rhee and Hunter, 1990), suggesting that these two pathways may 
share common mechanistic processes. 
Plasma membrane targeting is mediated by the MA domain of Gag through the N-
terminal myristoyl group and a cluster of basic amino acids (the so-called M 
domain) that confer specificity to the host cell membrane (Fig.  5) (Hamard-
Peron and Muriaux, 2011). During this process, MA also serves as a specific 
interface between Gag and membrane microdomains, including lipid rafts
11
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enriched with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and cholesterol. 
Two models, not mutually exclusives, have been postulated to explain the 
association between Gag and lipid rafts. In the first one, the interaction 
between the M domains of Gag and PI(4,5)P2 may induce exposure of the N-
terminal myristoyl group, as well as sequestration of other PI(4,5)P2 chains; 
these N-terminal myristate groups-PI(4,5)P2 complexes, in turn, may promote 
Gag multimerization. Alternatively, multiple PI(4,5)P2 chains, associated with a 
Gag cluster, may induce formation of a stable raft-like domain that, in turn, may 
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Several studies demonstrate that Gag possesses late (L) domains that actively 
promote separation of the lipid envelope of the nascent virion from the cell 
surface, by engaging components of cellular budding pathways (Freed, 2004). 
These pathways are topologically similar to the membrane fission events that 
occur during cellular  cytokinesis (Carlton and Martin-Serrano, 2007). The L 
domains directly bind to class E vacuolar proteins sorting (Vps), which 
participate  in  the biogenesis of three distinct endosomal sorting complexes 
required for transport (ESCRT) (Göttlinger and Weissenhorn, 2010). To date, 
three L domains have been characterized: (i) the P(T/S)AP-type, which binds to 
the Tsg101 protein, (ii) the LYPxnL-type,  which  mediates the interaction 
between Tsg101 and its partner ALIX, and (iii) the PPxY-type, which promotes 
binding of proteins containing tryptophan-tryptophan (WW) domains to Nedd4-
related E3 ubiquitin ligases (Göttlinger and Weissenhorn, 2010). 
Orthoretroviruses and spumaretroviruses differ also in this step of the viral 
replication cycle. Indeed, budding and release by spumaviruses strictly depends 
on Gag-Env interactions, while orthoretroviruses can release viral particles even 
in absence of Env (Baldwin and Linial, 1998; Pietschmann et al., 1999), although 
the latter greatly facilitate intracellular Gag trafficking and viral particle release 
(Arnaud et al., 2007b; Sfakianos and Hunter, 2003).  In addition, it has been 
demonstrated that the late steps of FV replication cycle depend on the presence 
of the signal  peptide  (or leader peptide) of the viral Env protein (Elp)
12
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(Cartellieri et al., 2005; Lindemann et al., 2001; Wilk et al., 2001). Elp lies at 
the N-terminal portion of the Env precursor protein (pre-gp130Env), which it is 
processed by furin or furin-like protease during its intracellular transport 
towards the cell membrane (Duda et al., 2004; Geiselhart et al., 2004; 
Lindemann et al., 2001; Netzer et al., 1990; Stange et al., 2008; Wang and 
Mulligan, 1999). It has  been  shown that Elp mediates particle egress by 
specifically interacting with the budding domain in gp130Env and the N-terminus 
of Gag (Cartellieri et al., 2005; Lindemann et al., 2001; Wilk et al., 2001). 
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egress of viral and subviral particles
13
1.6.7 Release and maturation 
 from infected cells, thus determining viral 
infectivity (Stanke et al., 2005). 
Finally, when all the viral components are recruited together, the cell 
membrane bends until the virion pinches-off and is released in the supernatant 
(Fig. 5). Upon release from the host cell surface, orthoretroviruses undergo an 
obligatory maturation step  that  yields infectious virions. This process is 
mediated by the viral PR enzyme, which promotes proteolytic cleavages of Gag 
and Gag-Pro-Pol precursors, thus leading to major structural changes (Fig. 5). In 
spumaretroviruses, by contrast, Gag is not proteolytically processed in NC, CA 
and MA domains, and thus viral particles  retain an “immature” morphology 
(Göttlinger and Weissenhorn, 2010; Hartl et al., 2011). 
1.7 Interplay between retroviruses and their hosts: 
restriction factors 
Host–pathogen interaction is a classic example of genetic conflict, in which both 
entities try to gain evolutionary advantages over the other. As illustrated above, 
retroviruses rely completely upon host factors to successfully complete their 
replication cycle. Hence, over time, they have developed different strategies to 
hijack the cell machinery and optimize viral replication. Accordingly, hosts have 
evolved many defence mechanisms to prevent viral transmission, including 
intrinsic, innate and adaptive immune responses, which are, respectively, the 
first and second lines of defence against spreading of infectious pathogens. The 
driving force of host-pathogen interaction is therefore  the genetic plasticity 
that,  by  continuously demanding functional “innovations”,  points to different 
layers of complexity and renders this interplay evolutionary dynamic. 
Innate immune response is acquired at birth and changes little throughout the 
life of an individual. In general, it requires sentinel and cytolytic cells (i.e., 
macrophages and natural killer cells),  as well as the secretion of cytokines 
(including interferon, IFN) and an array of serum proteins known as complement. If 
this strategy fails, the  adaptive immune response  is mobilized. This includes 
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activated lymphocytes (B and T cells ) and the synthesis and release of epitope-
specific antibodies. Although this mechanism of defence takes longer to develop, 
it is far more specific and, most importantly, shows memory (Lydyard et al., 
2004). 
Besides the innate and adaptive immune responses, vertebrates have developed 
an «intrinsic immunity» (Bieniasz, 2004), which consists in a cell-autonomous 
defence against viral infections. This mechanism of response relies on cellular 
proteins known as «restriction factors», which specifically target different steps 
of the viral replication cycle, thus potently inhibiting spreading of infection. 
Restriction factors have been conserved across the speciation of mammals 
(Luban, 2010), suggesting that they might have co-evolved with retroviruses 
throughout mammalian orders. They include IFN-induced proteins, such as 
APOBECs, tripartite motif (TRIM) proteins and bone marrow stromal cell antigen 
2 (BST-2), and the zinc finger antiviral protein (ZAP). Retroviruses, in turn, have 
evolved a number of mechanisms to avoid and/or  modify  the  host immune 
response  and  establish successful infections. For example, lentiviruses and 
spumaviruses encode accessory proteins to overcome cellular restriction (Löchelt 
et al., 2005; Strebel et al., 2009), whereas MMTV uses cells of the host immune 
system for viral spread (Golovkina et al., 1998). 
1.7.1 TRIM5α 
In 2004, Matthew Stremlau and colleagues observed that Old World monkeys’
14
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cells were resistant to HIV-1 infections (Stremlau et al., 2004). The factor 
responsible for this restriction activity was identified as TRIM5α, a protein that 
is able to block the early steps of retroviral replication by preventing the process 
of reverse transcription (Fig. 8). The underlying mechanism adopted by TRIM5α 
to exert its block remains still poorly understood, even though it is now 
becoming increasingly clear that its restriction activity may occur through 
multistep and redundant pathways (Anderson et al., 2006; Luban, 2010; Towers, 
2007). One possibility is that TRIM5α forms complexes with retroviral cores that 
are rapidly degraded by the proteasomal machinery in a ubiquitin-mediated 
mechanism (Wu et al., 2006). Alternatively, TRIM5α may rapidly uncoat incoming Chapter 1                                                                                                                                          47 
HIV-1 capsids, thereby causing premature disassembly of viral cores (Stremlau et 
al., 2006). Finally, it has been proposed that TRIM5α exerts its block by 
impairing nuclear entry to PICs, thus preventing integration into the host 
genome (Anderson et al., 2006). 
 
Figure 8│ Mechanism of action of host restriction factors. Cellular restriction factors follow 
different strategies and act at different stages of the retroviral replication cycle. See text for details. 
APOBEC, apolipoprotein B mRNA-editing enzyme; BST-2, bone marrow stromal cell antigen 2; 
CA, capsid; cDNA, complementary  DNA;  DLS, dimer-linkage structure;  enJSRV, endogenous 
Jaagsiekte sheep retrovirus; Fv1,  Friend-virus-susceptibility-1;  Fv4,  Friend-virus-susceptibility-4; 
IN, integrase; MA, matrix; NC,  nucleocapsid; PIC, pre-integration complex; RT, reverse 
transcriptase; RTC, reverse transcription complex; TRIM, tripartite motif; vRNA, viral genomic RNA 
(unspliced); ZAP, Zinc-finger antiviral protein. Figure adapted from (D'Souza and Summers, 2005) 
and (Jern and Coffin, 2008). 
TRIM5α is one of the multiple protein isoforms encoded by TRIM5 family genes, 
defined by the presence of three zinc-binding domains: an amino-terminal ring 
finger that functions as E3 ubiquitin ligase, one or two B-box domains and a 
coiled-coil region known as B30.2/SPRY domain. The two first domains are 
required for efficient restriction activity, whereas the latter enhances binding 
avidity for the viral capsid by promoting TRIM5α oligomerization. In particular, 
the B30.2/SPRY domain exhibits species-specific restriction activity to HIV-1. 
Replacement of the amino-terminal residues in the B30.2/SPRY domain of human 
TRIM5α  (TRIM5αhu) with the corresponding amino acids of rhesus TRIM5α 
(TRIM5αrh) confers to the resulting TRIM5αhu mutant protein the ability to block 
HIV-1, with an efficiency comparable to that of the wild-type TRIM5αrh (Stremlau Chapter 1                                                                                                                                          48 
et al., 2005). The importance of this domain is further emphasized by the fact 
that these residues have been positively selected during primate evolution 
(Sawyer et al., 2005; Song et al., 2005), suggesting that TRIM5α has been co-
evolving with retroviruses for millions of years. 
The TRIM family arose through gene duplication events. The human genome, for 
instance, contains over seventy TRIM family genes, including an active TRIM5 
gene and a TRIM5 pseudogene. Multiple copies of TRIM5 genes are also found in 
mouse, rat and cow genomes, whereas in  the  dog  genome  there  is  only one 
TRIM5  gene  present and this has been interrupted by gene insertion and has 
therefore decayed into a pseudogene (Johnson and Sawyer, 2009). This pattern 
of gene duplication and/or loss indicates highly dynamicity of the TRIM5 loci, 
which might have contributed to the “endogenous” restriction of retroviruses 
throughout mammals evolution. This notion is further supported by recent 
findings that TRIM5 is involved in promoting innate immune signalling pathways 
(Pertel et al., 2011). Moreover, it is noteworthy that a number of TRIM proteins 
have been found to block different steps of the retroviral replication cycle (Uchil 
et al., 2008). 
1.7.2 CypA and TRIM5-CypA 
CypA is a cellular peptidyl-prolyl isomerase that is incorporated in about 10% of 
HIV-1 virions through interactions with the CA domain of the Gag polyprotein 
(Franke et al., 1994; Thali et al., 1994). Most likely, CypA has been selectively 
co-opted by HIV-1 as it promotes viral infectivity by preventing TRIM5αhu-CA 
interaction (Sokolskaja et al., 2006).  CypA is required in target but not in 
producer cells, since mutational inactivation of CypA binding site, or inhibition 
of the CA-CypA interaction by cyclosporin A (CsA), inhibits or attenuates HIV-1 
replication (Braaten and Luban, 2001). A similar block to HIV-1 infections is 
exerted by TRIM5αrh  in Old World monkey cells (Berthoux et al., 2005), 
suggesting that this step may be a point of vulnerability in the retroviral cycle. 
Some species belonging to Aotus  and  Macaca  genera (New World monkey
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express a TRIM5-CypA fusion protein that derives from the replacement of the 
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Nisole et al., 2004; Sayah et al., 2004). Some studies speculate that TRIM5-CypA 
arose after the divergence of New and Old World monkeys, when a LINE1 
catalysed the insertion of a CypA complementary DNA into the TRIM5  locus 
(Patthy, 1999; Towers, 2007). TRIM-CypA confers resistance to HIV-1 infection 
(Hofmann et al., 1999) and might have provided significant selective advantages 
to these animal species. It is worth noting that a human TRIM5-CypA-like gene 
would be a useful antiviral against HIV infections. 
1.7.3 APOBEC 
APOBEC proteins belong to a large family of cytidine deaminases, unique to 
mammals, involved in a variety of processes, including lipid metabolism, 
antibody diversification and inhibition of the replication of retroviruses and 
some DNA viruses. These enzymes replace the cytidine bases on single-stranded 
DNA or RNA uracil bases, thereby acting as DNA- and RNA-editing enzymes. In 
mammals, such substitutions may alter the amino acid sequence of important 
proteins, thus causing a variety of diseases, including cancers and immune 
disorders (Ross, 2009). In retroviruses, APOBEC3 proteins are packaged into 
newly forming virions and induce mutations in the minus strand of viral cDNA, 
thus greatly reducing viral replication efficiency (Fig. 8). It has been shown that 
APOBEC3 proteins can inhibit viral replication in either a cytidine deamination-
dependent or -independent manner, but the precise mechanism underlying these 
processes remains still to be defined (Holmes et al., 2007). 
Retroviruses have evolved a variety of strategies in order to counteract the 
effects of cellular APOBEC3 proteins and prevent their packaging into newly 
forming virions. These comprise (i) proteasome-mediated degradation of 
APOBEC3G and APOBEC3F by the viral Vif protein in HIV-1 (Mehle et al., 2004; Yu 
et al., 2003; Sheehy et al., 2002), and (ii) inhibition of the interaction between 
APOBEC3G and vRNA–NC complexes in HTLV-1 (Derse et al., 2007). Spumaviruses 
evade APOBEC3 antiviral activity by a distinct strategy that is mediated by the 
accessory protein Bet. Although the biochemical details of this mechanism have 
not been completely elucidated, several lines of evidence suggest that Bet forms 
complexes with APOBEC3C proteins  that are sequestered in subcellular 
compartments and undergo proteosomal degradation (Löchelt et al., 2005; 
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APOBEC3 genes arose through gene duplication of a single-copy primordial gene, 
and their copy number varies from one in mice, two to three in artiodactyls 
species and up to seven in humans (Conticello et al., 2005; LaRue et al., 2008). 
A growing body of evidence indicates that the primary function of these genes in 
mammals is to provide an innate immune defence to retrovirus and 
retrotransposon mobilization (Bogerd et al., 2006; Chen et al., 2006; Esnault et 
al., 2006; Esnault et al., 2008; Ikeda et al., 2011). This hypothesis is supported 
by the fact that primate mammals exhibit a larger repertoire of APOBEC3 genes 
than non-primate mammals, probably due to the higher exposure of the first to 
potentially invasive retroelements (Conticello et al., 2005). It is noteworthy, 
however, that the entire human APOBEC3 locus is flanked by repetitive elements 
(mainly LTRs from ERVs class I), suggesting that such amplification and 
recombination of APOBEC3  genes in primates might have been facilitated by 
retroviral elements (Conticello et al., 2005). Thus, it appears that host genomes 
have co-opted retroviral elements that fulfil key functions for the host biology, 
while host/virus interplay might have provided the driving force for the rapid 
expansion of the entire APOBEC3 locus and other restriction factors in primates. 
1.7.4 ZAP 
ZAP is a host antiviral protein that inhibits the late stages of replication of MLV 
(Gao et al., 2002), alphaviruses (Bick et al., 2003) and filoviruses (Müller et al., 
2007). Putative orthologs of ZAP gene can be found in the genomes of a variety 
of mammals, including rat (where it was firstly identified) (Gao et al., 2002), as 
well as chicken and fish (Amé et al., 2004), suggesting that this gene family 
dates back to the origin of vertebrates. Viral recognition by ZAP is mediated by 
four CCCH-type zinc-finger motifs, which specifically bind to target viral mRNAs 
and mediate exosome-dependent RNA degradation (Gao et al., 2002; Guo et al., 
2007) (Fig. 8). Surprisingly, phylogenetic analyses found no evidence of positive 
selection of this domain throughout primates evolution, arguing that the 
antiviral activity of ZAP was not shaped by rapid alterations in the viral RNA 
binding sites (Kerns et al., 2008). In primates and rat, ZAP encodes two isoforms 
that derive from alternative RNA splicing events. In primates, the longer isoform 
ZAP(L) contains a poly(ADP-ribose) polymerase (PARP)-like domain, which  is 
absent in the shorter protein ZAP(S). In rat, by contrast, neither isoforms possess 
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revealed that the PARP-like domain has been positively selected throughout 
primates evolution, even though the mechanisms by which this region mediates 
ZAP antiviral activity have not yet been characterized (Kerns et al., 2008). 
However, it is possible to speculate that the PARP-like domain may increase the 
affinity of ZAP for viral RNAs or, alternatively, counteract putative viral factors 
involved in ZAP degradation (Kerns et al., 2008). 
1.7.5 BST-2 
BST-2, also known as CD317, HM1.24 or tetherin, is a transmembrane protein 
that restricts many enveloped viruses, including retroviruses, filoviruses and 
herpesviruses. BST-2 is expressed constitutively in several cell types, such as B 
cells, T cells, macrophages and cancer cell lines and it can be induced by type I 
IFN in response to viral infections (Evans et al., 2010; Neil et al., 2008; Van 
Damme et al., 2008). 
BST-2  localizes within several endosomal compartments, including trans-Golgi 
network (TGN) and recycling endosomes. In addition, it is present at the plasma 
membrane where it tethers fully formed virions to the cell surface, thereby 
preventing their release (Fig. 8). Virtually, any lipid-enveloped virus could be 
restricted by BST-2. However, because the antiviral activity of BST-2 most likely 
requires co-localization with budding virions, its restriction is probably limited to 
viruses that bud from cellular membranes enriched in BST-2 (Habermann et al., 
2010). 
It has been proposed that BST-2 exerts its antiviral activity without cellular 
cofactors. This “direct tethering” model is strongly supported by an elegant 
experiment that demonstrated that an artificial protein, lacking significant 
sequence homology to the native BST-2 but retaining its topology, was still able 
to mimic its antiviral activity (Perez-Caballero et al., 2009). Key domains for 
BST-2 restriction are the N-terminal transmembrane (TM) portion, which faces 
the cytoplasm, and the glycosylphosphatidylinositol (GPI) membrane anchor at 
the C-terminal portion. This unusual topology enables BST-2 to interact with the 
nascent virions and tether them to the cell surface (Perez-Caballero et al., 
2009). In addition, recent studies revealed that BST-2 is incorporated into 
nascent infectious virions (Fitzpatrick et al., 2010). The exact mechanism 
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Several lines of evidences favour the “membrane spanning” model, whereby 
BST-2 is incorporated into virions as a dimer, whose TM domains are inserted 
into the virion envelope, while the GPI anchors remain embedded in the host-
cell membrane (Perez-Caballero et al., 2009). Retained virions can be 
internalized and subsequently degraded by late endosomes, due to the 
interaction between the C-terminal domain of BST-2 and the cellular endocytic 
machinery (Miyakawa et al., 2009). Alternatively, virions can be trapped at the 
cell surface by BST-2 and form large aggregates (Casartelli et al., 2010). In both 
cases, their spread as cell-free virions is restricted. 
Over time, retroviruses have evolved different strategies to counteract BST-2 
restriction. For example, HIV-1 encodes the Vpu protein  that enhances viral 
particle release from infected cells by preventing the incorporation of BST-2 into 
budding virions. It has been proposed that Vpu may down-regulate BST-2 
expression at the plasma membrane by (i) promoting proteosomal degradation of 
the proteins already present on the cell surface, and/or (ii) sequestering newly 
synthesized proteins into the TGN, thus impairing them to reach the cell 
membrane (Neil et al., 2008; Van Damme et al., 2008). Similarly, it has been 
suggested that HIV-2 Env may remove BST-2 proteins from the cell surface and 
subsequently divert them from the normal recycling pathway, thus depleting 
their global level (Hauser et al., 2010). Finally, it has been recently 
demonstrated that the SIV Nef protein reduces the expression of cell surface 
BST-2 by sequestering the protein away from sites of particle release (Zhang et 
al., 2011). 
1.8 Endogenous retroviruses (ERVs) 
ERVs represent remnants of past rounds of germ line infections by exogenous 
retroviruses. They have been found in all vertebrates studied to date, where 
they represent a significant percentage of the total genome. Up to 8-10% of 
human and mouse genomes, for instance, is thought to be of retroviral origin 
(Jern and Coffin, 2008). 
Over time,  in some species, including human and non-human primates, most 
ERVs have accumulated  mutations and/or deletions, which  prevent them to 
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2008). Conversely, in other species, such as koala and sheep, some ERVs have 
maintained intact open reading frames for most of their genes and, therefore, 
are potentially able to produce infectious particles. These, in turn, can re-infect 
the host germ line and give rise to genomic amplification of some proviral loci. 
Interestingly, both koala and sheep genomes are thought to be invaded by 
exogenous retroviruses at the present time, suggesting that,  in these animal 
species, the process of endogenization is still  ongoing (Arnaud et al., 2007a; 
Tarlinton et al., 2006). 
For many years, ERVs have been considered as merely molecular “junk” or 
parasites. It is now clear that host genomes have coevolved with ERVs, 
preventing or minimizing the deleterious consequences of  their unrestrained 
integrations while capitalizing their adaptive potential: in other words, turning 
some “junk” into treasure (Goodier and Kazazian, 2008). Indeed, over time, 
some ERVs have been positively and repeatedly selected by host genomes, and 
fulfil now useful functions in diverse aspects of host biology, including antiviral 
activity and placental morphogenesis (Blaise et al., 2003; Dupressoir et al., 
2005; Varela et al., 2009). 
1.8.1 ERVs and host defence 
Some ERVs have been co-opted by host species for their role in protecting them 
against related exogenous and pathogenic retroviruses. For instance, in mouse, 
Fv1 blocks the early steps of MLV replication by binding to the viral CA (Hilditch 
et al. 2011) (Fig. 8), with a mechanism similar to that adopted by TRIM5α. Fv1 is 
a relic of a gag-like gene from an endogenous retrovirus not related to MLV (Best 
et al., 1996; Friend, 1957; Lilly, 1967). This locus exists as two major alleles, 
Fv1
n and Fv1
b, exhibiting co-dominance and interference with different strains of 
MLV. Fv1
n is present in NIH-Swiss mice and confers resistance to B-tropic
16
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not to N-tropic MLV strains. Fv1
b, on the other hand, is expressed in BALB/c mice 
and displays the opposite phenotype (Lilly and Steeves, 1973). A less common 
third allele, Fv1
nr, inhibits B-tropic viruses and some N-tropic viruses (Steeves 
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defective ERV that encodes an ecotropic MLV-like Env (Kozak et al., 1984). 
Expression of Fv4 can saturate cell surface receptors sufficiently to block entry 
by exogenous ecotropic MLV strains (Fig. 8) (Ikeda and Odaka, 1983; Ikeda et al., 
1985). 
Similarly to Fv4, endogenous sheep betaretroviruses (enJSRVs) prevent JSRV 
infections by receptor interference in in vitro experiments (Spencer et al., 2003) 
(Fig.  8). Moreover, some of them can block JSRV in vitro,  by a unique 
mechanism of interference that occurs at a post-integration step of the viral 
replication cycle (see paragraph 1.10.3) (Arnaud et al., 2007b; Mura et al., 2004; 
Murcia et al., 2007) (Fig. 8). 
Endogenous MMTV proviruses (Mtvs) exert a completely different restriction 
activity, as they reduce, or completely abolish, viral spread of their exogenous 
counterparts by altering host immune response (Fig. 8). MMTV infects newborn 
pups during the first weeks of their life, passing through the milk of viremic 
female mice. The primary target of MMTV are B lymphocytes and dendritic cells 
(Baribaud et al., 1999) that, following infection, express Sag (for superantigen) 
at their cell surface (Korman et al., 1992) and initiate T cell responses (Baribaud 
et al., 1999). Activation of T cells, in turn, promotes division of infected cells 
and, thus, viral spread (Golovkina et al., 1998). By contrast, expression of 
different subtypes of Sag by Mtvs leads to progressive deletion of T cells, 
thereby reducing spread of exogenous MMTV (Golovkina et al., 1992; Golovkina 
et al., 1998; Mustafa et al., 2000). Recently, it was shown that Mtv-null BALB/c 
mice are resistant to MMTV infection, suggesting that they may possess other 
mechanisms of viral defence besides Mtvs. Interestingly, these mice were found 
to be resistant to Vibrio cholerae and susceptible to Salmonella typhimurium 
infections, arguing that Mtv-encoded Sag may also provide a unique genetic 
susceptibility towards specific bacteria (Bhadra et al., 2006). 
1.8.2 ERVs and placental development 
Several lines of evidence suggest that retroviruses have contributed to the 
evolution of placental mammals. Intact env genes derived from full-length or 
defective ERVs are highly expressed in the genital tract and placental tissues of 
many mammals, including mice, sheep and humans (Blaise et al., 2003; Blond et 
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Mi et al., 2000). It has been proposed that ERVs might have infected some 
primitive aplacental mammal-like species at an early intrauterine stage, giving 
rise to cellular proliferation and formation of a primitive placenta (Harris, 1991). 
Alternatively, ERVs might have been independently acquired by mammals, 
during evolution, for a convergent biological role in placental morphogenesis 
(Stoye, 2009; Villareal, 1997). 
Env proteins promote membrane fusion, a process that highly resembles the 
formation of the syncytiotrophoblast. A systematic screening of the human 
genome led to the identification of syncytin-1  and  syncytin-2  genes, which 
derive from HERV env  genes and are specifically expressed at the 
cytotrophoblast–syncytiotrophoblast interface of placenta
17
1.8.3 ERVs and effects on host transcriptome 
 (Blaise et al., 2003). 
Syncytin-1 was shown to be directly involved in cell fusion (Blond et al., 2000; Mi 
et al., 2000), whereas Syncytin-2 displays immunosuppressive activity, most 
likely associated with maternal-fetal tolerance (Mangeney et al., 2007). The 
identification of sequences in mouse (syncytin-A and syncytin-B) (Dupressoir et 
al., 2005) and sheep (enJSRV env) (Dunlap et al., 2006b), which exhibit similar 
physiological properties to those of human syncytin genes (Dunlap et al., 2006b; 
Dupressoir et al., 2009), strongly supports the hypothesis that ERVs have been 
positively selected for their critical roles in the evolution of placenta and 
viviparity in mammals. 
Curiously, despite the copious number of ERVs and related elements in host 
genomes, most tissues do not express high levels of ERV RNA or replicating 
viruses. Hosts control ERVs expression in many ways, including ERVs diversion 
outside of genes and/or in antisense orientation, cellular restriction factors, DNA 
methylation and small interfering  RNAs (siRNAs) (Maksakova et al., 2008). 
Moreover, ERVs expression is restricted in most differentiated tissues in order to 
prevent insertional mutagenesis events that may have potentially deleterious 
effects for the host (Rowe and Trono, 2011). Indeed, ERVs usually “tend” to 
integrate and become fixed into non essential regions of the genome, where 
their presence is less harmful for the host (Jern and Coffin, 2008). Nevertheless, 
they  can influence the transcriptional activity of nearby genes, due to the 
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potential binding sites for transcription factors in their proviral LTRs. For 
example, the transcriptional activity of human beta-like globin genes is 
regulated by a solo LTR sequence, related to HERVs and integrated upstream of 
the locus control region (Long et al., 1998; Pi et al., 2010). 
There has been considerable debate on whether ERVs may be associated with 
diseases or not. Some studies have shown that HERVs may play roles in human 
neuronal syndromes, including multiple sclerosis (Antony et al., 2007). In 
contrast, some retrovirologists have dismissed them as merely “human rumour 
viruses”, because they produce
 high levels of “background noise” that may alter 
the signal
 from infectious retroviruses or, alternatively, produce false-positive
 
results (Jern and Coffin, 2008; Voisset et al., 2008). Further work is needed to 
evaluate carefully any potential correlation between ERVs and diseases. 
1.9 Jaagsiekte sheep retrovirus (JSRV) 
JSRV is an exogenous pathogenic retrovirus and the etiological agent of ovine 
pulmonary adenocarcinoma (OPA), a contagious lung cancer of sheep (Palmarini 
et al., 1999a). OPA was firstly reported in 19th century in South Africa, when 
farmers coined the term jaagsiekte to describe the respiratory distress observed 
in affected animals and that they associated to sheep being chased (in Afrikaans 
jag means chase and ziekte sickness) (Tustin, 1969). Since then, OPA has spread 
in many geographical areas around the world, where it affects both domestic 
and wild sheep (Griffiths et al., 2010). 
The earliest evidence that OPA is induced by a retrovirus dates back to 1970s, 
when retrovirus-like particles were observed by electron microscopy in lung 
cancer cells (Malmquist et al., 1972; Perk et al., 1971). These results were 
strengthened by the identification of RT activity (Verwoerd et al., 1980) and 
retroviral RNA (Perk et al., 1974; Verwoerd et al., 1980) in tumour extracts, and 
the experimental reproducibility of clinical and histological signs of the disease 
in sheep injected with tumour extracts from OPA-affected animals (Martin et al., 
1976). In 1991, Denis York and colleagues isolated the genomic RNA of what we 
now know as JSRV-SA (JSRV-South Africa), from washes of OPA-affected lungs 
(York et al., 1991). One year later, the same group provided the first evidence 
of enJSRVs in the genome of sheep and goats (York et al., 1992). This discovery Chapter 1                                                                                                                                          57 
raised suspicions about a potential role of enJSRVs in the development of OPA. 
These  doubts were soon ruled out when it was demonstrated that only JSRV 
could be detected from lung tumour samples (Bai et al., 1996; Palmarini et al., 
1996a). Conclusive evidence that JSRV was the causative agent of OPA came 
from the isolation of the infectious molecular clone JSRV21. The inoculation of 
new-born lambs with viral particles collected from the supernatants of 293T 
cells expressing JSRV21  proved that this virus is necessary and sufficient to 
induce OPA (Palmarini et al., 1999a). 
1.9.1 Ovine pulmonary adenocarcinoma (OPA) 
Sheep affected by OPA show different symptoms, including progressive dyspnoea 
associated with loss of weight, and usually die for respiratory failure after a 
protracted incubation period (Sharp and DeMartini, 2003). One of the 
characteristic clinical signs of OPA is the production of copious amount of fluid 
in the lungs, which drains from the nostrils of affected sheep once their hind 
limbs are raised above their head. However, in many cases, no lung fluid can be 
observed and, therefore, definitive diagnosis of OPA can be made only after 
histopathological examination (De las Heras et al., 2003). At the post-mortem 
exam, naturally infected animals at advanced stages of OPA present usually a 
thin carcass with enlarged lungs infiltrated with tumour and airways filled with 
fluid. Extrathoracic metastases have also been reported, but are generally rare 
(DeMartini  et al., 1988). Remarkably, JSRV infected animals do not develop 
antibodies against the virus (Ortín et al., 1998), probably because of the 
expression of the highly related enJSRVs, during ontogeny, that may lead  to 
tolerance (Spencer et al., 2003). 
In natural conditions, JSRV can infect both adult sheep and lambs, perhaps 
through aerosolized particles and maternal colostrum/milk (Caporale et al., 
2005; Grego et al., 2008). Curiously, the virus is primarily detected in peripheral 
blood leucocytes and lymphoid organs rather than in lungs, and only a minority 
of naturally JSRV infected animals develop OPA (Caporale et al., 2005). These 
findings led to the hypothesis that JSRV may use lymphoreticular cells as a viral 
reservoir, and spreads to the lungs only when the latter are more susceptible to 
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lungs, JSRV infects and transforms proliferating type 2 pneumocytes (also 
termed lung alveolar proliferating cells, LAPCs) (Murgia et al., 2011) (Fig. 9). 
 
Figure  9│  Schematic  representation of cell types present in  the  terminal bronchioli and 
alveoli of sheep lungs. Figure adapted from (Murgia et al., 2011). 
These cells are normally  abundant in young lambs during post-natal 
development, and in adult sheep,  following injury to the bronchioalveolar 
epithelium. Sheep naturally developing OPA present often a wide variety of 
other respiratory pathogens, including lungworms (Snyder et al., 1983), Maedi-
Visna virus (MVV, lentivirus) (Dawson et al., 1990) and other bacterial infections. 
It has been proposed that these pathogens may act synergistically to render 
more susceptible sheep  lungs to JSRV transformation (Caporale et al., 2005; 
Murgia  et al., 2011). Similarly to most  retroviruses  [see paragraph 1.6.3  and 
(Suzuki and Craigie, 2007)], JSRV infects more efficiently cells in division, when 
the nuclear membrane dissolves. Lung inflammation induced by primary 
pathogens may indeed  promote active divisions of LAPCs to repair injured 
tissues, thus providing optimal conditions for JSRV transformation. This 
hypothesis is supported by the observation that lung lesions increase the number 
of LAPCs, and render infected animals more susceptible to JSRV infection and 
OPA (Murgia et al., 2011). 
OPA represents an excellent animal model to study human bronchioalveolar 
carcinoma, as both diseases share many clinical and histological traits (Palmarini 
and Fan, 2001; Murgia et al., 2011). Indeed, recent results obtained in our group 
suggest that human lung cancer may originate from cell types that are more 
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1.9.2 JSRV: genomic organization and mechanism of 
oncogenesis 
JSRV is an exogenous sheep betaretrovirus phylogenetically related to ENTV, M-
PMV and MMTV. Its genome is approximately 7.5 Kb in length and exhibits a 
simple organization, typical of replication competent retroviruses. Besides 
encoding the classical retroviral genes gag, pro, pol and env, JSRV harbours an 
additional open reading frame of unknown function (hence termed orf-x), which 
overlaps the 3' end of pol (Palmarini et al., 1999a; York et al., 1992) (Fig. 10). 
 
Figure 10│ Genetic organization of the JSRV21 molecular clone. 
This reading frame displays no homology to any known viral or cellular genes, 
and is highly conserved among different JSRV isolates (Rosati et al., 2000), 
although it does not appear to be required for viral pathogenesis (Cousens et al., 
2007). To date, three highly related JSRV isolates (Palmarini and Fan, 2003), 
have been cloned from OPA affected sheep: JSRV-SA (York et al., 1991), JSRV21 
(Palmarini et al., 1999a) and JSRVJS7 (DeMartini et al., 2001). JSRV21 is probably 
the most extensively studied among these three viral strains. 
The lung tropism of JSRV is determined by its LTR sequences. Indeed, besides 
containing the viral promoter, these regions include enhancer elements 
activated by lung-specific transcription factors, including the hepatocyte nuclear 
factor-3β (HNF-3 β), nuclear factor I (NFI), and CCAAT/enhancer binding protein 
(C/EBP) (McGee-Estrada and Fan, 2006; McGee-Estrada et al., 2002; Palmarini et 
al., 2000). 
The  gag  gene encodes a single polyprotein that is cleaved  into at least five 
products: matrix (MA), p15, capsid (CA), nucleocapsid (NC) and p4 (Murcia et al., 
2007; Palmarini et al., 1999b). Similarly to other retroviruses, JSRV contains a 
putative M domain at the N-terminal portion of Gag consisting of a myristate 
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trafficking (Mura et al., 2004; Murcia et al, 2007; Swanstrom and Wills 1997). 
Mutations in this region alter the ability of JSRV to reach the cell membrane and 
release viral particles (Mura et al., 2004; Murcia et al., 2007). The L domain lays 
within the p15 protein and contains core amino acid motifs of PSAP and PPAY 
(Murcia et al., 2007) analogous to those present in M-PMV (Gottwein et al., 
2003). In accordance to what observed in other retroviruses, mutations in the 
JSRV L domain result in a defect of the late steps of viral replication cycle that 
impairs viral budding (Freed, 2002; Murcia et al., 2007). 
As described for other betaretroviruses, pro and pol are encoded in different 
open reading frames (Palmarini et al., 1999a). The pro  gene expresses (i) a 
deoxyuridine triphosphatase (dUTPase) that prevents incorporation of 
deoxyuridine triphosphate (dUTP) by the reverse transcriptase, and  (ii) a 
protease that cleaves  viral polyprotein precursors. The pol  gene encodes the 
reverse transcriptase and the integrase, involved, respectively, in the reverse 
transcription and integration processes (Leroux et al., 2007). 
The  env  mRNA is approximately 2.4 Kb in length and derives from a single-
splicing event (Palmarini et al., 2002). After maturation, it gives rise to the 
transmembrane (TM) and surface (SU) domains. SU mediates viral entry into the 
cells by interacting with Hyal2, the cellular receptor of JSRV (Spencer et al., 
2003). Hyal2 is a member of the hyaluronglucosaminidase family, involved in the 
enzymatic degradation of hyaluronic acids present in vertebrates’ extracellular 
matrix. It is ubiquitously expressed in sheep, in accordance with the ability of 
JSRV to infect different cell types both in vitro (Palmarini et al., 1999b) and in 
vivo (Palmarini et al., 1996b). However, viral expression is restricted to specific 
bronchioalveolar epithelial cells due to the tropism conferred to JSRV by the LTR 
sequences. The TM domain anchors the virus to the cell lipid bilayer and confers 
to JSRV the ability to induce cell transformation (Palmarini et al., 2001b). In 
particular, the cytoplasmic tail (CT) of the Env glycoprotein bears a YXXM motif
18
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that, most likely, activates Ras/MEK/MAPK and PI-3K/Akt-dependent pathways 
(Chow et al., 2003; Maeda et al., 2005; Palmarini et al., 2001b; Varela et al., 
2006). Remarkably, expression of JSRV Env glycoprotein alone is sufficient to 
induce cell transformation both in vitro (Maeda et al., 2001) and in vivo (Murgia Chapter 1                                                                                                                                          61 
et al., 2011). This renders JSRV the only virus to harbour a dominant oncoprotein 
that is necessary and sufficient to trigger tumor development (Alberti et al., 
2002; Murgia et al., 2011). 
As already mentioned (paragraph 1.6.4.3), recent studies demonstrated that 
JSRV Env possesses a signal peptide (JSE-SP) located at the N-terminal portion of 
the protein (Caporale et al., 2009; Hofacre et al., 2009). Similarly to MMTV SP 
(Byun et al., 2010), JSE-SP plays a critical role in viral replication cycle, as it 
acts as a post-transcriptional regulator of viral gene expression (Caporale et al., 
2009; Hofacre et al., 2009; Nitta et al., 2009) (see paragraph 4.1). 
1.10  Endogenous sheep betaretroviruses: enJSRVs 
In a recent study, Frédérick Arnaud and colleagues screened a bacterial 
artificial chromosome (BAC) library derived from the genomic DNA of a single 
Texel ram. Sequence analyses revealed that sheep genome harbours, at least, 
twenty-seven copies of endogenous betaretroviruses, highly related to the 
exogenous and pathogenic JSRV and hence termed enJSRVs (Arnaud et al., 
2007a)  (Fig.  11). Most of  these loci possess defective genomes,  due to the 
presence of premature termination codons, large deletions and/or 
recombinations. However, five enJSRV loci (enJSRV-7, enJSRV-15, enJSRV-16, 
enJSRV-18 and enJSRV-26) display intact genomic organization and 
uninterrupted open reading frames for all of the retroviral genes (gag, pro, pol, 
orf-x, and env), resembling replication competent retroviruses. Four of the five 
intact enJSRVs (enJSRV-15, enJSRV-16, enJSRV-18 and enJSRV-26) exhibit 
identical 5' and 3' LTRs, which is indicative of relatively recent integration into 
the host germ line. This hypothesis is further reinforced by the presence of two 
loci (enJSRV-16 and enJSRV-18) that are 100% identical at the nucleotide level 
along their entire genomes (Arnaud et al., 2007a). Chapter 1                                                                                                                                          62 
 
Figure 11│ Genetic organization of enJSRV proviruses. All the genomic sequences flanking 
enJSRV proviruses contain a six base pairs duplication that is the hallmark of retroviral integration. 
The only exceptions  are represented by enJSRV-20,  which contains a portion of an env gene 
(indicated by a purple box and a question mark) before the 5′LTR, and enJSRV-2, which does not 
contain the same six base pairs sequences flanking the LTRs. Five of the twenty-seven enJSRVs 
possess an intact genomic organization, typical of replication competent exogenous retroviruses 
(top). The two transdominant proviruses enJS56A1 and enJSRV-20 possess a trypthophan residue 
(W) at position 21 of Gag  and identical 3'  genomic  flanking regions.  The enJSRV-6  locus 
possesses an additional methionine (M) in Env besides the canonical start codon present in JSRV 
and other enJSRV loci. Moreover, in enJSRV-6, gag and pro are in opposite direction compared to 
the 5′ and 3′ LTRs and env (indicated by horizontal arrows). enJSRV-1 presents a LINE element 
within the pol coding region. Premature termination codons are represented by a vertical line and 
an asterisk (*). Large deletions in proviral genomes  are indicated by hatched boxes. Figure 
adapted from (Arnaud et al., 2007a). 
The enJSRVs loci share 85-89% identity with the gag and env sequences of the 
infectious molecular clone JSRV21 (Arnaud et al., 2007a; Palmarini et al., 1999a). 
The major differences are found in the U3 sequences (Bai et al., 1996) and three 
regions spanning gag  and  env, referred to as variable regions (VR1, VR2 and 
VR3). VR1 and VR2 lie within the MA domain of Gag, while VR3 encompasses the 
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seven  enJSRVs possess intact open reading frames for env  (Fig.  1.11), even 
though two of them (enJSRV-4 and enJSRV-24) lack most of the other genes 
(Arnaud et al., 2007a; Palmarini et al., 2000). Standard entry assays revealed 
that enJSRV Env mediates viral entry via Hyal2, which serves also as a cellular 
receptor for the exogenous JSRV and ENTV sheep betaretroviruses (Spencer et 
al., 2003). However, enJSRVs Env glycoproteins lack the YXXM motif critical for 
JSRV cell transformation and, therefore, are unable to induce foci in classical 
transformation assays of rodent and chicken cell lines (Arnaud et al., 2007a; 
Palmarini et al., 2001b). 
1.10.1  Evolutionary history of enJSRVs 
Once retroviruses infect germ cells, they leave a permanent footprint in the 
genome of their hosts, which can reveal the dynamics of host-pathogen interplay 
across long evolutionary periods,  spanning even millions of years. ERVs hold 
therefore great potential as informative markers for evolutionary studies of both 
viral and host genomes. Along this line, in a recent work conducted by Bernardo 
Chessa and colleagues  in our laboratory, the characterization of the enJSRVs 
distribution in various breeds of domestic sheep (Ovis aries) has provided 
valuable insights into the history of sheep domestication (Chessa et al., 2009). 
The  “age” of a provirus can be directly inferred by knowing the time of 
speciation of species phylogenetically related. Alternatively, retroviral 
integration time can be estimated assessing the sequence divergence of 5' and 
3'LTRs, assuming that both regions were identical at the time of infection but 
evolved separately afterwards, at the same evolutionary rate of non-coding 
regions. According to that, “young” ERVs most likely possess identical or nearly-
identical LTRs, while “old” proviruses have LTRs significantly divergent. 
However, it is important to note that LTRs may have different evolutionary 
rates, and homologous ERV loci may undergo different selective pressures in 
different species (Martins and Villesen, 2011). 
Sequence analyses and phylogenetic data suggest that enJSRVs entered the host 
genome before the speciation of Ovis  and  Capra  genera,  approximately 5-7 
million years ago (MYA) (Fig. 12). Some enJSRV loci were found in all of the 
species of Ovis genus, such as O. aries, O. nivicola, O. canadensis and O. dalli, 
whereas others were restricted to O. aries, including eight insertionally Chapter 1                                                                                                                                          64 
polymorphic loci
19
 
. These findings and the current knowledge on ruminant 
evolution suggest that the insertionally polymorphic enJSRVs entered the sheep 
genome  less than 9,000 years ago, after sheep domestication. In particular, 
enJSRV-26 was found only in a single Texel ram. Considering the history of this 
breed, it is possible to speculate that enJSRV-26 integrated very recently in the 
sheep genome, probably less than 200 years ago, and may even be a unique 
integration event (Arnaud et al., 2007a). 
Figure 12│ Evolutionary history of enJSRVs. Figure adapted from (Arnaud et al., 2007a). 
1.10.2  Role of enJSRVs in sheep reproductive biology 
enJSRVs are abundantly expressed in sheep reproductive organs, including 
endometrial luminal and glandular epithelia of uterus and epithelia of oviducts 
and cervix (Palmarini et al., 1996b; Palmarini et al., 2000; Palmarini et al., 
2001a; Spencer et al., 1999). enJSRV mRNAs can also be detected in the 
lymphoid cells of the lamina propria of the gut, in the bronchial epithelial cells 
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of  the  lungs and in the cortico-medullary junction of the thymus, where T 
lymphocytes undergo the process of maturation. Expression of enJSRVs in these 
organs may render sheep tolerant towards related exogenous betaretroviruses, 
and explain why JSRV infected animals do not develop antibodies against it 
(Ortín et al., 1998; Sharp and Herring, 1983). 
In the conceptus (embryo/foetus and associated extraembryonic membranes), 
enJSRV env mRNA is mainly detected in trophoblast giant binucleate cells (BNCs) 
and multinucleated syncytia, both required for implantation and nutrition of the 
conceptus (Palmarini et al., 1996b; Palmarini et al., 2000; Palmarini et al., 
2001a; Spencer et al., 1999) (Fig. 13). 
 
Figure  13│  Schematic representation of blastocyst implantation in sheep.  Figure adapted 
from (Spencer et al., 2004). 
In vivo  experiments demonstrate that  inhibition of enJSRV Env expression 
retards blastocyst growth and elongation, and inhibits differentiation of 
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These results indicate that enJSRV env  mRNA is required for conceptus 
elongation and trophectoderm growth in sheep.  During early pregnancy, the 
developing
 conceptus secretes IFN tau (IFNτ), which functions as a pregnancy 
recognition signal in ruminants. Like other type I IFNs, IFNτ activates signalling 
pathways involved in maintaining maternal tolerance of foetal  allograft and 
protecting the conceptus from viral infections (Bazer et al., 2008). In the ovine 
endometrium, IFNτ and progesterone upregulate expression of BST-2 (Arnaud et 
al., 2010) and enJSRV Env (Palmarini et al., 1996b; Palmarini et al., 2000; 
Palmarini et al., 2001a; Spencer et al., 1999), respectively. In particular, IFNτ 
enhances BST2 mRNA only in the stroma
  and not in the luminal epithelium 
endometrium, where enJSRVs are expressed. The BST-2 gene is duplicated in 
ruminants in the A and B isoforms (oBST-2A and oBST-2B). Phylogenetic analyses 
indicate that this duplication occurred approximately 25 MYA (Arnaud et al., 
2010), before the speciation of the Bovinae subfamily (Hassanin and Douzery, 
2003) and, thus, before the initial integration of enJSRVs in the host genome 
(Arnaud et al., 2007a). Both isoforms are able to block enJSRV viral particles in 
vitro, even though with different efficiencies (Arnaud et al., 2010). Preliminary 
data obtained by Lita Murphy, a PhD candidate in our group, indicate that the 
differences in the antiviral restriction by oBST-2A and oBST-2B are attributable 
to differences in their amino acid sequences (Murphy and Palmarini, unpublished 
data). 
1.10.3  Role of enJSRVs in host defence 
Besides their role in conceptus development and placenta morphogenesis, 
enJSRVs  could  protect their host by interfering with related exogenous 
retroviruses at early and late stages of the retroviral cycle (Fig.  8).  In vitro 
experiments demonstrated that JSRV cannot enter cell lines derived from the 
ovine genital tract that express enJSRV RNAs. Thus, it is possible that enJSRVs 
block JSRV entry by receptor interference, as both endogenous and exogenous 
betaretroviruses utilise Hyal2 as a cellular receptor (Spencer et al., 2003). This 
mechanism could also be adopted by the host to control unrestrained viral 
infections by newly emergent enJSRVs. Indeed, a recent study conducted by 
Sarah Black and colleagues demonstrated that the enJSRVs expressed in the 
uterine endometrial epithelia of sheep can release
 viral particles into the uterine 
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transferred into ovine uteri, these authors found that enJSRV viral particles can 
potentially infect the trophoblast of the developing conceptus. Interestingly, 
sequence analyses revealed that only the most recently integrated enJSRV loci 
(including enJSRV26-like sequences) were found to be consistently expressed in 
the
  uterine endometrium and form infectious viral particles  (Black et al., 
2010a). 
enJS56A1, one of the enJSRV loci, can block JSRV release by a mechanism known 
as JLR (for JSRV late restriction) (Mura et al., 2004). In addition, it has been 
recently demonstrated that enJS56A1 is able to restrict viral release by intact 
enJSRV proviruses as efficiently as the exogenous JSRV (Arnaud et al., 2007a) 
(see paragraph 3.1). Interestingly, enJSRV-26, which is the “youngest” enJSRV 
isolated to date, possesses the unique ability to escape JLR (Arnaud et al., 
2007a). The presence of such escape provirus strongly supports the hypothesis 
that transdominant proviruses play indeed a critical role as restriction factors 
against related exogenous retroviruses. The fact that (i) enJSRV-26 was detected 
only in a single Texel ram (Arnaud et al., 2007a) and  (ii)  enJSRV26-like 
sequences were found in trans species conceptuses of two Texel animals (Black 
et al., 2010a) strongly argues that an exogenous retrovirus related to enJSRV-26 
is still circulating within sheep population. Moreover, it is noteworthy that five 
of the twenty-seven enJSRV loci isolated to date (enJSRV-7, enJSRV-15, enJSRV-
16, enJSRV-18 and enJSRV-26) are insertionally polymorphic  and display an 
intact genomic organization (Arnaud et al., 2007a). Overall these findings 
suggest that, in sheep, the process of endogenization is still ongoing and, 
therefore, the evolutionary interplay between endogenous and exogenous sheep 
betaretroviruses and their hosts has not reached an equilibrium yet. 
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2.1 Plasmids 
Plasmids pCMV4JS21, pCMV5-enJS26, pCMV5-enJS18, and pCMV2en56A1 have 
been described previously (Arnaud et al., 2007a;  Palmarini et al., 1999a; 
Palmarini et al., 2000).  Briefly, pCMV4JS21  is an expression plasmid for the 
infectious and oncogenic molecular clone JSRV21, while pCMV5-enJS26, pCMV5-
enJS18 and pCMV2en56A1 express, respectively, the endogenous proviruses 
enJSRV-26, enJSRV-18 and enJS56A1. Viral particles can be recovered from the 
supernatant of 293T cells transiently transfected with either pCMV4JS21, pCMV5-
enJS26 or pCMV5-enJS18  (Arnaud et al., 2007a; Palmarini et al., 1999a). 
Conversely, pCMV2en56A1 is unable to release viral particles in vitro due to the 
presence of a defective Gag protein (Mura et al., 2004). In all the expression 
plasmids described above, the U3 region in the proximal LTR was replaced by 
the cytomegalovirus (CMV) immediate early promoter, as already described 
(Arnaud et al., 2007a;  Palmarini et al., 1999a;  Palmarini et al., 2000).  The 
complete sequences of the exogenous JSRV21  and enJSRV-26, enJSRV-18 and 
enJS56A1 proviruses have been already published (Arnaud et al., 2007a; 
Palmarini et al., 1999a; Palmarini et al., 2000) and are deposited in GenBank 
(http://www.ncbi.nlm.nih.gov/), under accession numbers AF105220.1, 
EF680297.1, EF680301.1 and AF153615.1, respectively. 
All  of  the chimeras/mutants employed in this study were derived from the 
plasmids listed above and are schematically represented in figure 14. Restriction 
maps of pCMV5-enJS26 and pCMV5-enJS18 expression plasmids are reported in 
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Figure 14│ Schematic representation of the expression plasmids employed in this study. 
Numbers indicate amino acid residues in the Env glycoprotein. The alanine and aspartic acid are 
indicated with the one-letter code as A and D, respectively. Premature termination codons are 
represented with vertical lines and asterisks. pNLgagSty330 is a HIV Gag-Pol expression plasmid 
that encodes the HIV Rev responsive element (RRE). pHIV-SPRE26, pHIV-SPRE 18 and pHIV-
SPRE56 were derived from pNLgagSty330 by replacing the HIV RRE with the correspondent 
signal peptide responsive element (SPRE) after enzymatic digestion with EcoRI and XbaI. CMV, 
cytomegalovirus;  CTE, constitutive transport element;  R, terminally redundant sequence; U5, 
unique 5' sequence; U3, unique 3' sequence; SP, signal peptide; PPT, preprotrypsin. Chapter 2                                                                                                                                          71 
Chimeras enJS26-Env18 and enJS18-Env26 were derived by digesting the 
correspondent full-length expression plasmids with BamHI  and  KpnI, and 
swapping the env gene between enJSRV-26 and enJSRV-18. 
In enJS26-5'Env18 and enJS18-5'Env26 chimeras, the 5' end of the env gene was 
exchanged between enJSRV-26 and enJSRV-18, following restriction digestion 
with BamHI and SwaI of the corresponding full-length expression plasmids. 
enJS26-3'Env18 and enJS18-3'Env26 chimeras were derived by site-directed 
mutagenesis, by replacing the 3' end of enJSRV-26 env with the corresponding 
sequence in enJSRV-18, and vice versa (enJS26-3'Env18: CTA to TTA at position 
1696 and TGT to TGC at position 1707, with respect to enJSRV-26 env; enJS18-
3'Env26: TTA to CTA at position 1696 and TGC to TGT at position 1707, with 
respect to enJSRV-18 env). 
enJS26-3'Env18LTR is an expression plasmid of a chimeric provirus containing 
most of the wild-type enJSRV-26 except for the 3' end of the sequence (i.e., the 
C-terminus Env and the 3'LTR) that derives,  instead,  from the corresponding 
sequence of the enJSRV-18 provirus. Accordingly, enJS18-3'Env26LTR contains 
the genomic sequence of the enJSRV-18 provirus apart from the 3' end of the Env 
protein and the 3'LTR, which were replaced by those of the enJSRV-26 provirus. 
enJS26-3'Env18LTR and enJS18-3'Env26LTR were obtained by digesting, 
respectively, enJS26-3'Env18 and enJS18-3'Env26 with PmlI and KpnI and then 
swapping the corresponding LTR regions. Chimeras enJS26-3'LTR18 and enJS18-
3'LTR26 express, respectively, the majority of enJSRV-26 and enJSRV-18 genomic 
sequences,  except for the 3'LTR  that  were exchanged between the two 
proviruses. These chimeras were derived by digesting the corresponding wild-
type expression plasmids with PmlI and KpnI and then swapping the LTR regions 
between them. 
All  of  the enJSRV-26 and enJSRV-18 chimeras were  a courtesy of Frédérick 
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Figure  15│  Restriction maps of the expression plasmids for enJSRV-26 and enJSRV-18. 
Maps were generated using the SeqBuilder program (Lasergene 9 Core suite). Relevant restriction 
sites are indicated. f1 (+) ori, phage origin of replication; ampicillin, antibiotic resistance; pUC ori, 
prokaryote origin of replication; P lac, lactose promoter; MCS, multiple cloning site; CMV, 
cytomegalovirus promoter; PBS, primer binding site. 
Mutants enJSRV-26ΔEnv and enJSRV-18ΔEnv contain two premature termination 
codons at the first and third methionine of env,  derived by site-directed 
mutagenesis. As a result, enJSRV-26∆Env and enJSRV-18∆Env encode the 
genomic sequence of the correspondent wild-type provirus except the Env 
glycoprotein.  
Mutants enJSRV26-EnvD6A, enJSRV18-EnvA6D and JSRV-EnvA6D express the full-
length viruses containing a single point mutation in their Env glycoproteins, and 
were derived by site-directed mutagenesis. The nomenclature of the mutants 
indicates the virus from which they were derived (enJSRV-26, enJSRV-18 or 
JSRV21, respectively), followed by the protein mutated (the Env glycoprotein), a 
single letter indicating the amino acid mutated (A is for alanine and D for 
aspartic acid), a number representing its position in Env, and a letter indicating 
the amino acid residue in the resulting mutant. 
Plasmids enJSEnv26, enJSEnv18 and enJSEnv56 express, respectively, the Env of 
enJSRV-26, enJSRV-18 and enJS56A1, and have already been described (Arnaud 
et al., 2007a). These mutants were obtained from the pCMV3JS21∆GP expression 
plasmid (Maeda et al., 2001) by replacing the env and 5' LTR of JSRV21 with those 
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pSP26-HA, pSP18-HA and pSP56-HA encode, respectively, the signal peptide of 
the Env glycoprotein (SP)  of enJSRV-26, enJSRV-18 and enJS56A1 proviruses. 
These mutants were obtained by polymerase chain reaction (PCR) from the 
corresponding Env expression plasmids encompassing the signal peptide region, 
and were tagged with the hemagglutinin (HA) epitope (YPYDVPDYA). 
In enJS18Env-PPT, the signal peptide of enJSRV-18 Env was replaced by the 
signal peptide of the human preprotrypsin protein (PPT), followed by the FLAG 
epitope fused at the N-terminus of enJSRV-18 surface domain (SU) of Env. 
enJS18Env-PPT has been described elsewhere (Caporale et al., 2009) and was 
provided by Claudio Murgia. 
In enJS56A1-CTE, enJS56A1 env was replaced by four copies of the constitutive 
transport element (CTE) of Mason-Pfizer Monkey Virus (M-PMV) by restriction 
digestion with BamHI. The M-PMV CTE was derived from pSarm4 as already 
described, and was a gift of Eric Hunter (Rhee et al., 1990). This mutant was a 
courtesy of Marco Caporale. 
Mutant enJS56A1ΔGag contains two nonsense mutations replacing the first and 
third methionine of enJS56A1 Gag, and was obtained by site-directed 
mutagenesis.  
pNLgagSty330 and pRev were kindly provided by Barbara Felber and have already 
been described (Felber et al., 1989; Mermer et al., 1990). pNLgagSty330 is a Rev 
and Tat-dependent HIV-1 Gag-Pol expression
  plasmid and,  for simplicity,  is 
termed pHIV1-RRE in this study. pRev is an expression plasmid for HIV-1 Rev. The 
expression plasmid for HIV-1 Tat was a gift from Mauro Giacca, and has been 
described elsewhere (Vardabasso et al., 2008). pHIV-SPRE26 and pHIV-SPRE18 
were obtained by PCR by replacing the Rev responsive element (RRE) in pHIV1-
RRE with the signal peptide responsive elements (SPRE), encompassing env and 
3'LTR, of enJSRV-26 and enJSRV-18, respectively. In order to avoid spurious 
expression of enJSRV-26 and enJSRV-18 SPs, PCR amplifications were carried out 
on enJSRV-26∆Env and enJSRV-18∆Env mutants, respectively. The expression 
plasmid  for SPRE56, which was termed pHIV-SPRE56 in this study, has been 
already described elsewhere (Caporale et al., 2009) and was a courtesy of Marco 
Caporale. This plasmid contains two premature termination codons in enJS56A1 Chapter 2                                                                                                                                          74 
env. After PCR amplification, fragments were digested with EcoRI and XbaI and 
ligated into the pHIV-1 RRE plasmid. 
For cloning purposes, PCR was performed using PfuUltra II Fusion HS DNA 
Polymerase (Stratagene).  For site-directed mutagenesis experiments, the 
QuickChange site-directed mutagenesis kit (Stratagene) was employed according 
to manufacturer’s instructions. Restriction enzymes were purchased from Roche 
and  New England Biolabs.  Ligation reactions were carried out using T4 DNA 
Ligase (Roche). Plasmid DNA was produced in DH5α strain of E. coli (Invitrogen) 
or XLI-Blue Supercompetent Cells (Stratagene), using the DNA Maxiprep kit 
(Invitrogen). All of the constructs described above were sequenced to ensure the 
presence of the introduced mutations. A list of all the primers used in this study 
is reported in the appendix (table 3). 
2.2 Cell cultures, transfections and viral preparations 
293T and COS cells were cultured in Dulbecco’s modified Eagle medium (GIBCO), 
supplemented with 10% foetal bovine serum at 37°C, 5% CO2 and 95% humidity. 
For western blotting purposes, cells were transiently transfected with 2 µg of 
the appropriate plasmids in Petri dishes of 10 cm in diameter, unless otherwise 
indicated, using the Calphos mammalian transfection kit (Clontech),  as 
recommended by the manufacturer. The empty vector pcDNA3.1 (Invitrogen) 
was used to calibrate the amount of DNA used in each experiment. Cells 
supernatants were collected at 48 hours post-transfection, and viral particles 
were concentred by ultracentrifugation (35000 rpm, SW41 Beckman centrifuge 
rotor, for 1 hour at 4°C on 29% sucrose cushion) and then resuspended in 1x TNE 
buffer, as already described (Arnaud et al., 2007a; Palmarini et al., 1999a). For 
analysis of intracellular proteins, cells were lysed by standard techniques as 
described previously (Arnaud et al., 2007a). Briefly, at 48 hours post-
transfection, cells were washed once with cold phosphate buffer saline (PBS), 
and lysed on ice for 10 minutes with modified RIPA buffer (150 mM Tris-HCl, 
pH7.4; 1% NP-40; 1 mM EDTA; 150 mM NaCl; 1 µM PMSF; 1 mM NaF) 
supplemented with a cocktail of protease inhibitors (Complete™, Roche), 
according to the manufacturer’s recommendations. Cells were then snap frozen 
in liquid nitrogen, thawed on ice, and sonicated. Lysates were further 
centrifuged at 10000 rpm (SW41 Beckman centrifuge rotor) for 30 minutes at Chapter 2                                                                                                                                          75 
4°C, supernatants were collected, and protein concentration was determined by 
the method of Lowry (Lowry et al., 1951). 
2.3 Western blotting 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blotting were performed on concentrated viral particles and cell lysates 
(15 µl of 200x concentrated virus and 200 mg of protein extracts), as previously 
described  (Arnaud et al., 2007a; Palmarini et al., 1999a). Briefly, after SDS-
PAGE, proteins were transferred to nitrocellulose membranes (Hybond, 
Amersham), and blocked for 1 hour at room temperature with blocking buffer 
(5% skimmed milk in TBS/T [0.1% Tween 20 in TBS]). Membranes were then 
rinsed with TBS/T three times for 5 minutes, and incubated with the selected 
primary antibody. This step was performed either for 1 hour at room 
temperature or overnight at 4°C. For western blotting, all primary and 
secondary antibodies employed in this study were diluted in blocking buffer. 
enJSRVs/JSRV Gag protein was detected using a rabbit polyclonal serum against 
the JSRV major capsid protein (CA) (working dilution: 1:5000) (Mura et al., 
2004). A rabbit polyclonal serum towards the JSRV transmembrane protein (TM) 
was employed to detect Env proteins (working dilution: 1:100). Signal peptides 
tagged with the HA epitope were detected with a mouse monoclonal anti-HA 
antibody (Abcam) (working dilution: 1:3000), while γ-tubulin was detected with 
a rabbit polyclonal antibody (Sigma) (working dilution: 1:1000). After incubation 
with the primary antibody, membranes were rinsed three times in TBS/T for 5 
minutes, and further exposed to the appropriate peroxidase-conjugated 
secondary antibodies for 1 hour at room temperature. Donkey anti-rabbit 
(F[ab’]2 fragment) (Amersham, GE) (working dilution: 1:50000) and donkey anti-
mouse (IgG F[ab’]2) (Fitzgerald) (working dilution: 1:5000) were used as 
secondary antibodies. If membranes were exposed again to a different primary 
antibody, they were stripped with Restore Western Blot Stripping Buffer (Thermo 
Scientific) for 1 hour at 37°C, and washed three times with TBS/T for 5 minutes. 
Membranes were subsequently developed by using ECL Plus (Amersham) and 
signals were further quantified by measuring chemiluminescence in a Molecular 
Dynamics Storm 840 imaging system, employing the ImageQuant TL software 
(Molecular Dynamics). Each experiment was repeated independently at least 
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standard error). P values were calculated using the 2-tailed Student’s T-test, 
assuming that the two groups had equal variance. 
2.4 Immunoprecipitation 
Immunoprecipitation was performed essentially as already described (Murcia et 
al., 2007). Briefly, 293T cells were transfected with 2 µg of the appropriate 
plasmids, as indicated in Results. 48 hours after transfection, cells were lysed as 
described above. Protein extracts were then sonicated and quantified. 2 mg of 
whole-cell extract were rocked with 20 µl of anti-FLAG M2 Affinity Gel (Sigma) 
and incubated at 4°C for 1 hour. The beads were then washed three times with 
the IP buffer (20 mM Hepes buffer, pH 7.4; 150 mM NaCl; 0.1% Triton), 
supplemented with the protease inhibitor cocktail and resuspended in 50 µl of IP 
buffer or 3X FLAG epitope (Sigma). Samples were then boiled for 5 minutes and 
subjected to SDS-PAGE gradient gels (NuPAGE 4-12% Bis-Tris Gel; Invitrogen) and 
western blot analysis, as described above. The FLAG epitope was detected with 
a mouse monoclonal anti-FLAG (Sigma) antibody (working dilution: 1:5000). 
2.5 Confocal microscopy 
293T and COS cells were plated onto two well-chambered glass slides (Lab-Tek; 
Nalge Nunc International) and transfected with 2 µg of the appropriate plasmids, 
employing Lipofectamine supplemented with PLUS Reagent (Invitrogen), 
according to the manufacturer's instructions. 24 to 48 hours after transfection, 
cells were washed with PBS and fixed with 3% v/v formaldehyde for 15 minutes. 
After fixation, cells were processed essentially as already described (Mura et al., 
2004; Sfakianos and Hunter, 2003). Briefly, cells were permeabilized with PBS 
containing 0.1% Triton X-100 for 10 minutes at room temperature. Cells were 
then blocked for 5 minutes at room temperature, firstly with PBS containing 
0.4% fish skin gelatine and 0.2% Tween 20, and secondly with PBS containing 
2.5% normal goat serum and 0.2% Tween 20. Next, cells were incubated with the 
appropriate primary antibody overnight at 4°C. SP proteins tagged with the HA 
epitope were detected with mouse monoclonal anti-HA (Abcam) antibody 
(working dilution: 1:800). Rabbit polyclonal antibody to fibrillarin (Abcam) was 
used as a marker for the nucleolus (working dilution: 1:300). Cells were then 
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above. Subsequently, cells were incubated for 45 minutes at 37°C with the 
appropriate secondary antibody. Goat anti-mouse and anti-rabbit 
immunoglobulin G conjugated respectively with Alexa Fluor 488 and Alexa Fluor 
594 (Molecular Probes)  were used as secondary antibodies (working dilutions: 
1:3000). For confocal analysis, all primary and secondary antibodies were diluted 
in PBS containing 2.5% normal goat serum and 0.2% Tween 20. Finally, cells were 
washed three times, firstly with PBS containing 0.2% Tween 20, and secondly 
with PBS. Slides were mounted with medium containing DAPI (4',6'-diamidino-2-
phenylindole; Vectashield, Vector Laboratories) and analyzed with a Leica TCS 
SP2 confocal microscope. Single sections from confocal optical sections along 
the z axis were analyzed. 
2.6 Enzyme-linked immunosorbent assay (ELISA) 
ELISA assay was performed essentially as already described (Caporale et al., 
2009). Briefly, 293T cells were transfected with 1 µg of the appropriate plasmid 
(or 0.2 µg for HIV-1 Tat), as illustrated in Results. 48 hours after transfection, 
100  µl  of  cell supernatants were collected, filtered through a 0.45 µm 
microfilter (Millipore) and assessed
 for the presence of HIV-1 Gag proteins using 
a
 Murex HIV Antigen mAb kit (Abbot Murex), according to the manufacturer’s 
instructions. Absorbance was read at 450 nm with a microplate reader. Each 
experiment was repeated independently at least three times, and results are 
presented as the mean value for each sample (± standard error). 
2.7 Quantitative polymerase chain reaction (qPCR) 
2.7.1 Overview of the assay 
Quantitative PCR (qPCR) is a technique that allows accurate amplification and 
quantification of DNA. The assay is based on the PCR procedure, with the 
advantage that the amplified products are detected in “real time”, and not at 
the end of the reaction as for the standard technique. This permits a more 
sensitive quantification of target molecules (Higuchi et al., 1992). The amplified 
products can be detected employing fluorescence-labelled probes, such as 
TaqMan or molecular beacons probes, or DNA binding dyes, like SYBR Green. 
Both methods rely on the emission of fluorescence that is directly proportional 
to the amount of target product present in the reaction at any given cycle Chapter 2                                                                                                                                          78 
(Wilhelm and Pingoud, 2003). As the qPCR reaction proceeds, the quantity of 
amplified products, and thereby of fluorescence signals, increases  in the 
exponential phase, proportional to the initial amount of target DNA. The point at 
which fluorescence crosses the threshold value (arbitrarily chosen within the 
exponential phase of the reaction) is termed "threshold cycle" (Ct). This value is 
inversely proportional to the starting quantity of the amplified target DNA, i.e., 
the higher is the value of the Ct, the smaller is the initial amount of DNA present 
in the reaction mixture (Kubista et al., 2006). qPCR products can be quantified 
by (i) relative quantifications, which determine the levels of a target gene in 
test samples by expressing it as relative to the levels in reference samples (e.g., 
untreated versus treated cells, normal versus cancer cells, etc.), or (ii) absolute 
quantifications, which employ an external standard curve. The standard curve is 
generated by amplifying multiple dilutions containing known amounts of target 
DNA and, subsequently, relating them to their respective Ct values. Such  a 
standard curve is then used to extrapolate the quantity of DNA (or copy number) 
in unknown samples. In both relative and absolute quantifications, it is always 
recommended to perform an additional normalisation of the target gene with an 
endogenous standard gene. For this purpose, housekeeping genes, such as the 
glyceraldehyde-3-phosphate dehydrogenase (G3PDH or GAPDH), albumin, actins, 
tubulins, cyclophilin, 18S rRNA or 28S rRNA, are often used as reference genes 
(Mar et al., 2009; Popovici et al., 2009). In this study, the β-actin and SOX9 were 
used as reference genes. They were selected among different functional classes, 
in order to reduce the chance that they might be co-regulated, thus affecting 
the accuracy of the results. 
β-actin belongs to the actin family, a diverse group of proteins that includes α, β 
and  γ  isoforms  (Garrels and Gibson, 1976). Actins are the most abundant 
proteins in eukaryotic cells, highly conserved from yeast to humans (Schmidt and 
Hall, 1998). They have also been found in plants as actomyosin complex, where 
they are involved in intracellular movements as well as in plant cell cycle (Kost 
et al., 2002; Takagi, 2003; Vorobev and Ia, 1963; Wick, 1991). Actins play 
important roles in different cellular processes, including cell motility and 
cytoskeleton organization (Hunter and Garrels, 1977). In particular, the β-actin, 
together with the γ-actin, is one of  the major components of the 
microfilamentous structures in mammals and avian non-muscle cells (Clarke and Chapter 2                                                                                                                                          79 
Spudich, 1977), and is involved in cytokinesis and cell motility (Weaver and 
Weissmann, 1979). Sequential mutations in the β-actin protein have been shown 
to be associated with incremental increase in human fibroblasts tumorigenicity 
(Leavitt et al., 1982). 
SOX9 is a member of the SOX family, which consists of a large number of genes 
well conserved in vertebrates and invertebrates, closely related to the SRY (Sex 
Determining Region of Y chromosome) DNA-binding HMG (High Mobility Group) 
box (Denny et al., 1992; Gubbay et al., 1990; Wright et al., 1993). SOX genes 
family encodes transcription factors involved in several aspects of 
developmental processes, such as central nervous system differentiation, sex 
determination, and heart and kidney development (Bowles et al., 2000). In 
particular, SOX9 appears to be a key regulator of skeletal development and sex 
determination, as mutations in a single allele cause a severe skeletal 
malformation syndrome (referred to as campomelic dysplasia in humans) and 
autosomal sex reversal (Bi et al., 2001; Foster et al., 1994). Moreover, it has 
been shown that heterozygous SOX9  mutant mice die  perinatally due to 
haploinsufficiency of the gene (Bi et al., 2001). Finally, individuals with trisomy 
for chromosome 17, including the region containing SOX9, show skeletal 
anomalies and central nervous system deficiencies (Lenzini et al., 1988). 
2.7.2 Determination of the copy number variation of the 
transdominant enJS56A1 provirus in sheep genomic DNA 
qPCR assays were designed in order to assess the copy number variation of 
target genes (enJS56A1, enJSRV-6 and enJSRV-18) relative to reference genes (β-
actin and SOX9) in sheep genomic DNA. The copy number variation of each locus 
was determined by employing an absolute quantification method. To this end, 
external standard curves were generated. PCR products for enJS56A1 (532 bp), 
enJSRV-6 (577 bp), enJSRV-18 (497 bp), β-actin (438 bp) and SOX9 (438 bp) were 
amplified from sheep genomic DNA, employing antisense primers complementary 
to the genomic 3' flanking region of each provirus
20, and sense primers designed 
in a conserved region in env
21. Primers for β-actin
22 and SOX9
23
                                         
20 The antisense primers used to amplify the enJSRV-6 and enJSRV-18 proviruses have been 
already described (Arnaud et al., 2007a). 
 were designed on 
21 The env sequences of enJSRV-6, enJSRV-18 and enJS56A1 proviruses have been already 
reported and deposited in GenBank,  under accession numbers EF680319.1, EF680301.1 and 
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highly conserved regions of both genes. A list of all the primers used in this study 
is reported in the appendix (table 4). qPCR assays were carried out in triplicate 
in a total volume of 25 µl,  and performed in a Mx30005P (Stratagene) 
thermocycler, using the Brilliant II SYBR Green QPCR Low ROX Master Mix 
(Stratagene) and the Brilliant SYBR Green QPCR Core Reagent Kit (Stratagene), 
according to the manufacturer's instructions. The reaction mixture contained 20 
ng of sheep genomic DNA. A negative control, containing all reagents but no 
genomic DNA, was also used to check for contamination by exogenous DNA. The 
reaction was subjected to a denaturation step at 95°C for 10 minutes, followed 
by 40 cycles of denaturation at 95°C for 30 seconds, primer annealing at the 
temperature appropriate for each primer (55°C to 59°C for 30 seconds), and 
elongation at 72°C for 35 seconds, ending with a melting curve analysis to 
validate the specificity of the PCR products. The amplified fragments were then 
cloned into a PCR-4 TOPO vector (Invitrogen) and sequenced. qPCR reactions 
were performed on serial dilutions of plasmid DNA encoding for each locus (from 
10
2  to 10
7  copies) and containing a known number of molecules, and run in 
parallel with the samples of sheep genomic DNA. Reactions ended with a 
dissociation curve to validate the specificity of the PCR products. The presence 
of a single peak in the dissociation curve is indicative of specific amplification of 
target genes, whereas multiple extra peaks are usually due to contaminating 
DNA or primer dimers. 
Below are reported the amplification plots (Fig. 16), and the dissociation curve 
(Fig. 17) of serial dilutions of the β-actin expression plasmid, used to generate 
the standard curve for the reference gene. 
                                                                                                                             
22 Sense and antisense primers were designed using the β-actin sequence of Ovis aries deposited 
in GenBank under accession number NM_001009784.1. 
23  Oligonucleotide primers were designed in the 3'UTR of the ovine SOX9  gene (Payen and 
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Figure 16│ Amplification plots of the β-actin gene standard curve. The curve was generated 
on serial dilutions (from 10
2  to 10
7  copies) of plasmid DNA containing  the  β-actin  gene, as 
described in the text. The fluorescence data generated in the amplification plots are expressed as 
number of cycles (X-axis)  versus  fluorescence (Y-axis), and are baseline-corrected raw 
fluorescence (dR). ROX dye was used as a negative control for the qPCR assay. 
 
Figure 17│ Dissociation curve of serial dilutions (from 10
2 to 10
7 copies) of plasmid DNA 
encoding the β-actin gene. Dissociation curve analysis was performed at the end of PCR cycles. 
Data were obtained by increasing the temperature of reaction solutions from 55°C to 95°C, while 
continuously collecting fluorescence data. The increase in temperature causes PCR products to 
undergo denaturation, thereby reducing the fluorescence of specific products containing the SYBR 
Green dye. The fluorescence data generated in the dissociation curve are expressed as a function 
of fluorescence (Y-axis), and are baseline-corrected raw fluorescence (dR). ROX dye was used as 
a negative control for the qPCR assay. 
Copy number of standard DNA molecules was calculated by the MxPro QPCR 
Software (Stratagene), using the following formula (Godornes et al., 2007): Chapter 2                                                                                                                                          82 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑝𝑖𝑒𝑠
𝜇𝑙 � =
6.022 × 1023�𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙𝑒 � � × 𝐷𝑁𝐴 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛�𝑔
𝜇𝑙 � �
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑎𝑠𝑒𝑠 𝑝𝑎𝑖𝑟𝑠 × 660 𝑑𝑎𝑙𝑡𝑜𝑛𝑠
 
The resulting Ct values were plotted as a function of the log10 concentration of 
the input plasmid amount. The slope of the line was used to determine PCR 
efficiency and the unknown fold change of each locus in sheep genomic DNA. 
The equation that relates the slope to the amplification efficiency is: 
𝑃𝐶𝑅 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = 10
�−1
𝑠𝑙𝑜𝑝𝑒 � � − 1 
where PCR Efficiency corresponds to the proportion of template molecules that 
are doubled every cycle. From this equation it follows that a slope of –3.322 will 
result in a reaction with 100% efficiency, as for the β-actin gene standard curve 
(Fig. 18). 
 
Figure 18│ Standard curve of the β-actin gene. Ct values are plotted on the standard curve as a 
function of the log10 concentration of the input amount of the expression plasmid containing the β-
actin gene (SYBR Standards), and genomic DNA of the samples analyzed (SYBR Unknowns). The 
R Squared (RSq) value is an indicator of the quality of the fit of the standard curve to the standard 
data points plotted. The value is between 0 and 1: the closer the value is to 1, the better the fit of 
the line. The equation for the line is: 𝑌 = 𝑚 × log𝑥 + 𝑏, where 𝑚 is the slope of the line. 
Results were expressed as the ratio between the estimated number of molecules 
in the target and reference genes in each sample, using the following formula 
(Bieche et al., 1998): 
𝑁 =
𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑎𝑟𝑔𝑒𝑡 𝑔𝑒𝑛𝑒
𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑔𝑒𝑛𝑒
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2.7.3 Analysis of genomic DNA of wild and domestic sheep 
qPCR assays were designed to estimate the dosage of the transdominant 
enJS56A1 provirus (target gene) relative to the β-actin  and  SOX9  genes 
(reference genes) in genomic DNA of domestic and wild sheep. Gene dosage of 
enJSRV-6 and enJSRV-18 proviruses was also determined as additional control. 
The genomic DNA tested was collected from various breeds of domestic sheep 
(Ovis aries) (Dorset, Suffolk, Texel, Jacob, Red Maasai, Merino, Xalda, 
Rambouillet, Soay, Norway and Finsheep), wild sheep (O. dalli, O. canadensis, 
O. ammon and O. vignei), Mediterranean mouflon (O. orientalis musimon), and 
members of the genera Budorcas (B. taxicolor) and Pseudois (P. nayaur). All DNA 
samples were obtained and used in a previous study (Arnaud et al., 2007a). To 
determine the fold change of each locus, qPCR assays were carried out as 
already described. Standard curve efficiency was 99.2% for enJS56A1, 96.6% for 
enJSRV-6, 99% for enJSRV-18, 100% for β-actin, and 100% for SOX9. 
2.7.4 Analysis of genomic DNA of healthy and OPA affected 
domestic sheep 
qPCR assays were designed to estimate the copy number variation of enJS56A1 
in the genomic DNA of healthy and OPA-positive sheep, belonging to different 
flocks where OPA was endemic. The genomic DNA tested was collected from a 
total of fourteen  sheep  (seven  healthy  and  seven  OPA  affected  animals) 
belonging to the Blackface breed. To determine the copy number of the 
enJS56A1 locus in each animal, samples were subjected to an absolute qPCR 
analysis, as described above, employing β-actin as a reference gene. Standard 
curve efficiency was 92.9% for enJS56A1 and 99% for β-actin. All the samples 
used in this study were a courtesy of Dr. Chris Cousens at the Moredun Research 
Institute in Edinburgh. Note that the term “healthy sheep” refers to animals that 
did not show any clinical sign of OPA at the time of blood collection. By 
contrast, “OPA affected sheep” stands for animals that developed OPA and were 
found positive for JSRV by PCR on lung tumour samples. Chapter 2                                                                                                                                          84 
2.8 Genotyping enJS56A1-like proviruses 
The presence of a codon encoding an arginine or tryptophan residue at position 
21 of enJS56A1 (and enJS56A1-like proviruses) Gag protein was assessed by PCR. 
Genomic DNA samples collected from various breeds of domestic (Texel, n=2; 
Merino, n=1) and wild sheep (O. dalli, n=1; O. canadensis, n=1; O. ammon, n=1), 
and the Mediterranean Mouflon (Ovis orientalis musimon, n=1) were amplified by 
PCR using a forward primer complementary to the genomic 5' flanking region of 
enJS56A1 or enJSRV-20 proviruses, and a reverse primer complementary to their 
gag, as previously described (Arnaud et al., 2007a). PCR reactions were carried 
out in a total volume of 50 µl, and contained 100 ng of sheep genomic DNA and 
the HotStar Taq DNA polymerase system. Standard amplification cycles and 
annealing temperature at 55°C were used as recommended by the manufacturer 
(Qiagen). PCR products were then cloned into a pCR4-TOPO vector (Invitrogen), 
and forty individual clones for each PCR product were completely sequenced. 
2.9 Fluorescence in situ hybridization (FISH) 
FISH analysis was performed by Giulia Pia di Meo in  the  Leopoldo Iannuzzi 
laboratory  in Naples (Italy). The assay was carried out essentially as already 
described  (Chessa et al., 2009). Briefly, sheep peripheral blood cells were 
cultured  at 37°C in  RPMI 1640 medium (Invitrogen), supplemented with 15% 
foetal bovine serum,  1.5% concanavalin A (Sigma) and penicillin-streptomycin 
(Invitrogen). Cells were then synchronized with 300 µg/ml thymidine (Sigma) 
and, after 18 hours, washed and resuspended in medium containing 15 µg/ml 
bromodeoxyuridine (Sigma) and 30 µg/ml Hoechst 33258 (Invitrogen). Cells were 
then incubated for 6 hours at 37°C (the last hour in presence of 0.1  µg/ml 
colcemid, Sigma), treated with a hypotonic solution, and washed three times 
with methanol-acetic anhydride. Cell suspensions were then plated onto slides, 
incubated overnight at 50°C, and stained for 10 minutes with 25 µg/ml Hoechst 
33258. Slides were further probed with biotin-labelled BAC clones containing the 
appropriate provirus. Hybridization, chromosome staining, signal detection and 
image processing were performed as already described (Chessa et al., 2009) in 
at least thirty methaphases for each probe. Chromosome identification was 
carried out using the R-banding karyotype, by adding Fluorescein Avidin DCS and 
Biotinylated Anti-Avidin (Vectors Laboratories), as recommended by the Chapter 2                                                                                                                                          85 
manufacturer. Chromosome identification and band nomenclature followed the 
International System for Chromosome Nomenclature of Domestic Bovids 
(ISCNDB2000, 2001). 
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Chapter III 
Molecular determinant of JLR escape 
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3.1 Introduction 
As already discussed in paragraph 1.10.3, enJS56A1 can block JSRV release by a 
mechanism known as JLR (for JSRV late restriction) (Mura et al., 2004). This 
restriction activity is unique compared to those exerted by other retroviral and 
cellular restriction factors (e.g., Fv1, TRIM5α and APOBEC) (Luban, 2010), as it 
occurs at late steps of the viral replication cycle. In a previous work, Manuela 
Mura and colleagues demonstrated that enJS56A1 cannot release viral particles 
in the supernatant of transfected cells, despite abundant levels of Gag 
polyprotein in  cell lysates. Electron microscopy experiments revealed that 
enJS56A1 can form virus-like particles that assemble in the cytoplasm, but they 
cannot reach the plasma membrane and bud (Mura et al., 2004). The defect in 
enJS56A1 exit was mapped to a trypthophan residue (W) in position 21 of Gag 
polyprotein, which substitutes an arginine (R) that is well conserved  in all 
betaretroviruses (Mura et al., 2004). It has been suggested that the presence of 
W21 affects the general conformation of enJS56A1 Gag that, as a result, behaves 
like an unfolded or misfolded protein and is degraded by the proteasome. The 
W21R mutation confers to enJS56A1 a transdominant phenotype over JSRV: when 
co-expressed in the same cells, enJS56A1 Gag associates with JSRV Gag early 
after its synthesis, resulting in the formation of aggregates that are unable to 
traffic to the cell membrane, and are ultimately degraded by the proteasome 
(Arnaud et al., 2007b; Mura et al., 2004; Murcia et al., 2007). 
A recent study conducted by Frédérick  Arnaud and colleagues revealed that, 
during domestication, the  sheep genome  has been invaded by endogenous 
proviruses highly related to the exogenous and pathogenic JSRV, and hence 
termed enJSRVs. Five of the twenty-seven enJSRV loci (enJSRV-7, enJSRV-15, 
enJSRV-16, enJSRV-18 and enJSRV-26) display an intact genomic organization. 
Interference assays demonstrated that the transdominant enJS56A1 is able to 
block viral release from intact enJSRVs as efficiently as the exogenous JSRV. 
Interestingly, enJSRV-26, which is the “youngest” enJSRV locus isolated to date, 
possesses the unique ability to escape JLR (Arnaud et al., 2007a). 
In this chapter are presented the experimental evidence  that led to the 
characterization of the molecular determinant that allows enJSRV-26 to escape 
the restriction mechanism exerted by enJS56A1. Chapter 3                                                                                                                                        88 
3.2 Results 
3.2.1 The 5′ end of enJSRV-26 env contains the determinant of 
JLR escape 
The first aim of this study was to identify the molecular determinant that allows 
enJSRV-26 to escape JLR. Sequence analysis revealed that, at the nucleotide 
level, enJSRV-26 is 98% identical to another insertionally polymorphic provirus in 
the sheep genome, enJSRV-18. In particular, enJSRV-26 and enJSRV-18 gag are 
100% identical. However, despite their high degree of similarity, these viruses 
display different phenotypes in the  presence of the transdominant enJS56A1: 
enJSRV-18 is restricted like the exogenous JSRV and other enJSRVs, while 
enJSRV-26 is able to escape JLR (Arnaud et al., 2007a) (Fig. 19). 
 
Figure  19│  enJSRV-26 is able to escape JLR.  (A) Schematic representation of expression 
plasmids encoding enJSRV-26 and enJSRV-18. CMV, cytomegalovirus immediate early promoter; 
R, terminally repeated sequences; U5, unique 5' sequence; U3, unique 3' sequence. (B) Western 
blots of concentrated supernatants (virus) and cell extracts (cells) of 293T cells transfected with the 
plasmids (2 µg) indicated in the panel. Membranes were incubated with antibodies against the 
major capsid protein of JSRV (CA) or γ-tubulin as loading control. Levels of CA associated with 
viral particles released in the supernatants were quantified by chemifluorescence using 
ImageQuant TL software (Molecular Dynamics). Graphs represent data obtained from three 
independent experiments. The values obtained by the wild-type enJSRV-26 or enJSRV-18 
expressed in the absence of enJS56A1 (black bars) were arbitrarily set as 100%. Error bars 
indicate standard errors; statistically significant differences (P<0.01) are indicated with two 
asterisks. 
As JLR depends on the interaction between transdominant and functional Gag 
proteins, one would expect that the lower the levels of functional  Gag, the 
better the efficiency of JLR. However, it is noteworthy that enJSRV-26, which Chapter 3                                                                                                                                        89 
exhibits lower levels of Gag compared to  enJSRV-18, is able to elude the 
restriction mechanism induced by enJS56A1 (Fig.  19). In addition, even by 
normalizing the levels of enJSRV-26 and enJSRV-18 Gag, interference assays 
revealed that the latter is still restricted by enJS56A1 (Fig. 20). 
 
Figure 20│ The amount of functional Gag protein does not determine JLR escape. Western 
blot analysis of concentrated supernatants (virus) and cell extracts (cell) of 293T cells co-
transfected with fixed amount of enJS56A1 expression plasmid (2 µg), and JSRV (1 µg), enJSRV-
26 (2 µg), or enJSRV-18 (0.5 µg) expression plasmids. Membranes were incubated with an 
antibody towards the major capsid protein of JSRV (CA). Note that JSRV and enJSRV-18 are 
restricted by enJS56A1 albeit they express the same levels of Gag as enJSRV-26. 
These results indicate that the relative amount of functional  Gag does not 
necessarily influence the ability to escape JLR. Indeed, similar studies showed 
that JSRV is still restricted by the transdominant enJS56A1 even when the ratio 
between the two expression plasmid is 10 (JSRV) to 1 (enJS56A1) (Mura et al., 
2004). 
Sequences alignments revealed that the major differences between enJSRV-26 
and enJSRV-18 are found in the 3'LTR (Fig. 21) and env (Fig. 22). Chapter 3                                                                                                                                        90 
 
Figure 21│ Alignment of enJSRV-26 and enJSRV-18 LTR sequence. Sequence alignment was 
generated by CLC Sequence Viewer program version 6.5.1. Identical nucleotides are represented 
as dots, while different nucleotides are reported in red. The deletion of thirty-three base pairs 
exhibited by enJSRV-26 LTR is indicated as a red dashed line. Numbering starts from the U3 
sequence of the LTR. In enJSRV-26, U3, R and U5 are located respectively between nucleotide 
positions 1 and 287, 288 and 300, 301 and 413. In enJSRV-18, the corresponding sequences span 
from nucleotide positions 1 and 320, 321 and 333, and 334 and 446 respectively. The enJSRV-26 
and enJSRV-18 LTR sequences reported in the figure have been deposited in GenBank, under 
accession numbers EF680297.1 and EF680301.1, respectively. 
As shown in figure  21,  enJSRV-26 and enJSRV-18 LTRs differ for three 
nucleotides located within the U5 sequence. In addition, enJSRV-26 LTR exhibits 
a deletion of thirty-three base pairs  in the U3 region, with respect to the 
corresponding sequence in enJSRV-18 LTR. 
The env genes of enJSRV-26 and enJSRV-18 differ for ten nucleotides, resulting 
in six synonymous and four nonsynonymous mutations (Fig. 22). Chapter 3                                                                                                                                        91 
 
Figure 22│ Alignment of enJSRV-26 and enJSRV-18 env sequence. Legend on next page. Chapter 3                                                                                                                                        92 
(From previous page) Sequence alignment  was generated by CLC Sequence Viewer program 
version 6.5.1. Nucleotide numbering is from transcription start site. Identical nucleotides are 
represented as dots, while different nucleotides are indicated in red. The amino acid residues 
resulting from the four nonsynonymous (indicated respectively in violet and green in the resulting 
enJSRV-26 and enJSRV-18 Env glycoproteins) and six synonymous mutations (in black) are 
reported above each relevant codon. The enJSRV-26 and enJSRV-18 env sequences reported in 
figure have been deposited in GenBank, under accession numbers EF680297.1 and EF680301.1, 
respectively. Ala. 
In particular, four of the six synonymous mutations are located at the 5' end of 
env, while the two remaining ones lie at the 3' end of the sequence. Conversely, 
all of the four nonsynonymous mutations are found in the 5' end of env (Fig. 22). 
A synonymous mutation, also known as a silent mutation, is a base change in the 
DNA coding sequence that does not affect the amino acid sequence of the 
resulting protein. Indeed, these changes usually occur at the third position of 
the codon and, due to the redundancy of the genetic code
24
A nonsynonymous mutation, on the other hand, is a point mutation, which 
causes insertion of a different amino acid into the growing polypeptide chain, 
giving rise to an altered protein. For instance, the codon GAC spanning from 
nucleotide positions 16 and 18 in enJSRV-26 env, which encodes an aspartic acid 
(Asp), in enJSRV-18 env is mutated to GCT, which codes for an alanine (Ala). The 
CAA codon in enJSRV-26 env (nucleotide positions 73-75) encodes a glutamine 
(Gln) and is replaced with a CAT nucleotide triplet in enJSRV-18  env, which 
codes for a histidine (His). Between nucleotide positions 197 and 199, enJSRV-26 
env  possesses  the  AAT  codon (asparagine, Asn) which in enJSRV-18  env  is 
, do not alter the 
polypeptide  sequence. For instance, both AGC (enJSRV-26  env) and AGT 
(enJSRV-18  env) codons, located between nucleotide positions 98 and 100, 
encode a serine (Ser), while the threonine (Thr) is encoded by the ACC (enJSRV-
26 env) and ACT (enJSRV-18 env) triplets spanning from nucleotide positions 122 
to 125. The CGA (enJSRV-26  env) and CGT (enJSRV-18  env) codons, located 
between nucleotide positions 149 and 151, encode an arginine (Arg), whereas 
the alanine is encoded by the GCG (enJSRV-26 env) and GCA (enJSRV-18 env) 
codons between nucleotide positions 235 and 237. Both CTA (enJSRV-26 env) and 
TTA (enJSRV-18 env) triplets, spanning from nucleotide positions 1696 to 1698, 
encode a leucine (Leu), while the TGT (enJSRV-26 env) and TGC (enJSRV-18 env) 
codons, at nucleotide positions 1707-1709, encode a cysteine (Cys) (Fig. 22). 
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mutated to AAA (lysine, Lys). Finally, the GCG codon in enJSRV-26  env, at 
nucleotide positions 251-253, encodes an alanine (Ala) and is replaced with the 
TCG nucleotide triplet (serine, Ser) in enJSRV-18 env (Fig. 22). 
As illustrated above, the major differences between enJSRV-26 and enJSRV-18 
are found in their env genes and 3'LTR sequences, therefore it could be possible 
that these regions might contain the main determinant of enJSRV-26 JLR escape. 
In order to experimentally prove this hypothesis, a series of chimeras between 
enJSRV-18 and enJSRV-26 env genes and/or 3'LTR sequences were derived, and 
interference assays were carried out in presence of the transdominant enJS56A1 
(Fig.  23).  The release of viral particles  from enJS26-Env18 was restricted in 
presence of enJS56A1, while enJS18-Env26 escaped JLR (Fig. 23A). Furthermore, 
enJS18-5'Env26 and enJS26-3'Env18 chimeras were able to elude enJS56A1-
induced restriction, whereas enJS26-5'Env18 and enJS18-3'Env26 virus exit was 
impaired by enJS56A1 (Fig.  23, panels B and  C). Finally, enJS26-3'LTR18 and 
enJS26-3'Env18LTR chimeras were able to escape JLR, whereas the presence of 
enJS56A1 restricted viral particles release from enJS18-3'LTR26 and enJS18-
3'Env26LTR (Fig.  23, panels D  and  E). Collectively, these results demonstrate 
that the 5' end of enJSRV-26 env contains the main determinant of JLR escape. Chapter 3                                                                                                                                        94 
 
Figure 23│ The 5' end of enJSRV-26 env contains the main determinant of JLR escape. (A-E) 
Western blots of concentrated supernatants (virus) and cell extracts (cells) of 293T cells 
transfected with the plasmids indicated and schematically represented above each panel. Numbers 
indicate amino acid residues in Env. For simplicity, the U5, R and U3 regions of enJSRV-26 and 
enJSRV-18 are indicated as white and grey boxes respectively. Membranes were incubated with 
antibodies towards the major capsid protein of JSRV (CA) or γ-tubulin as loading control. Levels of 
CA associated with viral particles released in the supernatants were quantified by 
chemifluorescence using ImageQuant TL software (Molecular Dynamics). Graphs represent data 
obtained from three independent experiments. Note that for the graphs of panels C and D different 
scales were adopted. The values obtained by each chimera expressed in absence of enJS56A1 
(black bars) were arbitrarily set as 100%. Error bars indicate standard errors; statistically significant 
differences are indicated with one (P<0.05) or two (P<0.01) asterisks. Only those chimeras 
containing the 5' end of enJSRV-26  env  are able to escape enJS56A1 restriction.  CMV, 
cytomegalovirus immediate early promoter. Chapter 3                                                                                                                                        95 
3.2.2 The enJSRV-26 Env protein per se induces JLR escape 
The data presented above demonstrated that the main determinant of JLR 
escape is located at the 5' end of enJSRV-26 env. However, it was not possible to 
discriminate whether the enJSRV-26 Env protein per se,  or  cis-acting regions 
within the env mRNA, determined JLR escape. To this end, enJSRV-26ΔEnv and 
enJSRV-18ΔEnv mutants were generated by inserting two premature termination 
codons in the env coding region, in order to prevent Env glycoprotein expression 
while maintaining the full-length viral genome. Interference assays were then 
carried out with enJS56A1 and the Env mutants (enJSRV-26ΔEnv  or  enJSRV-
18ΔEnv) in presence or absence of their corresponding Env proteins (enJSEnv26 
and enJSEnv18, respectively) (Fig. 24). 
 
Figure 24│ The enJSRV-26 Env glycoprotein per se is involved in JLR escape. (A and B) 
Western blots of concentrated supernatants (virus) and cell extracts (cells) of 293T cells 
transfected with the plasmids indicated in each panel. Membranes were incubated with antibodies 
against the major capsid protein (CA) of JSRV or γ-tubulin as a loading control. Levels of CA 
associated with viral particles released in the supernatants were quantified by chemifluorescence 
using ImageQuant TL software (Molecular Dynamics). Graphs represent data obtained from three 
independent experiments. The values obtained by each mutant expressed in absence of enJS56A1 
(black bars) were arbitrarily set as 100%. Error bars indicate standard errors; statistically significant 
differences are indicated with two (P<0.01) asterisks. Env expression was controlled by incubating 
membranes with antibodies towards the transmembrane (TM) domain of JSRV. 
enJSRV-26ΔEnv was able to escape JLR when its Env (enJSEnv26) was provided in 
trans, whereas it was restricted in presence of enJSRV-18 Env (enJSEnv18) (Fig. 
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of its Env (enJSEnv18), while escaped JLR when co-expressed with enJSRV-26 
Env (enJSEnv26) (Fig.  24B). These results indicate that the enJSRV-26 Env 
protein per se, and not cis-acting regions in its mRNA, is sufficient to determine 
JLR escape. 
3.2.3 Aspartic acid at position 6 (D6) in enJSRV-26 Env is the 
main determinant of JLR escape 
The results collected thus far shown that the 5' end of enJSRV-26 Env 
glycoprotein contains the determinant of JLR escape. As already discussed in 
chapter I (paragraphs 1.6.4.3 and 1.9.2), previous studies demonstrated that the 
N-terminal region of JSRV Env contains a signal peptide sequence (JSE-SP), 
which favours full-length viral RNA nuclear export and enhances Gag proteins 
synthesis and viral particle release (Caporale et al., 2009; Hofacre et al., 2009). 
Interestingly, enJSRVs were also shown to possess signal peptides located at the 
5' end of their Env glycoproteins (residues 1 to 80) with the same domains and 
functions as JSE-SP (Caporale et al., 2009). 
Analysis of the signal peptide sequences of enJSRV-26 and enJSRV-18 Env 
glycoproteins (SP26 and SP18, respectively) revealed that they possess three 
different amino acid residues (aspartic acid at position 6, D6; histidine at 
position 25, H25; lysine at position 63, K63) (Fig. 25). Interestingly, two other 
enJSRVs loci, enJSRV-7 and enJSRV-15, that are restricted like  enJSRV-18 by 
enJS56A1, contain only one different residue (D6) from SP26. The alanine (A) at 
position 6 is well conserved in the signal peptides of JSRV and all the 
insertionally polymorphic enJSRVs, with the exception of enJSRV-26, where is 
replaced by an aspartic acid (D) residue (Fig. 25). Note that the A6D substitution 
in the signal peptide of the enJSRV-26 Env does not alter the hydrophobic profile 
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Figure  25│  Amino acid sequence alignments of the  signal peptide  of four insertionally 
polymorphic enJSRV proviruses and the exogenous JSRV.  Sequence  alignments were 
generated by CLC Sequence Viewer, version 6.5.1 program. Amino acid sequences are reported 
according to the one-letter code.  Nucleotide numbering is from transcription start site. Dots 
represent identical residues, while in red are indicated different amino acids. The dashed line 
represent the cleavage site for the signal peptidase. Complete sequences of Env glycoproteins 
have been deposited in GenBank, under accession numbers AAD45228.2 (JSRV Env), 
ABV71076.1 (enJSRV-7 Env), ABV71081.1 (enJSRV-15 Env), ABV71091.1 (enJSRV-18 Env) and 
ABV71071.1 (enJSRV-26 Env). ARM, arginine-rich motif; NLS, nuclear localization signal; NES, 
nuclear export signal. 
 
Figure 26│ Hydrophobic profile of the enJSRV-26 Env glycoprotein. The hydrophobic profile of 
the enJSRV-26 was generated by CLC Sequence Viewer, version 6.5.1 program and calculated 
according to the Kyte and Doolittle method (Kyte and Doolittle, 1982). The orange box indicates the 
signal peptide, while the green line represents the consensus proteolytic cleavage site separating 
SU from TM. 
Thus, it was possible that the D6 residue might play a critical role in enJSRV-26 
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derived by replacing the alanine at position 6 in enJSRV-18 Env with an aspartic 
acid (enJSRV18-EnvA6D), and mutating the aspartic acid at position 6 in enJSRV-
26 Env to an alanine (enJSRV26-EnvD6A) (Fig. 27). 
 
Figure 27│ Aspartic acid residue at position 6 (D6) in enJSRV-26 Env is responsible for JLR 
escape. (A and B) Western blots of concentrated supernatants (virus) and cell extracts (cells) of 
293T cells transfected with the plasmids indicated in each panel. Membranes were incubated with 
antibodies against the major capsid protein (CA) of JSRV or γ-tubulin as a loading control. Levels 
of CA associated with viral particles released in the supernatants were quantified by 
chemifluorescence using ImageQuant TL software (Molecular Dynamics). Graphs represent data 
obtained from three independent experiments. The values obtained by each mutant expressed in 
absence of enJS56A1 (black bars) were arbitrarily set as 100%. Error bars indicate standard 
errors; statistically significant differences are indicated with one (P<0.05) or two (P<0.01) asterisks. 
The D6A mutation was found to confer to enJSRV-26 susceptibility to JLR, while 
the opposite mutation (A6D) allowed enJSRV-18 to escape enJS56A1-induced 
restriction (Fig.  27A). Interestingly, similar results were obtained for JSRV, 
normally restricted by enJS56A1 (Fig. 27B). Overall the data collected thus far 
demonstrate that the A6D mutation in SP26  is the main determinant of JLR 
escape. 
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3.3 Discussion 
The data presented in this chapter demonstrate that the molecular determinant 
of JLR escape maps to the aspartic acid residue (D) at position 6 of the signal 
peptide of  enJSRV-26 Env glycoprotein  (SP26). The D6 residue substitutes an 
alanine (A6), well conserved in JSRV and all the other enJSRVs. The A6D 
mutation allows enJSRV-18 and JSRV to escape the restriction induced by 
enJS56A1, while the opposite mutation (D6A) renders enJSRV-26 susceptible to 
JLR. 
The D6 residue lies within the N-terminus of enJSRV-26 Env, and indeed only 
those mutants containing this protein  portion in their chimeric Env (enJS18-
Env26, enJS18-5'Env26, enJS26-3'Env18, enJS26-3'LTR18 and enJS26-3'Env18LTR) 
are able to escape JLR. Accordingly, chimeras expressing the 5' end of enJSRV-18 
Env (enJS26-Env18, enJS26-5'Env18, enJS18-3'Env26, enJS18-3'LTR26 and enJS18-
3'Env26LTR) are restricted by enJS56A1 (Fig. 23). 
Interestingly, although some chimeras share the same portions of Env, they are 
inhibited by enJS56A1 at different levels. For instance, even if both enJS26-
5'Env18 and enJS26-Env18 contain the 5' end of enJSRV-18 Env, the first chimera 
is more restricted than the second by the transdominant enJS56A1  (Fig.  23, 
panels A and B). Similarly, in presence of enJS56A1, enJS18-Env26 is able to 
release greater levels of viral particles  than enJS18-5'Env26,  despite both 
chimeras contain the determinant to escape JLR (i.e., the A6D substitution in 
Env) (Fig. 23, panels A and B). Finally, enJS18-3'LTR26 is restricted by enJS56A1 
at greater levels than the correspondent wild-type enJSRV-18 virus (cfr. Fig. 19 
and Fig. 23D) while, in presence of enJS56A1, enJS26-3'LTR18 releases higher 
amount of viral particle compared to the wild-type enJSRV-26 (cfr. Fig. 19 and 
Fig. 23D). These differences may  be due to modifications in the genomic 
sequence of the chimeras (i.e., introduction or removal of portions of env or 
LTR) that may alter the RNA stability, thereby leading to decreased viral protein 
expression and particle release. It is noteworthy that enJSRV-26 LTR contains a 
deletion in the U3 sequence, which may render its RNA less stable. 
In presence of the transdominant enJS56A1, the co-expression of enJSRV-26∆Env 
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enJSEnv18) does not recapitulate the phenotypes of the corresponding wild-type 
viruses. Indeed, the levels of viral particles  released by both enJSRV-26 and 
enJSRV-18 are considerably lower than those of the mutants in presence of the 
corresponding Env (cfr. Fig. 19 and Fig. 24). These differences may be explained 
assuming  that enJSEnv26 and enJSEnv18 expression plasmids produce higher 
levels of Env than those encoding the wild-type viruses. Indeed, in a previous 
study, enJSRVs Env glycoprotein was found to enhance Gag expression and viral 
particle production (Caporale et al., 2009).  Thus, in our system,  one could 
speculate that higher levels of Env glycoprotein may promote Gag synthesis and 
viral particle release. 
It was recently demonstrated that that the signal peptide of JSRV and enJSRV 
Env possesses a predicted nuclear localization signal (NLS) and an arginine-rich 
RNA-binding motif (ARM) that determine its intracellular localization as well as 
function. Indeed, a signal peptide  deleted of NLS or ARM sequence  displays 
altered intracellular localization and/or inability to enhance Gag expression and 
viral particle release (Caporale et al., 2009). Interestingly, the A6D mutation lies 
within the NLS and ARM motifs of SP26, and could therefore affect the 
intracellular localization and/or the biological function of the latter. In the next 
chapter these hypothesis will be investigated. 
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Chapter IV 
How enJSRV-26 escapes enJS56A1-
induced restriction 
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4.1 Introduction 
Recent studies have shown that the signal peptide of JSRV Env glycoprotein (JSE-
SP) functions as a post-transcriptional regulator of viral gene expression, as it is 
able to enhance nuclear export of unspliced viral RNAs and increase viral 
particle release (Caporale et al., 2009; Hofacre et al., 2009; Nitta et al., 2009). 
Similarly to HIV Rev (Stauber et al., 1995), JSE-SP contains a nuclear localization 
signal (NLS), an arginine-rich RNA-binding motif (ARM) and a nuclear export 
sequence (NES) (Caporale et al., 2009; Hofacre et al., 2009). These motifs map 
to the N-terminal end of the protein and determine its intracellular localization 
(Caporale et al., 2009; Hofacre et al., 2009). In  particular, the NLS domain 
targets  JSE-SP  to the nucleoli of transfected cells, while the NES motif is 
involved in the nucleocytoplasmic export of the aforementioned  protein 
(Caporale et al., 2009; Hofacre et al., 2009). NLS, ARM and NES motifs have also 
been shown to be important for the functional activity of JSE-SP (Caporale et 
al., 2009; Hofacre et al., 2009). Indeed, mutations in these domains alter JSE-SP 
function, resulting in a decrease of Gag synthesis and viral production (Caporale 
et al., 2009). 
Upon targeting Env to the ER, JSE-SP is cleaved-off from the protein and enters 
the nucleus. Once there, JSE-SP is targeted by NLS to the nucleolus, where it 
forms  ring-like structures (Caporale et al., 2009; Hofacre et al., 2009).  The 
nucleolus is a dynamic subnuclear compartment involved in various processes, 
including ribosome biogenesis and regulation of cell cycle (Emmott and Hiscox, 
2009). These functions are frequently mediated by the sequestration or release 
of nucleolar proteins. Viruses usually interact with the nucleolus to take over 
host cell functions and recruit nucleolar proteins to help with virus replication 
(Wang et al., 2010). It is possible to hypothesize that JSE-SP localizes to the 
nucleolus to hijack the host cellular machinery, thereby  facilitating JSRV 
replication. There,  most likely,  JSE-SP  binds  to  its signal peptide-responsive 
element (SPRE), an RNA secondary structure located at the 3' end of the viral 
RNA (spanning the last fifty  nucleotides of env  and  one hundred fourteen 
nucleotides of U3) (Caporale et al., 2009). A recent study conducted by Marco 
Caporale and colleagues in our laboratory demonstrated that the function of 
JSE-SP  depends on the presence of an  intact  SPRE.  Indeed,  293T  cells co-
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able to release viral particles (Caporale et al., 2009). The binding between JSE-
SP and SPRE seems to be mediated by ARM (Nitta et al., 2009), and results in the 
nucleocytoplasmic export of full-length viral transcripts via the cellular Crm1 
protein (Caporale et al., 2009; Nitta et al., 2009). 
The results presented in the previous chapter demonstrate that the main 
determinant of JLR escape is the residue D6 of SP26. Interestingly, this amino 
acid residue maps to predicted NLS and ARM motifs of the protein. Thus, it could 
be speculated that the A6D mutation might affect the intracellular localization 
and/or the activity of SP26. In this chapter are illustrated all the experiments 
performed to unveil the mechanism adopted by enJSRV-26 in order to escape 
JLR. 
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4.2 Results 
4.2.1 SP26 does not localize to the nucleolus 
The first aim of this study was to assess whether the A6D mutation could affect 
the intracellular localization of SP26. To this end, the hemagglutinin (HA) 
epitope was fused to the C-terminus of SP26 and SP18, in order to generate 
pSP26-HA and pSP18-HA expression plasmids, respectively. Confocal microscopy 
of cells transfected with pSP26-HA or pSP18-HA showed that both SP18 and SP26 
localized in the cytoplasm and in the nucleus of transfected cells. However, 
while SP18  co-localized with nucleolar markers,  such as fibrillarin, SP26 
displayed a diffuse nuclear staining
 pattern with no accumulation in the nucleoli 
(Fig.  28). The relative number of cells expressing SP18  with nucleolar 
localization was about 80-fold  higher than those expressing SP26  (Fig.  28C). 
Collectively, these data suggest that the A6D mutation most likely affects the 
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Figure  28│  SP26  does not localize  to the nucleolus. 293T (A) and COS  (B) cells were 
transfected with pSP26-HA or pSP18-HA expression plasmids, fixed at 24 hours post-transfection, 
and incubated with anti-HA (green) and fibrillarin (red) antibodies. Nuclei are shown in blue. Both 
SPs display nuclear localization, but only SP18 shows a strong co-localization with the nucleolar 
marker fibrillarin. Bars correspond to 10 µm. (C) Percentage of 293T cells expressing pSP26-HA or 
pSP18-HA and displaying nuclear or nuclear/nucleolar localization. Approximately fifty cells were 
counted for each experiment. Chapter 4                                                                                                                                        106 
4.2.2 The presence of SPRE does not alter the intracellular 
localization of SP26 
Both JSRV and enJSRVs contain a signal peptide responsive element (SPRE) 
located at the 3' end of the viral genome, spanning the env and U3 regions. This 
sequence was found to affect the intracellular localization of JSE-SP  in cis 
(Caporale et al., 2009; Nitta et al., 2009). Indeed, in presence of SPRE, JSE-SP 
relocalized from the nucleus to the cytoplasm of transfected cells, facilitating 
the export of unspliced viral RNAs (Caporale et al., 2009; Nitta et al., 2009). 
Hence, the next step of this study was to assess whether the SPREs of enJSRV-26 
and enJSRV-18 were also able to affect the intracellular localization of their 
corresponding signal peptides. 
To this end, confocal microscopy experiments were performed on 293T cells co-
transfected with pSP26-HA or pSP18-HA expression plasmids and their 
corresponding  Env mutants  (enJSRV-26∆Env or enJSRV-18∆Env respectively), 
containing  intact  SPREs. In presence of enJSRV-26∆Env, SP26  was found to 
display a diffuse nuclear staining in the cytoplasm and nucleus of transfected 
cells with no accumulation in the nucleoli (Fig. 29A), thereby maintaining the 
same localization pattern as when expressed in absence of SPRE (cfr. Fig. 29, 
panels A and C and Fig. 28). Conversely, in presence of enJSRV-18∆Env, SP18 
accumulated preferentially in the nucleoli (Fig. 29B), but the relative number of 
cells displaying nucleolar localization was lower compared to those expressing 
SP18 by itself (Fig. 29C versus 28C). These results suggest that only the SPRE of 
enJSRV-18 is able to affect the intracellular localization of its  corresponding 
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Figure 29│ The presence of the enJSRV-26 signal peptide responsive element (SPRE) does 
not relocalize SP26. (A and B) 293T cells transfected with the indicated plasmids were fixed at 24 
hours  post-transfection and stained with anti-HA (green) and fibrillarin (red) antibodies. For 
confocal experiments of 293T cells expressing pSP18-HA and enJSRV-18∆Env expression 
plasmids, both nuclear (top) and nuclear/nucleolar (bottom) staining are shown. Scale bars 
correspond to 10 µm. (C) Quantification of nuclear or nuclear/nucleolar staining pattern of SP26 
and SP18 expressed in presence of the respective Env mutants in 293T cells. Approximately fifty 
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4.2.3 The signal peptide of enJS56A1 Env does not relocalize 
SP26 to the nucleolus 
Previous studies showed that a HIV-1 Rev mutant with an altered RNA-binding 
site (RevM5) localized predominantly in the cytoplasm of mammalian cells and 
was unable to bind the RRE (Malim et al., 1989). However, in presence of HIV-1 
Rev, RevM5 accumulated in the nucleoli, indicating that the wild-type protein 
was able to relocalize this mutant (Daelemans et al., 2004). Therefore, in our 
experimental system, it was possible that, when co-expressed in the same cell 
type, the functional SP56 could rescue the defect of SP26 by relocalizing it to 
the nucleolus. 
To test this hypothesis, confocal microscopy experiments were performed on 
293T cells transiently transfected with expression plasmids encoding SP26 or 
SP18 (pSP26-HA or pSP18-HA), their correspondent Env mutants (enJSRV-26∆Env 
or enJSRV-18∆Env respectively), and the expression plasmid for the full-length 
enJS56A1. In presence of enJS56A1, SP26  displayed  its typical  diffuse 
nucleocytoplasmic pattern with no accumulation in the nucleoli, indicating that 
it was not relocalized by the functional SP56 (cfr. Fig. 30, panels A and C and 
Fig. 29). Similarly, the presence of SP56 did not affect the nucleolar localization 
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Figure  30│  The functional SP56  does not relocalize  SP26.  (A and B) 293T cells were 
transfected with the indicated plasmids and analysed by confocal microscopy employing antibodies 
towards the HA epitope (green) and fibrillarin (red). Confocal experiments of cells transfected with 
pSP18-HA, enJSRV-18∆Env and enJS56A1 expression plasmids,  displaying both nuclear and 
nuclear/nucleolar staining are showed. Scale bars, 10 µm. (C) Percentage of 293T cells expressing 
SP26 or SP18, in presence of enJS56A1 and the correspondent Env mutants, displaying nuclear or 
nuclear/nucleolar localization. Approximately fifty cells were counted for each experiment. Chapter 4                                                                                                                                        110 
4.2.4 SP26 does not show dominant negative effects over 
enJS56A1 Gag expression 
The data presented above indicate  that  the A6D mutation affects the 
intracellular localization of SP26 and it is not rescued by SP56. However, it was 
possible that the A6D mutation could influence SP56 intracellular localization, 
thereby favouring JLR escape. As already mentioned, JSE-SP was found to 
enhance Gag protein synthesis and viral particle release (Caporale et al., 2009; 
Hofacre et al., 2009; Nitta et al., 2009). Thus, in our system, it was feasible to 
speculate that the A6D mutation in SP26 might exert dominant negative effects 
on the expression of enJS56A1 Gag protein, reducing the levels of defective Gag 
and promoting enJSRV-26 JLR escape. If this was the case, increasing amounts of 
SP26 would decrease the amount of enJS56A1 Gag. To test this hypothesis, the 
levels of enJS56A1 Gag were compared by western blotting in 293T cells co-
transfected with enJS56A1 and increasing amounts of expression plasmids for 
SP26 or SP18 (Fig. 31).  
 
Figure 31│ SP26 does not affect enJS56A1 Gag expression. Western blot of cell extracts (cells) 
of 293T cells transfected with a fixed amount (2 µg) of enJS56A1 expression plasmid and 
increasing amounts of enJSRV-18 and enJSRV-26 SPs expression plasmids, as indicated in the 
panel. Membranes were incubated with antibodies against the JSRV major capsid protein (CA), the 
HA epitope (to detect SPs), or γ-tubulin as a loading control. Levels of Gag protein extracted from 
the lysate of transfected cells were quantified by chemifluorescence using ImageQuant TL software 
(Molecular Dynamics). Graphs represent data obtained from three independent experiments. The 
values obtained by enJS56A1 (black bars) were arbitrarily set as 100%. Note that these values are 
not significantly different, suggesting that neither pSP-26HA nor pSP-18HA affect expression of 
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The presence of SP18 did not alter the level of enJS56A1 Gag proteins (Fig. 31, 
cfr. green bars and black bar). Interestingly, essentially the same results were 
obtained in presence of SP26 (Fig. 31, cfr. purple bars and black bar,), ruling out 
the hypothesis that the latter would act as a dominant negative on the 
expression of enJS56A1 Gag proteins. 
4.2.5 The A6D mutation in enJSRV-26 Env impairs at least some 
of the functions of its SP 
The results collected thus far demonstrate that the A6D mutation in SP26 does 
not impair the synthesis of transdominant Gag. However, it was possible that the 
altered localization of SP26 could affect  protein expression by enJSRV-26, 
thereby promoting JLR escape. To test this hypothesis, interference assays were 
carried out in 293T cells by co-expressing  enJSRV-26ΔEnv  or  enJSRV-18∆Env 
mutants and SP26 or SP18 (pSP26-HA and pSP18-HA, respectively), in presence or 
absence of enJS56A1 (Fig. 32). 
 
Figure 32│ The A6D mutation in enJSRV-26 Env affects the ability of its SP to enhance viral 
particle release. (A and B) Western blots of concentrated supernatants (virus) and cell extracts 
(cells) of 293T cells transfected with the plasmids indicated in each panel. Membranes were 
incubated with antibodies against the JSRV major capsid protein (CA), the HA epitope (to detect 
the SPs), or γ-tubulin as a loading control. Levels of CA associated with viral particles released in 
the supernatants were quantified by chemifluorescence using ImageQuant TL software (Molecular 
Dynamics). Graphs represent data obtained from three independent experiments. The values 
obtained by enJSRV-26, enJSRV-18 or related mutants in absence of enJS56A1 (black bars) were 
arbitrarily set as 100%. Error bars indicate standard errors; statistically significant differences are 
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enJSRV-26∆Env was able to escape JLR if SP26 was provided in trans (Fig. 32A, 
lanes 6 and 7), while it was impaired in presence of SP18 (Fig. 32A, lanes 8 and 
9). Similar results were obtained with enJSRV-18∆Env that, in presence of SP26, 
was able to escape the restriction induced by enJS56A1 (Fig. 32B, lanes 7 and 8). 
Interestingly, viral particle release from enJSRV26∆Env was strongly enhanced by 
SP18  compared to SP26  (Fig.  32A,  lanes 4, 6 and 8). Moreover, both 
enJSRV26∆Env and enJSRV18∆Env mutants were able to escape JLR when 
expressed by themselves (Fig. 32A,  lanes 4 and 5;  Fig.  32B,  lanes 3 and 4), 
suggesting that JLR escape might be due to a relative loss of SP26 function. 
As already mentioned in paragraph 1.6.6, betaretroviruses assemble
  in the 
pericentriolar area and their Env proteins are involved in intracellular
  Gag 
trafficking and particle release (Arnaud et al., 2007b; Sfakianos and Hunter, 
2003). The interference assays presented above were carried out in absence of 
functional Env protein and could therefore lead to misinterpretations of results. 
To this end, the same experiments as described above were performed in 293T 
cells by co-expressing enJSRV-26∆Env or enJSRV-18∆Env mutants in presence of 
enJSRV-26, enJSRV-18 or enJS56A1 Env glycoproteins (enJSEnv26, enJSEnv18 and 
enJSEnv56, respectively) (Fig. 33). 
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(From previous page) (A  and B) Western blots of concentrated supernatants (virus) and cell 
extracts (cells) of 293T cells transfected with the plasmids indicated in each panel. Membranes 
were incubated with antibodies against the JSRV major capsid protein (CA) and γ-tubulin as a 
loading control. Levels of CA associated with viral particles released in the supernatants were 
quantified by chemifluorescence using ImageQuant TL software (Molecular Dynamics). Graphs 
represent data obtained from three independent experiments. The values obtained by the wild-type 
enJSRV-26 or enJSRV-18 were arbitrarily set as 100%. Error bars indicate standard errors; 
statistically significant differences are indicated with two (P<0.01) asterisks. 
As expected, both enJSEnv18 and enJSEnv56 were able to enhance Gag protein 
synthesis and viral production from enJSRV-26∆Env mutant (Fig. 33A, lanes 2, 4 
and 5). Conversely, similar levels of viral particle and Gag protein were observed 
from enJSRV26∆Env mutant in presence or absence of enJSEnv26 (Fig. 33A, lanes 
2 and 3). Moreover, the levels of Gag protein and viral particle released from 
enJSRV18∆Env mutant were increased in presence of enJSEnv18 and enJSEnv56 
compared to when expressed with enJSEnv26 (Fig. 33B, lanes 3, 4 and 5). These 
results further confirm the hypothesis that the A6D mutation may impair some of 
the functions of SP26, thereby favouring JLR escape. 
4.2.6 The ability of enJSRV-26 to escape JLR can be attributed to 
a relative lack of function of its SP 
The data presented above demonstrate that JLR escape occurs even in absence 
of signal peptide (Fig. 32A, lanes 4 and 5; Fig. 32B, lanes 3 and 4), suggesting 
that the A6D mutation may confer loss of SP26 function. If this was the case, JLR 
escape would take place in presence of a heterologous, and thus not related, 
signal peptide. To this end, an expression plasmid for  enJSRV-18 Env was 
generated  by replacing its  signal peptide with the  one  of the human 
preprotrypsin protein (enJS18Env-PPT). Western blot analyses were then carried 
out on supernatant and cell lysates of 293T cells co-transfected with enJSRV-
26∆Env or enJSRV-18∆Env mutant in presence or absence of enJS18Env-PPT (Fig. 
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Figure 34│ The A6D mutation in enJSRV-26 Env determines a relative lack of function of its 
SP. (A and B) Western blots of concentrated supernatants (virus) and cell extracts (cells) of 293T 
cells transfected with the plasmids indicated in each panel. Membranes were incubated with 
antibodies against the JSRV major capsid protein (CA), the FLAG epitope (to detect the Env), or γ-
tubulin as a loading control. Levels of CA associated with viral particles released in the 
supernatants were quantified by chemifluorescence using ImageQuant TL software (Molecular 
Dynamics). Graphs represent data obtained from three independent experiments. The values 
obtained by enJSRV-26∆Env or enJSRV-18∆Env in absence of enJS56A1 (black bars) were 
arbitrarily set as 100%. Error bars indicate standard errors; statistically significant differences are 
indicated with one (P<0.05) or two (P<0.01) asterisks. 
As shown in figure 34, both enJSRV-26∆Env and enJSRV-18∆Env were found to 
escape JLR when enJS18Env-PPT was provided in trans. In addition, JLR escape 
occurred in presence of enJSRV-26∆Env and enJSRV-18∆Env mutants expressed 
by  themselves (i.e., in absence of SP26 or SP18). These data conclusively 
demonstrate that JLR escape is due to a loss of SP26 function. 
4.2.7 The presence of SP56 is necessary for enJSRV-26 to elude 
JLR 
Recent studies revealed that the JSE-SP activity is mediated by its SPRE, 
resulting in cytoplasmic accumulation of unspliced viral RNAs and increase of 
viral particle release (Caporale et al., 2009; Hofacre et al., 2009; Nitta et al., 
2009). The results presented thus far show that SP26 is not able to enhance Gag 
synthesis nor viral exit from enJSRV-26∆Env, unlike SP56 or SP18. However, in 
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viral particles. Thus, it was possible that the functional SP56 might be involved 
in enhancing enJSRV-26 expression. 
In order to test this hypothesis, a heterologous system, such as the Rev-RRE-
dependent HIV-1 Gag-Pol expression vector (pNLgagSty330; termed pHIV1-RRE in 
this study) (Felber et al., 1989; Sfakianos and Hunter, 2003), was employed and 
constructs were derived by replacing the HIV-1 RRE with the SPREs of enJS56A1 
(pHIV-SPRE56), enJSRV-18 (pHIV-SPRE18), and enJSRV-26 (pHIV-SPRE26). These 
constructs were co-transfected
 with either pSP18-HA, pSP26-HA, or pSP56-HA, 
and the release
 of HIV particles in the supernatants was measured by ELISA (Fig. 
35). The levels of Gag released in the supernatants of cells transfected with 
pHIV-SPRE56, pHIV-SPRE18 or pHIV-SPRE26 did not change in presence or 
absence of SP26 (pSP26-HA), while they increased considerably (~7 fold) when 
co-expressed with SP18 or SP56 (Fig. 35). In addition, both SP18 and SP56 were 
able to increase the levels of Gag expressed by pHIV-SPRE26 (Fig. 35). These 
results demonstrate that the A6D mutation affects the ability of SP26 to bind 
SPRE-26 and ultimately increase Gag protein synthesis. 
 
Figure 35│ SP18 and SP56, but not SP26, act as post-transcriptional regulators of viral gene 
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(From previous page) HIV Gag ELISAs were performed on supernatants of 293T cells transfected 
with HIV-1 Gag-Pol  expression derived plasmids (pHIV-SPRE26, pHIV-SPRE18, and pHIV-
SPRE56) in presence or absence of expression plasmids for enJSRV-26, enJSRV-18, and 
enJS56A1 SPs (pSP26-HA, pSP18-HA, and pSP56-HA). Controls included supernatants of cells 
transfected with HIV-1 Gag-Pol expression plasmid containing HIV-1 RRE (pHIV1-RRE) in 
presence or absence of HIV-1 Rev (pRev). SPRE, signal peptide-responsive element; RRE, Rev-
responsive element. 
In addition, these data indicate that SPRE26 interacts with both SP56 and SP18, 
reinforcing the notion that the inability of enJSRV-26 to increase Gag protein 
level is due to the defect in its SP. Indeed, bioinformatic analysis showed that 
enJSRV-18 and enJSRV-26 SPREs are predicted to possess an identical RNA 
secondary structure (Fig. 36). 
 
Figure 36│ Predicted RNA secondary structure of enJSRV-26 and enJSRV-18 SPREs. Mfold 
program (version 3.3) predicted the RNA secondary structure of enJSRV-18 and enJSRV-26 
SPREs (∆G=-54). SPREs include the last fifty nucleotides of env and the proximal one hundred 
and  nineteen  nucleotides of U3 (note that there is an overlapping of twenty-one  nucleotides 
between the 3' env and U3). Numbers refer to the nucleotide residues of enJSRV-26 and enJSRV-
18 env deposited in GenBank, under accession numbers EF680297 and EF680301, respectively. 
Overall, the results illustrated above demonstrate that SP56 is involved in 
increasing enJSRV-26 expression. Thus, it was possible that this enhancement by 
SP56 could favour enJSRV-26 JLR escape. If this was the case, in absence of 
SP56, enJSRV-26 would not be able to elude the restriction mechanism induced 
by enJS56A1. In order to experimentally address this hypothesis, an enJS56A1 
mutant  (enJS56A1-4CTE)  was generated by replacing the enJS56A1 Env 
glycoprotein (including its SP) with four M-PMV CTE repeats (Bray et al., 1994). 
Note that, in enJS56A1-4CTE,  the expression of the  transdominant Gag  is 
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were then carried out with enJSRV-26 and the wild-type enJS56A1 or the 
enJS56A1-4CTE mutant (Fig. 37). 
 
Figure  37│  enJS56A1 Env plays a key role in enJSRV-26  JLR escape.  Western blots of 
concentrated supernatants (virus) and cell extracts (cells) of 293T cells transfected with the 
plasmids indicated. Membranes were incubated with antibodies against the JSRV major capsid 
protein (CA) and γ-tubulin as a loading control. Note that enJS56A1-4CTE lacks the viral Env and 
is able to block  enJSRV-26. Levels of CA associated with viral particles released in the 
supernatants were quantified by chemifluorescence using ImageQuant TL software (Molecular 
Dynamics). Graphs represent data obtained from three independent experiments. The values 
obtained by enJSRV-26 were arbitrarily set as 100%. Error bars indicate standard errors; 
statistically significant differences are indicated with one (P<0.05) asterisk. 
In presence of enJS56A1-4CTE, viral particle release by enJSRV-26 was impaired 
considerably (Fig. 37,  lanes 1, 6 and 7), indicating that the expression of 
enJS56A1 Env, and therefore its functional SP, is necessary to enJSRV-26 to 
escape JLR. 
4.2.8 The ratio between enJS56A1 and enJSRV-26 Gag proteins is 
critical for JLR escape 
As already mentioned before (paragraph 3.1), the restriction mechanism induced 
by enJS56A1 depends on Gag-Gag interactions. The R21W mutation in enJS56A1 
Gag seems to alter the overall surface of the protein,  resulting in defective 
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proteasome. Interestingly, the enJS56A1 defect is transdominant over JSRV and 
enJSRVs; in other words, when co-expressed in the same cell, enJS56A1 Gag 
protein forms multimers with JSRV and enJSRVs Gag, which are targeted to the 
proteasomal machinery and subsequently degraded (Arnaud et al., 2007b; Mura 
et al., 2004; Murcia et al., 2007). Thus, one feasible hypothesis to explain 
enJSRV-26 JLR escape could be an insufficient amount of enJS56A1 Gag protein 
available to form multimers and target enJSRV-26 Gag to degradation, thus 
preventing viral particle release by the latter. If this was the case, increasing 
amount of enJS56A1 Gag proteins would be able to block enJSRV-26 virus exit. 
To test this hypothesis, 293T cells were co-transfected with different ratios of 
enJSRV-26 and enJS56A1 expression plasmids, and viral particle release was 
assessed by western blotting (Fig. 38A). 
 
Figure 38│ The ratio between enJS56A1 and enJSV-26 Gag is critical for JLR escape. (A) 
Western blot of concentrated supernatants (virus) and cell extracts (cells) of 293T cells transfected 
with the plasmids indicated in each panel. Membranes were incubated with antibodies against the 
JSRV major capsid protein (CA) and γ-tubulin as a loading control. Note that over-expression of 
enJS56A1 restricts viral particle release of enJSRV-26. Levels of CA associated with viral particles 
released in the supernatants were quantified by chemifluorescence using ImageQuant TL software 
(Molecular Dynamics). Graphs represent data obtained from three independent experiments. The 
value obtained by enJSRV-26 (black bar) was arbitrarily set as 100%. Error bars indicate standard 
errors; statistically significant differences are indicated with two (P<0.01) asterisks. (B) Western 
blot analysis of concentrated supernatants of 293T cells transfected with the indicated plasmids 
and analysed at 3, 6, 12, and 24 hours post-transfection. The bottom panel represents the 
quantification of blots by chemifluorescence as described for panel A. Values are expressed as 
arbitrary pixel units derived from three independent experiments. Chapter 4                                                                                                                                        119 
As expected, enJSRV-26 was able to escape JLR  when the ratio of the 
transfected expression plasmids was 1 to 1 (Fig. 38A, lane 4). However, when 
this ratio was 1 to 2, viral particle release from enJSRV-26 was blocked (Fig. 
38A, lane 5), confirming the hypothesis formulated above, and suggesting that 
JLR is directly related to the relative ratio between transdominant and 
functional Gag. 
These results were further confirmed by interference assays performed with 
enJSRV-26 in presence of the wild-type enJS56A1 or an enJS56A1 mutant deleted 
of  Gag  (enJS56A1∆Gag), and assessing viral particle release at various time 
points (Fig. 38B). The levels of enJSRV-26 viral particles release were higher in 
presence of the enJS56A1∆Gag mutant than the wild-type enJS56A1 (Fig. 38B, 
middle and bottom panels). These results further reinforced the notion that 
enJSRV-26 JLR escape relies on the ratio between functional and transdominant 
Gag proteins. 
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4.3 Discussion 
The results presented in the previous chapter demonstrated  that the main 
determinant of JLR escape is the A6D mutation in SP26. Here, it was found that 
the A6D mutation affects the intracellular localization of SP26. Indeed, the D6 
residue lies within predicted NLS and ARM motifs, which have been shown to be 
important for the intracellular localization and function of JSE-SP (Caporale et 
al., 2009; Hofacre et al., 2009). Confocal microscopy analysis revealed that SP26 
displays a diffuse staining within the nucleus and the cytoplasm of transfected 
cells, with no accumulation in the nucleolus. The presence of a hydrophilic 
residue, such as the aspartic acid (D), may alter the overall conformation of 
SP26, thereby affecting its intracellular localization. In particular, it is possible 
that only the nucleolar localization is altered, while SP26  may still passively 
diffuse into the nucleus, given the small size of this protein (approximately 
17kDa, on SDS-page gel). 
As already mentioned in paragraph 4.1, the nucleolus plays an important role 
during the course of viral infections. Indeed, several studies have shown that 
many viruses, including DNA viruses, retroviruses and RNA viruses, localize to the 
nucleolus to take over host cell functions and favour viral replication (Wang et 
al., 2010). The HIV-1 Rev protein, for instance, localizes predominantly to the 
nucleolus (Kubota et al., 1999), where it promotes the nucleocytoplasmic export 
of viral unspliced RNAs (Daelemans et al., 2004). Deletions of its NLS domain 
result in the disruption of nucleolar localization and in the inability of Rev to 
regulate viral gene expression (Cochrane et al., 1990). It is therefore possible to 
hypothesise that the inability of SP26  to reach the nucleolus may affect its 
ability to participate in the nucleocytoplasmic trafficking of viral unspliced 
RNAs. It is noteworthy that the staining pattern observed for SP26 resembled 
what was previously obtained with a JSE-SP mutant deleted of its NLS 
(pJSESP∆NLS-HA) (Caporale et al., 2009). Indeed, the JSESP∆NLS-HA mutant 
localizes both in the nucleus and in the cytoplasm but it is excluded from the 
nucleolus of transfected cells, and is unable to function as a post-transcriptional 
regulator of viral gene expression (Caporale et al., 2009). Overall data seem to 
suggest that, most likely, SP26 does not enhance Gag synthesis and viral particle 
release due to its  inability to bind its SPRE. Indeed, confocal analysis 
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presence of its SPRE, unlike SP18 (Fig. 29) and JSE-SP (Caporale et al., 2009; 
Nitta et al., 2009). 
JSE-SP  possesses  HIV Rev-like functions and, similarly to HIV Rev, it  favours 
nucleocytoplasmic export of full-length viral RNAs by binding the SPRE located at 
the 3' end of the viral genome (Hofacre et al., 2009; Nitta et al., 2009). Unlike 
JSE-SP, SP26  is not able to enhance Gag protein synthesis and viral particle 
release. However, this “defect” allows enJSRV-26 to elude enJS56A1 restriction. 
As already discussed, JLR depends on the interaction between defective and 
functional Gag, even though the exact stoichiometry between these proteins is 
currently unknown. A previous study revealed that enJS56A1 is still able to block 
JSRV even when the latter is over expressed in co-transfection assays (Mura et 
al., 2004). Conversely, the results presented in this chapter show that the higher 
the levels of enJSRV-26, the more efficient is the ability of this virus to elude 
enJS56A1-induced restriction. It was therefore possible that enJSRV-26 might 
rescue the defective enJS56A1 Gag during JLR. This would explain the increased 
amount of viral particle released from enJSRV-26 in presence of the 
transdominant virus. Unfortunately, all  the attempts to differentially tag 
enJSRV-26 and enJS56A1 Gag proteins  resulted in altered phenotypes of the 
wild-type viruses and, therefore, this point could not be experimentally 
addressed. However, western blot analysis indicates  that enJSRV-26 is not 
totally exempted from JLR, as a certain amount of its Gag protein is restricted 
by enJS56A1. Thus, it is feasible to assume that enJSRV-26 does not rescue the 
defect of the transdominant Gag proteins. 
As already mentioned (paragraph  1.6.6), betaretroviruses assemble in the 
pericentriolar area, where their Env glycoproteins facilitate intracellular Gag 
trafficking and viral particle release (Arnaud et al., 2008; Sfakianos and Hunter, 
2003). However, enJSRV-18 and enJSRV-26 Env mutants (enJSRV-26∆Env and 
enJSRV-18∆Env) always showed significant amounts of viral particle release. 
These results could be due to the high transcriptional levels of the expression 
plasmids for enJSRV-26∆Env and enJSRV-18∆Env driven by a CMV promoter or, as 
postulated by others, to the presence of a CTE in JSRV (and enJSRVs) RNA, which 
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enJSRV-26 JLR escape can be overcome by increasing the levels of 
transdominant Gag. These results suggest that JLR escape depends on the 
stoichiometry between enJS56A1 and enJSRV-26 Gag which, in turn, is regulated 
by the SPs of these viruses. Data obtained by HIV ELISA seem to suggest that 
SP26 does not facilitate RNA export, even if more experiments are necessary to 
formally prove this point. Moreover, it appears that the SPREs of enJS56A1 and 
enJSRV-26 respond equally well to SP56. Overall, the data presented in this 
chapter support a model where, when co-expressed in the same cell, the SPREs 
of enJS56A1 and enJSRV-26 compete for the only functional SP (i.e., SP56), 
resulting in an increased synthesis of enJSRV-26 and reduced levels of enJS56A1 
Gag proteins (Fig. 39). 
 
Figure 39│ Model of enJSRV-26 JLR escape. The ability of enJSRV-26 to elude JLR restriction is 
dependent on the impaired function of its SP. Consequently, SPRE26 and SPRE56 compete for 
the only functional SP (i.e., SP56), resulting in a reduced expression of transdominant Gag. 
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Chapter V 
The transdominant enJSRV 
proviruses are amplified in the 
sheep genome 
 Chapter 5                                                                                                                                        124 
 
5.1 Introduction 
It is difficult to correlate results obtained in in vitro  experiments with the 
evolution of enJSRVs that,  in vivo, lead to the selection of transdominant 
proviruses and viruses able to escape  JLR.  Previous studies suggest  that 
enJS56A1 was positively selected during sheep domestication, most probably as 
it conferred advantages in protecting the host against infections by related 
exogenous retroviruses  (Arnaud et al., 2007a).  Interestingly, another enJSRV 
locus, enJSRV-20, was also found to possess the same R21W mutation in Gag that 
confers the defective and transdominant phenotype to enJS56A1 (Arnaud et al., 
2007a). enJS56A1 and enJSRV-20 are 99% identical at the nucleotide level and 
possess intact open reading frames for all of the retroviral genes but orf-x 
(Arnaud et al., 2007a; Palmarini et al., 2000). enJS56A1 contains a two base 
pairs deletion in pol that causes a frameshift and yields a shorter protein than 
enJSRV-20 and the exogenous JSRV21 Pol (Arnaud et al., 2007a; Palmarini et al., 
2000).  enJS56A1 and enJSRV-20 possess  identical  3'  genomic  flanking regions; 
however, enJSRV-20 contains a portion of an env gene immediately before the 
5'LTR (Fig. 11). Overall, these findings lead to hypothesise that enJSRV-20 arose 
from various processes of recombination between enJS56A1 and other 
proviruses, rather than independent mutations. 
It has been estimated that enJS56A1 and enJSRV-20 entered the sheep genome 
within the last 3 MYA, during speciation of Ovis (Fig. 12). The exogenous enJSRV-
like virus from which these transdominant proviruses derived possessed the 
“wild-type” R residue at position 21 in Gag when it first entered host genome, in 
order to replicate and infect host germ line. Only subsequently, around the time 
of sheep domestication, the “transdominant” enJS56A1 genotype harbouring 
W21 appeared in the host genome and became fixed in the host  population 
(Arnaud et al., 2007a). 
During evolution, transdominant proviruses might have been positively selected 
for the ability to interfere with related exogenous pathogenic retroviruses and 
enJSRVs already colonizing sheep genome (Arnaud et al., 2007a). The results 
presented thus far indicate that the relative ratio between defective 
transdominant and functional Gag could determine the efficiency of JLR. Sheep 
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(i.e.,  harbouring an R at position 21)  (Fig. 11). Interestingly, the BAC clones 
containing enJS56A1 were found to be overrepresented in the sheep genomic 
BAC library used to clone the known enJSRV loci. Indeed, 22% of BAC positive for 
enJSRV sequences contained the enJS56A1 provirus, whereas the expected 
frequency was 3.7% (Arnaud et al., 2007a). 
The overrepresentation of particular clones could be due to artefacts related to 
the construction and the screening of the library or to the amplification of the 
genomic region containing enJS56A1. In order to address this point, the copy 
number variation of the transdominant enJS56A1 was assessed in the genomic 
DNA of wild and domestic sheep by quantitative polymerase chain reaction 
(qPCR) assays. 
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5.2 Results 
5.2.1 The chromosomal region containing the enJS56A1 provirus 
is amplified within the genome of domestic sheep 
The relative gene dosage of the transdominant enJS56A1 was determined by 
employing locus-specific primers annealing in the host  genomic DNA and the 
provirus (Fig. 40). 
 
Figure 40│ Schematic representation of an enJSRV provirus. Primers used for qPCR assays 
are indicated by arrows. 
Samples analysed included wild sheep (O. dalli, n=1; O. canadensis, n=2; O. 
ammon, n=4; O. vignei, n=1), the Mediterranean Mouflon (Ovis orientalis 
musimon, n=4), and different breeds of  domestic sheep (O. aries),  including 
Dorset (n=1), Suffolk (n=1), Texel (n=10), Jacob (n=2), Red Masai (n=2), Merino 
(n=3), Xalda (n=2), Rambouillet (n=1), Soay (n=3), Norway (n=2) and Finsheep 
(n=3). DNA from animals within the genera Budorcas  (B. taxicolor, n=2) and 
Pseudois (P. nayaur, n=1) was used as a negative control (Fig. 41). 
Figure 41│ Representative species within the Caprinae subfamily. Simplified phylogenetic tree 
(branch length  are not shown to scale) of representative species belonging to the Caprinae 
subfamily used in this study. Images of the various animal species were kindly provided by Brent 
Huffman (http://www.ultimateungulate.com) and Wolfgang Dreier.  The tree was derived from 
(Hernandez-Fernandez and Vrba, 2005). 
Moreover, relative gene dosages of enJSRV-6 (a provirus fixed throughout the 
Ovis genus) and the insertionally polymorphic enJSRV-18 (present in most but 
not all domestic sheep) (Arnaud et al., 2007a) were used as additional controls. 
The data were expressed as the ratio between the estimated copy number of 
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increase the accuracy of the results, two host genes, β-actin and SOX9, were 
used as internal controls to standardize the qPCR assays. 
As expected, when β-actin was used as the reference gene, the dosage of SOX9 
did not change significantly across domestic and wild sheep. The modern 
enJSRV-18 provirus showed low variations among domestic sheep, whereas 
enJSRV-6  displayed modest divergences between the samples tested. In 
contrast, the transdominant enJS56A1 revealed major differences between the 
samples analyzed, with clear indications of genomic amplification in some 
domestic sheep breeds. It is noteworthy that, within the Ovis genus, wild sheep 
phylogenetically closer to O. aries, such as O. ammon and O. vignei, displayed a 
higher variation in enJS56A1 copy number compared to those phylogenetically 
more distant from domestic sheep, such as O. dalli and O. canadensis (Fig. 42). 
 
Figure 42│ Copy number variation of the enJS56A1 provirus relative to the β-actin gene in 
wild and domestic sheep. Graph representing the copy number variation of the transdominant 
enJS56A1 (purple), enJSRV-6 (blue), enJSRV-18 (red) and SOX9 (green) loci relative to the β-
actin  gene. Each bar represents a  single  animal and each letter represents a different 
species/breed. The absence of a bar indicates that the assay could not be performed due to limited 
amount of the DNA sample available. Samples tested included genomic DNA collected from B. 
taxicolor  (a),  P. nayaur (b),  O. dalli  (c),  O.  canadensis  (d),  O. ammon (e),  O. vignei (f),  Ovis 
orientalis musimon (g), and various breeds of the domestic sheep (O. aries), such as Soay (h),  
Norway (i), Dorset (j), Suffolk (k), Texel (l), Jacob (m), Red Masai (n), Finsheep (o), Merino (p), 
Xalda (q), and Rambouillet (r). Note that enJS56A1 is amplified within the genome of domestic 
sheep. 
A similar pattern was observed when SOX9 was employed as reference gene to 
determine the copy number variation of enJS56A1, enJSRV-6 and enJSRV-18 in 
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Figure  43│  Copy number variation of enJS56A1 relative to the SOX9  gene in wild and 
domestic sheep. Graph representing the copy number variation of the transdominant enJS56A1 
(purple), enJSRV-6 (blue), enJSRV-18 (red) and β-actin (green) loci relative to the SOX9 gene. 
Each bar represents a single animal and each letter represents a different species/breed. The 
absence of a bar indicates that the assay could not be performed due to exhaustion of the DNA 
sample. Samples tested included genomic DNA collected from B. taxicolor (a), P. nayaur (b), O. 
dalli (c), O. canadensis (d), O. ammon (e), O. vignei (f), Ovis orientalis musimon (g), and various 
breeds of the domestic sheep (O. aries), such as Soay (h), Norway (i), Dorset (j), Suffolk (k), Texel 
(l), Jacob (m), Red Masai (n), Finsheep (o), Merino (p), Xalda (q), and Rambouillet (r). The 
transdominant enJS56A1 is amplified within the genome of domestic sheep. 
Curiously, all the loci examined displayed a higher gene dosage compared to 
those obtained with β-actin  used  as  the  reference gene.  Nevertheless, it is 
noteworthy that the relative gene dosage of enJS56A1 was maintained in each 
sample, confirming the notion that the transdominant provirus is amplified 
within the genome of domestic sheep, regardless of the control gene used in the 
analysis. 
FISH analysis on metaphase chromosomes derived from domestic sheep (Fig. 44) 
showed that at least one of the copies of the transdominant enJS56A1 provirus 
(enJSRV-20) maps exactly to the same chromosomal location as enJS56A1 in 
chromosome 6 (6q13). Interestingly, as already mentioned, enJS56A1 and 
enJSRV-20 share identical 3' genomic flanking regions (Arnaud et al., 2007a). 
Thus, overall data  suggest that genome amplification has driven the 
amplification of enJS56A1-like proviruses with identical genomic flanking regions 
in any given animal  analyzed in this study. FISH data were performed in a 
collaborative study by Giulia Pia di Meo in Leopoldo Iannuzzi laboratory in Naples 
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Figure 44│ Fluorescent in situ hybridization of metaphase R-banded chromosomes derived 
from a Merino sheep (mixed breed). Fluorescent probes were derived from BAC clones 
containing enJSRV-20, enJS56A1 or enJSRV-6 as described in chapter 2. The green fluorescent 
signals (indicated by arrows) are specific for the two transdominant proviruses (both located on 
chromosome 6, band 6q13) and the enJSRV-6 locus (situated on chromosome 1, band 1q41). 
Ideograms of Ovis aries chromosomes with R-banding patterns are also shown. 
As already mentioned (paragraph 5.1), it was previously speculated that enJSRV-
20 arose by a process of recombination/gene conversion with enJS56A1. These 
two proviruses can be distinguished by minor nucleotide sequence differences 
(twenty-three nucleotides along the entire genome) and the 5' flanking region, 
but they share identical 3' flanking regions (Arnaud et al., 2007a). The qPCR 
assays performed in this study uses a forward primer designed in a conserved 
region in env and a reverse primer located in the 3' flanking region of enJS56A1. 
Consequently, all the enJS56A1-like proviruses sharing identical 3' flanking 
regions (and not only the enJS56A1 provirus per se) might have been amplified 
from the genomic DNA of all the samples analyzed. In order to address this 
point, PCR experiments were performed on those BAC clones resulted positive 
for  enJSRV-20 and already characterized in a previous study (Arnaud et al., 
2007a), employing the same primers and conditions used to amplify enJS56A1 by 
qPCR in the present work. 
 
Figure  45│  Amplification of the enJSRV-20 locus using  enJS56A1-specific  PCR  primers. 
PCR fragments amplified from BAC clones previously showed to be positive for enJSRV-20 (81J8 
and 63N7; lanes 1 and 2) or enJS56A1 (106U3, 40N10 and 14C5; lanes 4-6). Control primers for 
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As shown in figure 45, enJSRV-20 was amplified from all the BAC clones analyzed 
confirming that, during qPCR assays, enJS56A1-like proviruses with identical 
genomic flanking regions were amplified in all the samples tested. 
5.2.2 Frequency of the W21 residue in the Gag of enJS56A1-like 
proviruses in the genome of domestic and wild sheep 
Previous results obtained in our laboratory demonstrated that the W21 residue in 
enJS56A1 and enJSRV-20 Gag became fixed during sheep domestication (Arnaud 
et al., 2007a). The data presented thus far show the presence of multiple copies 
of enJS56A1-like proviruses in the genome of domestic sheep. Hence, the next 
step was to assess the relative frequency of R21 and W21 codons in the Gag of 
proviruses present in the genome of representative wild and domestic sheep. To 
this end, the 5' gag coding region of enJS56A1-like proviruses (including enJSRV-
20) was amplified from the genomic  DNA of wild sheep (O. dalli, n=1; O. 
canadensis, n=1; O. ammon, n=1), the Mediterranean Mouflon (O. orientalis 
musimon, n=1), and two different breeds of domestic sheep (Texel, n=2; Merino, 
n=1). The PCR products were then cloned and at least forty individual clones for 
each sample were sequenced (Table 2). 
Table 2│ Relative frequency of the wild-type arginine (R) or the transdominant tryptophan 
(W) residue at position 21 in the Gag of enJS56A1-like proviruses
a. 
Genus  enJS56A1  enJSRV-20 
O. dalli 
(c)  100% R  - 
O. canadensis 
(d)  100% R  100% R 
O. ammon 
(e)  90% W, 10% R  - 
O. orientalis 
(g)  73% W, 27% R  100% W 
O. aries 
(l)  100% W  100% W 
O. aries 
(l)  100% W  100% W 
O. aries 
(p)  100% W  100% W 
a The 5' gag coding region of enJS56A1 and enJSRV-20 was amplified by PCR from genomic DNA 
collected from the species indicated in the table. Note that letters in parentheses (c, d, e, etc.) refer 
to the code used for figure 42. PCR products were cloned into the pCR4-TOPO vector (Invitrogen), 
and forty individual clones for each PCR product were sequenced to determine the relative 
presence of an R or W residue at position 21 in Gag. 
The codon corresponding to the Gag R21 residue was detected in 100% of the 
PCR clones derived from the amplification of DNA collected from O. dalli and O. 
canadensis, which are the species phylogenetically more distant from domestic 
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of genomic amplification (Arnaud et al., 2007a). Conversely, and as expected, 
100% of the PCR clones derived from the amplification of DNA collected from O. 
aries  was found to possess the W21 codon, indicating that all the copies of 
enJS56A1-like proviruses  are transdominant within the genome of domestic 
sheep. Finally, in  O. ammon  and  O. orientalis, which are the species 
phylogenetically closer to O. aries among those analyzed in this study, the great 
majority of enJS56A1-like proviruses  was found to possess the transdominant 
phenotype (Table 2). 
5.2.3 Analysis of copy number variation of transdominant 
enJS56A1-like proviruses in OPA affected sheep 
Previous studies conducted in our laboratory suggested that the W21 residue in 
enJS56A1 Gag might have been positively selected, during evolution, for the 
ability to interfere with related exogenous and pathogenic retroviruses (Arnaud 
et al., 2007a). Interestingly, in the field, most JSRV infected sheep do not 
develop OPA during their commercial lifespan (Caporale et al., 2005). Thus, it 
could be speculated that animals infected with JSRV and that develop lung 
tumours possess a lower copy number variation of transdominant enJS56A1-like 
proviruses compared to those that do not develop OPA. 
 
Figure 46│ Copy number variation of the transdominant enJS56A1 in the genomic DNA of 
normal and JSRV infected sheep. Graph representing the copy number variation of the 
transdominant enJS56A1 relative to the β-actin  gene.  Each bar represents a different animal. 
Samples tested included genomic DNA collected from seven healthy (in grey) and seven OPA 
affected (in red) Blackface sheep (O. aries). 
In order to address this point, a pilot experiment was performed to evaluate the 
gene dosage of transdominant proviruses in healthy (n=7) and OPA affected (n=7) 
Blackface  sheep  by qPCR,  as already described.  OPA  affected  sheep did not Chapter 5                                                                                                                                        132 
display a lower copy number of enJS56A1-like proviruses compared to healthy 
animals (Fig. 46), ruling out the hypothesis that the genomic amplification of 
transdominant proviruses per se may determine OPA outcome. 
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5.3 Discussion 
The results presented in this chapter reinforce the notion that transdominant 
proviruses have been positively selected by the host during sheep domestication. 
In particular, these data demonstrate that the chromosomal region containing 
enJS56A1-like proviruses is amplified in the sheep genome,  resulting in the 
generation of multiple copies of transdominant proviruses. Previous studies 
conducted in our laboratory suggested that these enJS56A1-like proviruses might 
have been co-opted because they provided adaptive advantages to the host 
(Arnaud et al., 2007a; Arnaud et al., 2007b; Mura et al., 2004; Murcia et al., 
2007).  In particular, in accordance with a “protective” role in sheep, it was 
speculated that a second transdominant provirus, enJSRV-20, most likely arose 
by processes of recombination and/or gene conversion with enJS56A1 (Arnaud et 
al., 2007a). The results presented in this chapter suggest that the chromosomal 
location  containing enJS56A1 has been amplified several times, especially  in 
some breeds of domestic sheep, thereby further supporting the idea that sheep 
domestication  has contributed to the selection and amplification of 
transdominant proviruses. 
Previous work conducted by Frédérick Arnaud and colleagues demonstrate that 
enJS56A1 possessed the “wild-type” R residue at position 21 in Gag, when it first 
entered sheep  genome. Only subsequently, the “transdominant”  enJS56A1 
genotype harbouring W21 appeared in the host and became fixed around the 
time of sheep domestication (Arnaud et al., 2007a). In line with these findings, 
by determining the relative frequencies of W21 residues in the Gag of enJS56A1-
like proviruses in both  wild  and domestic sheep,  we confirmed  that 
transdominant  proviruses became fixed in the host genome around sheep 
domestication, further corroborating previous results (Arnaud et al., 2007a). 
The challenge of this study was to identify meaningful differences in the copy 
number variation of transdominant enJSRV proviruses between wild and 
domestic sheep by qPCR assays. The accuracy of this technique greatly relies on 
the use of multiple valid control genes for normalization, as well as on the size 
of the fragments amplified from the genomic DNA. Indeed, it has been shown 
that amplicon size is a critical factor for qPCR assays,  as smaller fragments 
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hundred fifty  base  pairs  in length  (Varga and James, 2006). In our assays, 
however, PCR products were clearly too long (between four hundred and thirty-
eight  and  five hundred and seventy-seven  base  pairs)  than usually 
recommended, due to the limited possibilities of designing specific primers that 
would not include the LTR regions
25
Furthermore, it is important to bear in mind that one of the limits of our qPCR 
method is the reliability of the reference genes employed in the assay. Indeed, 
the absolute copy number estimated for  all the loci examined in this study 
greatly differed depending on the reference gene used as internal control. 
However, reassuringly, the relative gene dosage of the various enJSRV proviruses 
in wild and domestic sheep was generally maintained. A possible explanation 
could be that the sheep genome possesses different copies of β-actin and SOX9 
genes due to the presence, for example, of pseudogenes that could affect the 
gene dosage estimation of the loci examined. 
. Thus, amplicons length might have reduced 
primers binding specificity, raising the possibility that the  copy number 
variations of all the loci investigated in this  study might have been 
underestimated. Moreover, reverse primers were designed assuming that all the 
copies of enJS56A1-like proviruses that integrated into the sheep genome shared 
the same 3' flanking region, which might not have been necessarily the case, and 
might have, therefore, further contributed to underestimate the gene dosage of 
transdominant proviruses. 
Another critical point to consider is that the qPCR assays presented in this study 
assessed the gene dosage, and not the expression, of the transdominant 
proviruses. Therefore, the twenty or more copies of enJS56A1-like proviruses 
detected in some animals may not be necessarily (all) expressed.  Indeed, 
although  it is possible that the  genomic  amplification of transdominant 
proviruses  in the sheep genome may be directly proportional to the level of 
expression of these loci, one cannot rule out the hypothesis that some of these 
copies may be (genetically and/or epigenetically) silenced. 
Finally, the pilot experiment on the evaluation of gene copy number variation of 
transdominant enJSRVs in healthy and OPA affected sheep did not confirm our 
hypothesis on a protective role played by  these proviruses against the 
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development of lung tumours. The analysis of a much larger number of samples 
will be necessary to firmly address this point. In addition, it would be interesting 
to include a group of JSRV infected sheep that do not develop OPA, in order to 
assess whether there is any direct correlation between JSRV infection and OPA 
resistance. 
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The evolutionary interplay between endogenous and exogenous retroviruses has 
always been a difficult subject to study in outbreed animal species, because of 
the lack of reliable in vivo models. For example, the hypothesis that ERVs may 
protect the host against infections by related exogenous retroviruses came 
almost exclusively from experiments performed in laboratory mice (Kozak et al., 
1984). Sheep, on the other hand, represent an extremely fascinating model to 
study these evolutionary mechanisms in natural conditions, because of the co-
existence, in the genome of these animal species, of at least twenty-seven 
enJSRV loci highly related to the exogenous and pathogenic JSRV. Moreover, 
most of the enJSRV proviruses are biologically active and are still invading the 
sheep genome (Arnaud et al., 2007a). 
Over time, sheep and enJSRVs have engaged in mutualistic relationships, in 
which both of them have gained mutual benefits. Sheep have contributed to the 
maintenance of enJSRVs by transmission to subsequent generations; enJSRVs, on 
the other hand, have played critical roles in host  survival. Experiments 
conducted by Tom Spencer and our group demonstrated indeed that, in absence 
of functional enJSRV  Env proteins, ewes abort at  the  very early stages  of 
pregnancy (Dunlap et al., 2006b). 
Several studies suggest that enJSRVs might have also provided protection against 
infections by related exogenous retroviruses. Similarly to murine Fv4, expression 
of enJSRVs Env glycoproteins can block, in vitro, cell entry of related exogenous 
retroviruses by receptor  interference (Spencer et al., 2003). Moreover, the 
transdominant enJS56A1 can interfere, in vitro, with the late replication steps 
of JSRV, by a unique mechanism known as JLR. The main determinant of JLR was 
mapped to the W21 residue in enJS56A1 Gag, which substitutes a R21 well 
conserved in betaretroviruses (Mura et al., 2004). The R21W mutation confers to 
enJS56A1 Gag a defective phenotype that is transdominant over JSRV as well as 
other enJSRVs (Arnaud et al., 2007a; Mura et al., 2004). enJS56A1 and JSRV Gag 
molecules seemingly form chimeric multimers that cannot traffic properly and 
are further degraded by the proteasome (Arnaud et al., 2007b; Murcia et al., 
2007). 
The results presented in this thesis cover relevant biological aspects of enJSRVs 
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expression of transdominant and functional Gag proteins can lead to JLR escape. 
In order to better characterize the molecular bases of enJSRV-26 JLR escape, we 
performed a variety of in vitro  experiments, in which we compared the 
phenotype of the escape mutant to that of enJSRV-18. Indeed, at the nucleotide 
level,  enJSRV-18  is  98% identical  to enJSRV-26,  but it is blocked by the 
transdominant enJS56A1. Because JLR impairs viral exit and due to the lack of a 
robust  in vitro  replication system for JSRV and enJSRVs in ovine cells,  the 
experiments performed in this thesis were mainly based on transfections of 293T 
cells with virus-expressing plasmids, followed by western blot analysis of cell 
lysates and viral pellets obtained from supernatants. Within this experimental 
approach, we performed interference assays with chimeric mutants to map the 
molecular determinant of JLR escape. We found that a single point mutation 
(A6D) in enJRV/JSRV Env can alter the intracellular localization and function of 
its SP. We also revealed that the A6D mutation in Env confer to enJSRV/JSRV the 
ability to escape JLR. Furthermore, we proposed a model for JLR escape that 
strictly depends on the intracellular kinetics of functional and defective SPs. The 
experimental data generated in this thesis suggest that the ARM and NLS 
domains of enJSRV/JSRV  SP  are critical in determining the balance between 
transdominant and wild-type Gag and, therefore, the outcome of JLR. Finally, 
we unveiled that the chromosomal region  containing enJS56A1 has been 
amplified several times during domestication, particularly in some breeds of 
domestic sheep. 
A key point to address in this chapter is the biological relevance of the work 
presented in this thesis. The importance of JLR escape can be considered from 
different perspectives. From a functional point of view, we showed that a single 
point mutation (A6D) impairs the biological function of SP26. This observation is 
directly connected to the ability of  enJSRV/JSRV  SPs  to act as post-
transcriptional regulators of viral gene expression. Previous work conducted by 
Marco Caporale and colleagues demonstrated that, similarly to HIV-1 Rev, 
enJSRVs  and JSRV  SPs  are  critical for the  nucleocytoplasmic export of viral 
unspliced RNAs (Caporale et al., 2009). We showed that the A6D substitution in 
SP26  affects  its  intracellular localization. Although we do not know whether 
enJSRV/JSRV SP localizes to the nucleolus to take over host cell functions, we 
assume that, most likely, this is the site where binding between SP and viral 
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that the nucleolus is the site where HIV-1 Rev multimerizes and it  is  likely 
involved in nucleocytoplasmic transport (Daelemans et al., 2004; Michienzi et 
al., 2006). 
Within the context of the evolutionary interplay between host and pathogen, the 
emergence of animals harbouring transdominant proviruses must have exerted 
selective pressure for the appearance of exogenous viruses able to escape JLR. 
Exogenous viruses could have used different ways to evade the restriction 
activity exerted by transdominant proviruses. For example, they might have “run 
away”  by acquiring different tissue tropism. Most likely, this represents the 
strategy adopted by JSRV to avoid JLR: replicating in tissues where interfering 
enJSRVs are not highly expressed. Indeed, enJSRVs are primarily detected in the 
genital tract of sheep (Palmarini et al., 1996b; Palmarini et al., 2000; Palmarini 
et al., 2001a; Spencer et al., 1999), while JSRV is abundantly expressed in 
proliferating type 2 pneumocytes of sheep lung (Murgia et al., 2011). Several 
lines of evidences seem to indicate that, over time, endogenous and exogenous 
sheep betaretroviruses acquired different tissue tropism due to their LTR regions 
(Palmarini et al., 2000).  We speculate  that the ancestor of the modern 
circulating JSRV was  initially  expressed in the genital tract of sheep. 
Subsequently, during the process of endogenization and,  most likely,  in 
coincidence with the appearance of transdominant proviruses, some exogenous 
JSRV-like viruses might have diverted their  tropism from the genital tract 
towards the lung, in order to escape the restriction mechanism exerted by 
transdominant enJSRVs.  
In line with this, it is worth noting that enJSRV-26 possesses a thirty-three base 
pairs deletion in its LTRs, which might have contributed, besides the A6D 
mutation in SP26, to escape the restriction mechanism exerted by transdominant 
proviruses. 
From an evolutionary perspective, this study has provided important information 
on the dynamic interplay between host and pathogen. Previous studies 
estimated that enJS56A1 integrated into the sheep genome between 0.9 to 1.8 
MYA (Palmarini et al., 2000). Most likely, the exogenous virus from which 
enJS56A1 derives possessed the wild-type R residue at position 21 in Gag, in 
order to replicate and successfully infect host germ line (Arnaud et al., 2007a; Chapter 6                                                                                                                                        140 
Murcia et al., 2007). Only subsequently, the transdominant enJS56A1 genotype, 
harbouring W21, appeared in the host genome and became fixed around the 
time of sheep domestication, approximately 0.9 MYA (Arnaud et al., 2007a). We 
reason that, with domestication, a relatively large number of animals were 
suddenly kept in restricted spaces, and this likely facilitated the spread of 
infectious agents more easily than before. Under these circumstances, sheep 
with  transdominant proviruses might have had a selective advantage over 
animals not harbouring them. It is possible that the driving force that influenced 
the fixation of  transdominant  enJSRVs in the genome of domestic sheep was 
their role in protecting the host against infections by related exogenous 
retroviruses. Experiments conducted in our laboratory indicate indeed  that 
transdominant proviruses can interfere in vitro  with the late steps of 
JSRV/enJSRV viral replication. 
An important question to address is whether JLR influences the outcome of JSRV 
infections in vivo. Our preliminary results seem to indicate that this is not the 
case, even though more studies are needed to formally prove this point. 
However, before completely ruling out this hypothesis, certain considerations 
should be made. First, OPA is a very rare disease: it has been shown that only a 
minority of JSRV  infected sheep develop the tumour in natural conditions 
(Caporale et al. , 2005). Second, OPA is a very slow disease in naturally infected 
animals, which takes up to several months/years before developing (Caporale et 
al., 2005). Third, low levels of virus can be detected in peripheral leucocytes 
and lymphoid organs of infected animals with or without clinical OPA (Holland et 
al., 1999). These observations lead to hypothesize that JSRV uses cells of the 
lymphoreticular system as main reservoir of infection, without the requirement 
to infect the target cells (proliferating type 2 pneumocytes) for transformation. 
A recent study conducted by Claudio Murgia and colleagues suggests that OPA is 
triggered by JSRV infection of  proliferating type 2 pneumocytes  in active 
division,  which are abundantly present in young lambs during post-natal 
development,  and  in adults after  lung injury induced,  for example,  by 
respiratory pathogens (Murgia et al., 2011). However, the mechanisms involved 
in viral maintenance for such long periods of incubation in the host remain still 
to be elucidated, and it is tempting to speculate that JLR can potentially play a 
role in keeping the spread of the virus “on hold” within infected animals. 
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amplified several times strongly support the notion that JLR has provided some 
benefits to the host. 
enJSRVs are abundantly expressed in the genital tract of sheep. A recent study 
conducted by Frédérick Arnaud and colleagues in our laboratory suggests that 
enJSRVs viral tropism might have been influenced by host restriction factors, 
such as oBST-2. Support to this hypothesis comes from the observation that 
enJSRVs are expressed in the luminal and glandular epithelia of ovine uterus, 
while both isoforms of oBST-2 are mostly found in the stroma (Arnaud et al., 
2010). Since the duplication of the oBST-2 gene predated the initial invasion of 
enJSRVs in the sheep genome, it has been proposed that oBST-2 might have been 
one of the selective forces that confined enJSRVs within specific areas of the 
reproductive tract, where these cellular restriction factors were not expressed 
at all, or at very low levels (Arnaud et al., 2010). 
In response to IFNτ, intact enJSRV loci are able to release viral particles into the 
uterine lumen of pregnant ewes, and potentially infect ovine conceptus (Black 
et al., 2010b). The presence of transdominant proviruses in the genital tract of 
sheep may therefore prevent unrestrained integrations, potentially deleterious 
for the developing conceptus. The bovine genome does not contain enJSRVs 
(Hecht et al., 1996), thus bovine blastocysts were utilized in the aforementioned 
study to unequivocally assess the potential infectivity of enJSRVs in recipient 
ovine uteri. Phylogenetic analyses revealed that transdominant proviruses, such 
as enJ56A1 and enJSRV-20, were rarely recovered from ovine endometria, while 
enJSRV-26 escape mutants-like  (i.e., harbouring the A6D mutation in the SP) 
were found in two of the four bovine conceptuses analyzed. In addition, the 
great majority of enJSRV sequences, amplified from the endometria and uterine 
flushes of recipient ewes and transferred bovine embryos, clustered mainly with 
the youngest enJSRV loci (Black et al., 2010a). Perhaps, the low abundance of 
enJS56A1-like proviruses is necessary to promote de novo integrations of intact 
enJSRV loci in the sheep  genome that may render redundant the function 
provided by older proviruses  (e.g., role of enJSRV Env in placental 
morphogenesis). However, it is important to bear in mind that any retroviral 
integration is potentially mutagenic and, if uncontrolled, may jeopardize host 
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The presence of JLR escape mutants, together with the genomic amplification of 
transdominant proviruses in the sheep genome, illustrate really well the dynamic 
between host and pathogen. Phylogenetic analyses suggest that enJSRV-26 might 
have been derived from the closely related enJSRV-18 provirus (Arnaud et al., 
2007a). Under these circumstances, it is feasible to speculate that both the A6D 
mutation in SP26 and the LTR deletion might have conferred selective 
advantages to enJSRV-26 (and enJSRV26-like), including JLR escape. The recent 
integration of enJSRV-26 in the sheep genome strongly suggests that the 
interplay between endogenous and exogenous sheep betaretroviruses is still 
ongoing. Interestingly, enJSRV-26 was found only in one Texel ram and  may 
represent a unique integration event (Arnaud et al., 2007a). Thus, the most 
feasible scenario could be  that an exogenous retrovirus, closely related to 
enJSRV-26, is still circulating (or it has been circulating) within sheep 
population. 
Host-pathogen interaction is modelled as a typical “arms race”, in which each 
partner gains advantage over the other by maximizing its own fitness at the 
other expenses. Co-evolutionary processes favour rapid rates of evolution and 
are driven by recombinations that lead to constant natural selection for 
adaptation and counter-adaptation.  This “back-and-forth” interplay has been 
highly dynamic and contributed to rapid changes in viral and host strategies, 
with each “species” rushing to evolve the upper hand in the interaction in a 
never ending struggle or, in the words of Lewis Carroll’s Red Queen, «it takes all 
the running you can do, to keep in the same place»
26
 
. The studies presented in 
this thesis have provided further insights on how exogenous and endogenous 
sheep betaretroviruses have interacted with their hosts during evolution. 
                                         
26 The Red Queen hypothesis (Van Valen, 1973) is named after the Red Queen's race in Lewis 
Carroll's “Through the Looking-Glass, and What Alice Found There” (1871), in which the Red 
Queen states: «it takes all the running you can do, to keep in the same place». In evolutionary 
biology, this sentence can be translated as “continuous  adaptation is needed in order for a 
pathogen to maintain its relative fitness by escaping host defences, or for the host to counteract 
pathogen infections”. 143 
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Oligonucleotides employed in this study 
Table 3│ List of oligonucleotides employed for cloning and site-directed mutagenesis. 
Primer  Sequence (5'→3')  Plasmid
a 
enJS26-3'E18 For  ATAATTTGTTTAGCTCCTTGCCTTATTCGT 
enJS26-3'Env18 
enJS26-3'E18 Rev  ACGAATAAGGCAAGGAGCTAAACAAATTAT 
enJS18-3'E26 For  ATAATTTGTCTAGCTCCTTGTCTTATTCGT 
enJS18-3'Env26 
enJS18-3'E26 Rev  ACGAATAAGACAAGGAGCTATACAAATTAT 
enJS26Stop1Env For  GTGTTTTTCCACAGGTAACCGAAGCGCCGCGATG 
enJSRV-26∆Env 
enJS26Stop1Env Rev  CATCGCGGCGCTTCGGTTACCTGTGGAAAAACAC 
enJS26Stop2Env For  CACATCAAATGCAACGCTAAACACTGAGCGAGCCCAC 
enJS26Stop2Env Rev  GTGGGCTCGCTCAGTGTTTAGCGTTGCATTTGATGTG 
enJS18Stop1Env For  GTGTTTTTCCACAGGTAACCGAAGCGCCGCGC 
enJSRV-18∆Env 
enJS18Stop1Env Rev  GCGCGGCGCTTCGGTTACCTGTGGAAAAACAC 
enJS18Stop2Env For  CACATCAAATGCATCGCTAAACACTGAGTGAGCCCAC 
enJS18Stop2Env Rev  GTGGGCTCACTCAGTGTTTAGCGATGCATTTGATGTG 
enJS26-D6A For  ATGCCGAAGCGCCGCGCTGGATTCCGGAAAGG 
enJSRV26-EnvD6A 
enJS26-D6A Rev  CCTTTCCGGAATCCAGCGCGGCGCTTCGGCAT 
enJS18-A6D For  ATGCCGAAGCGCCGCGATGGATTCCGGAAAGG  enJSRV18EnvA6D/ 
JSRV-EnvA6D  enJS18-A6D Rev  CCTTTCCGGAATCCATCGCGGCGCTTCGGCAT 
pSP26-HA For 
pSP26-HA Rev 
CCCAGACTACGCTTGCGGGGGACGACCCGTGAAGGG
TTAAGTCTTGGGAGCT 
pSP26-HA 
ACGTCGTATGGGTAAGCCGCCCCGTTTTGTATCCGCT
GTAACAATAATAATAA 
pSP18-HA For 
CCCAGACTACGCTTGCGGGGGACGACCCGTGAAGGG
TTAAGTCTTGGGAGCT 
pSP18-HA 
pSP18-HA Rev 
ACGTCGTATGGGTAAGCTGCCCCGTTTTGTATCCGCT
GTAACAATAATAATAA 
pSP56-HA For 
CCCAGACTACGCTTGCGGGGGACGACCCGTGAAGGG
TTAAGTCTTGGGAGCT 
pSP56-HA 
pSP56-HA Rev 
ACGTCGTATGGGTAAGCCGCCCCGTTTTGTATCCGCT
GTAACAATAATAATAA 
enJS56Stop1Gag For  GTTGAGAGTATAAATTAAGGACAGACGCATAGTC 
enJS56A1ΔGag 
enJS56Stop1Gag Rev  GACTATGCGTCTGTCCTTAATTTATACTCTCAAC 
enJS56Stop2Gag For  CATATGTTATCTGTATAATTAAAACATTGGGG 
enJS56Stop2Gag Rev  CCCCAATGTTTTAATTATACAGATAACATATG 
pHIV-SPRE26 For  AGAGGAATTCTAACCGAAGCGCCGCGATGGATTC 
pHIV-SPRE26 
pHIV-SPRE26 Rev  AAAATCTAGAGCTGATACCTTGCTTTATTGTGC 
pHIV-SPRE18 For  AGAGGAATTCTAACCGAAGCGCCGCGCTGGATTC 
pHIV-SPRE18 
pHIV-SPRE18 Rev  AAAATCTAGAGCTGATACCTTGCTTTATTGTGC 
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Table 4│ List of oligonucleotides employed for qPCR assays. 
Primer  Sequence (5'→3')  Plasmid
a 
Env For  ATAAAGAGAGGGGAGCTGCG  enJS56A1 
enJS56A1_3flank Rev  GGAAGGATCTGAAACGTGGA 
Env For  ATAAAGAGAGGGGAGCTGCG  enJSRV-6 
enJSRV6_3flank Rev  CAGGGGAATAACTGGTGCTACCT 
Env For  ATAAAGAGAGGGGAGCTGCG  enJSRV-18 
enJSRV18_3flank Rev  CAAGTGCCAGAGCCCAGAGCCA 
β-actin For  ATCATGTTTGAGACCTTCAACACCCC  β-actin 
β-actin Rev  CCAGGAAGGAAGGCTGGAAGAGAGC 
SOX9 For  CCTAGCTTTTCTTGCAGCC  SOX9 
SOX9 Rev  GCATTCCCCAGACAGATTTC 
a Name of the resulting expression plasmids. 
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The exogenous and pathogenic Jaagsiekte sheep retrovirus (JSRV) coexists with highly related and biolog-
ically active endogenous retroviruses (enJSRVs). The endogenous enJS56A1 locus possesses a defective Gag
polyprotein which blocks the late replication steps of related exogenous and endogenous retroviruses by a
mechanism known as JSRV late restriction (JLR). Conversely, enJSRV-26, which most likely integrated into the
sheep genome less than 200 years ago, is able to escape JLR. In this study, we demonstrate that the ability of
enJSRV-26 to escape JLR is due to a single-amino-acid substitution in the signal peptide (SP) of its envelope
glycoprotein. We show that enJSRV-26 SP does not localize to the nucleolus, unlike the functional SPs of
related exogenous and endogenous sheep betaretroviruses. In addition, enJSRV-26 SP function as a posttran-
scriptional regulator of viral gene expression is impaired. enJSRV-26 JLR escape relies on the presence of the
functional enJS56A1 SP. Moreover, we show that the ratio between enJSRV-26 and enJS56A1 Gag is critical
to elude JLR. Interestingly, we found that the domestic sheep has acquired, by genome ampliﬁcation, several
copies of the enJS56A1 provirus. These data further reinforce the notion that transdominant enJSRV provi-
ruses have been positively selected in domestic sheep, and that the coevolution between endogenous and
exogenous sheep betaretroviruses and their host is still occurring.
Retroviruses must integrate their genome into the host
genomic DNA to replicate successfully. As a consequence of
their peculiar replication cycle, retroviruses exist in nature as
exogenous retroviruses, transmitted horizontally from infected
to uninfected host like any other virus, and endogenous retro-
viruses (ERVs). ERVs derive from the infection of the host
germ line during evolution and are transmitted vertically from
generation to generation like any other Mendelian gene (15,
18). ERVs colonize the genome of all vertebrates studied to
date, where they represent a signiﬁcant percentage of the DNA
of their host species (e.g., 8% of the human and mouse
genomes) (15, 18).
During evolution, most ERVs have accumulated genetic de-
fects and lost the ability to express proteins and/or infectious
viruses. However, some ERVs have been coopted by their
hosts because they fulﬁll useful functions (4, 5, 12–14, 18). In
addition, some ERVs protect the host against the infection of
related exogenous pathogenic retroviruses. In chickens and
mice, for example, it has been shown that the expression of Env
glycoproteins by some ERVs can saturate the receptors used
by related exogenous retroviruses to gain entry into the cell
(42).
Domestic sheep provide a fascinating model for studying the
interplay between retroviruses and their host. The sheep ge-
nome harbors at least 27 copies of endogenous betaretrovi-
ruses (enJSRVs) that are highly related to the exogenous and
pathogenic Jaagsiekte sheep retrovirus (JSRV) (1, 2, 4, 29, 30,
39). enJSRVs have been integrating into the genome of their
host throughout the evolution of the Caprinae for the last 5 to
7 million years (i.e., sheep, goats, and related species) (2).
enJSRVs (or at least some of the enJSRV proviruses) can be
considered to be in symbiosis with their host, as they play an
essential part in the reproductive biology of sheep and inter-
fere with the replication cycle of related exogenous retrovi-
ruses (4, 11, 12, 34, 35, 39). A transdominant provirus,
enJS56A1, blocks JSRV replication by a unique mechanism
that we termed JSRV late restriction (JLR) (25). enJS56A1
possesses a defective Gag protein that does not trafﬁc properly
to the pericentriolar area, where newly formed viral particles
assemble and use the recycling endosomes to exit from cells (3,
26). Interestingly, the defect of enJS56A1 is transdominant
over JSRV as well as other enJSRVs. In other words,
enJS56A1 Gag forms multimers with JSRV Gag, which con-
sequently cannot trafﬁc properly and subsequently are de-
graded by the proteasomal machinery of the cell (3, 26).
The main determinant of JLR is a tryptophan residue (W) at
position 21 in enJS56A1 Gag, which replaces an arginine (R)
that is well conserved in betaretroviruses (25). We showed that
enJS56A1 possessed an arginine residue in Gag at position 21
when originally integrated into the host genome. Subsequently,
the transdominant enJS56A1 with the W21 Gag residue ap-
* Corresponding author. Mailing address: MRC, University of Glasgow
Centre for Virus Research, Institute of Infection, Immunity and Inﬂam-
mation, College of Medical, Veterinary and Life Sciences, University of
Glasgow, Glasgow Q61 1QH, United Kingdom. Phone: 141-330-2541.
Fax: 141-330-2271. E-mail: massimo.palmarini@glasgow.ac.uk.
 Published ahead of print on 18 May 2011.
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174peared in the closest relatives of domestic sheep and then
became ﬁxed after domestication (2).
Interestingly, we also have identiﬁed ﬁve enJSRV proviruses
(enJSRV-7, enJSRV-15, enJSRV-16, enJSRV-18, and en-
JSRV-26) with an intact genomic organization that are able to
produce viral particles in vitro (2). These loci are insertionally
polymorphic in domestic sheep, in other words, they are pres-
ent in only some individuals/breeds. These observations sug-
gest that the original integration of these proviruses occurred
after domestication (i.e., in the last 10,000 years). In particular,
enJSRV-26 probably integrated into the host germ line less
than 200 years ago. Remarkably, this virus possesses the
unique ability to escape the restriction induced by enJS56A1
(2). enJSRV-26 has been detected in the germ line of a single
sheep to date, suggesting that an enJSRV-26-like exogenous
retrovirus still circulates within the sheep population.
Sheep betaretroviruses have allowed us to witness sequen-
tial counteradaptations between endogenous and exogenous
retroviruses and represent an ideal model to study the arms
race between virus and host over long evolutionary periods.
In this study, we investigated the molecular mechanisms
followed by enJSRV-26 to elude the restriction induced by
enJS56A1. Using a variety of approaches, we demonstrate
that a single amino acid substitution in the signal peptide of
the enJSRV-26 Env confers the ability of this virus to escape
JLR. We and others have shown previously that the signal
peptide (SP) of sheep and mouse betaretrovirus envelope
glycoproteins is a multifunctional protein acting as a post-
transcriptional regulator of viral gene expression (7, 8, 17).
Here, we demonstrate that the SP of enJSRV-26 lacks at
least some of these functions. In addition, we show that JLR
escape depends on the ratio between enJSRV-26 and
enJS56A1 Gag. Interestingly, we also obtain evidence sug-
gesting that the transdominant proviruses are ampliﬁed
within the genome of domestic sheep.
MATERIALS AND METHODS
Plasmids. pCMV4JS21, pCMV5-enJS26, pCMV5-enJS18, and pCMV2en56A1
express the full-length JSRV21 molecular clone and the endogenous enJSRV-
26, enJSRV-18, and enJS56A1, respectively. These plasmids have been de-
scribed previously (2, 28, 30). All of the chimeras/mutants employed in this
study were derived from the plasmids listed above and are schematically
represented in Fig. 1. Speciﬁc details for the cloning procedures of any of the
plasmids described below are available upon request. Mutants were obtained
by site-directed mutagenesis using the QuikChange kit (Stratagene), as
suggested by the manufacturer. Chimeras were derived by swapping, respec-
tively, the full-length (enJS26-Env18 and enJS18-Env26), the 5-end (enJS26-
5Env18 and enJS18-5Env26), or the 3-end (enJS26-3Env18 and enJS18-
3Env26) env between enJSRV-26 and enJSRV-18. Mutants enJSRV-26Env
and enJSRV-18Env contain two nonsense mutations in the ﬁrst and third
methionines of their respective Env glycoproteins. Mutant enJS56A1Gag con-
tains two nonsense mutations replacing the ﬁrst and third methionines of the
enJS56A1 Gag. enJS56A1-4CTE contains four copies of the constitutive trans-
port element (CTE) of Mason-Pﬁzer monkey virus (M-PMV) at the 3 end of
env. The M-PMV CTE was derived from pSarm4, as already described, and was
a gift from Eric Hunter (32). Single mutants enJSRV26-EnvD6A, enJSRV18-
EnvA6D, and JSRV-EnvA6D express the full-length proviruses with a single
point mutation in their Env glycoprotein at position 6. Plasmids penJSEnv26 and
penJSEnv18 express the Env of enJSRV-26 and enJSRV-18, respectively. These
mutants were obtained by deleting gag, pro, pol, and orf-x from the plasmids
encoding their respective full-length proviruses. pSP26-HA, pSP18-HA, and
pSP56-HA encode the signal peptide of enJSRV-26, enJSRV-18, and enJS56A1,
respectively, tagged with the hemagglutinin (HA) epitope. In penJS18Env-PPT,
the signal peptide of enJSRV-18 Env was replaced by the signal peptide of the
human preprotrypsin, followed by the FLAG epitope fused at the N terminus of
the enJSRV-18 surface domain (SU) of Env. pNLgagSty330 and pRev were
kindly provided by Barbara Felber and have been described already (16, 21).
pNLgagSty330 is a Rev- and Tat-dependent HIV-1 Gag-Pol expression plasmid
and, for simplicity, is termed pHIV1-RRE in this study. pRev is an expression
plasmid for HIV-1 Rev. The expression plasmid for HIV-1 Tat was a gift from
Mauro Giacca and has been described elsewhere (37). pHIV-SPRE26, pHIV-
SPRE18, and pHIV-SPRE56 were obtained by replacing the HIV-1 Rev-respon-
sive element (RRE) in pHIV1-RRE with the signal peptide-responsive elements
(encompassing env and the 3 untranslated region [UTR]) of enJSRV-26, en-
JSRV-18, and enJS56A1, respectively.
Cell cultures, transfections, and viral preparations. 293T and COS cells were
cultured in Dulbecco’s modiﬁed Eagle medium (Gibco) and supplemented with
10% fetal bovine serum at 37°C, 5% CO2, and 95% humidity. Virus preparations
were obtained by transient transfections of 293T cells with the appropriate
plasmids using the Calphos mammalian transfection kit (Clontech). The empty
vector pcDNA3.1 (Invitrogen) was used to calibrate the amount of DNA used in
each experiment. Cell supernatants were collected at 48 h posttransfection, and
viral particles were concentrated by ultracentrifugation as already described (8,
30, 31). For the analysis of intracellular proteins, cells were lysed by standard
techniques, as described previously (38).
Western blotting and immunoprecipitation. Sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and Western blotting were per-
formed on concentrated viral particles and cell lysates (200 g of protein ex-
tracts) as previously described (8, 30). enJSRV Gag was detected using a rabbit
polyclonal serum against the JSRV major capsid protein (CA) (26). A rabbit
polyclonal serum toward the JSRV transmembrane protein (TM) was employed
to detect Env proteins. Signal peptides tagged with the HA epitope were de-
tected with a mouse monoclonal anti-HA antibody (Abcam), while -tubulin was
detected with a rabbit polyclonal antibody (Sigma). Membranes were exposed to
the appropriate peroxidase-conjugated secondary antibodies and further devel-
oped by chemiluminescence using ECL Plus (Amersham). Levels of CA associ-
ated with viral particles released in the supernatants were quantiﬁed by measur-
ing chemiluminescence in a Molecular Dynamics Storm 840 imaging system
using ImageQuant TL software (Molecular Dynamics). Each experiment was
repeated independently at least three times, and results are presented as the
mean values for each sample ( standard errors). Env expression by enJS18Env-
PPT was assessed by immunoprecipitation using a mouse monoclonal anti-
FLAG antibody (Sigma) as already described (38).
Confocal microscopy. 293T and COS cells were plated onto two-well cham-
bered glass slides (Lab-Tek; Nalge Nunc International) and transfected with
the appropriate plasmids using Lipofectamine (Invitrogen) according to the
manufacturer’s instructions. Twenty-four h after transfection the cells were
washed with phosphate-buffered saline (PBS) and ﬁxed with 3% formalde-
hyde for 15 min. After ﬁxation, cells were processed essentially as already
described (25, 33). SP proteins tagged with the HA epitope were detected
with a mouse monoclonal anti-HA (Abcam) antibody. Rabbit polyclonal
antibody to ﬁbrillarin (Abcam) was used as a marker for the nucleolus. Goat
anti-mouse and anti-rabbit immunoglobulin G conjugated with Alexa Fluor
488 and Alexa Fluor 594, respectively (Molecular Probes), were used as
secondary antibodies. Slides were mounted with medium containing DAPI
(4,6-diamidino-2-phenylindole; Vectashield, Vector Laboratories) and ana-
lyzed with a Leica TCS SP2 confocal microscope. Single sections from con-
focal optical sections along the z axis were analyzed.
Gag ELISA. For enzyme-linked immunosorbent assay (ELISA), 293T cells
were transfected with the appropriate plasmids (1 g) in the presence or absence
of SP26-HA, SP18-HA, SP56-HA (or pRev, as a control), and HIV-1 Tat (0.2
g). At 48 h posttransfection, cell supernatants were assessed for the presence of
HIV-1 Gag proteins using a Murex HIV antigen monoclonal antibody (MAb) kit
(Abbot Murex) according to the manufacturer’s instructions. All experiments
were repeated independently at least three times.
qPCR. Quantitative PCR (qPCR) assays were designed to estimate the dosage
of target genes (enJS56A1, enJSRV-6, enJSRV-18, and SOX9) compared to that
of the -actin gene (used as reference gene) in genomic DNA of domestic and
wild sheep. The genomic DNA tested was collected from various breeds (Dorset,
Suffolk, Texel, Jacob, Red Maasai, Merino, Xalda, Rambouillet, Soay, Norway,
and Finsheep) of domestic sheep (Ovis aries), wild sheep (O. dalli, O. canadensis,
O. ammon, and O. vignei), Mediterranean mouﬂon (O. orientalis musimon), and
members of the genera Budorcas (B. taxicolor) and Pseudois (P. nayaur). All
DNA samples were obtained and used in a previous study (9). Standard curve
efﬁciency was 99.2% for enJS56A1, 96.6% for enJSRV-6, 99% for enJSRV-18,
100% for -actin, and 100% for SOX9. PCR assays were performed using a
reverse primer complementary to the genomic 3 ﬂanking region for each pro-
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175virus (enJS56A1, 5-GGA AGG ATC TGA AAC GTG GA-3; enJSRV-6,
5-CAG GGG AAT AAC TGG TGC TAC CT-3; and enJSRV-18, 5-CAA
GTG CCA GAG CCC AGA GCC A-3) and a forward primer designed in a
conserved region in env (5-ATA AAG AGA GGG GAG CTG CG-3). Primers
for -actin (forward, 5-ATC ATG TTT GAG ACC TTC AAC ACC CC-3;
reverse, 5-CCA GGA AGG AAG GCT GGA AGA GAG C-3) and SOX9
(forward, 5-CCT AGC TTT TCT TGC AGC C-3; reverse, 5-GCA TTC CCC
AGA CAG ATT TC-3) were designed on highly conserved regions of both
genes. qPCR assays were carried out in triplicate in a total volume of 25 l and
performed in a Mx30005P (Stratagene) thermocycler, using the Brilliant II
SYBR green QPCR low ROX master mix (Stratagene) and the Brilliant SYBR
green QPCR core reagent kit (Stratagene) according to the manufacturer’s
instructions. The reaction mixture contained 20 ng of sheep genomic DNA. The
reaction mixture was subjected to a denaturation step at 95°C for 10 min,
followed by 40 cycles of denaturation at 95°C for 30 s, primer annealing at the
temperature appropriate for each primer (55°C to 60°C for 30 s), and elongation
at 72°C for 30 s, ending with a melting-curve analysis to validate the speciﬁcity of
the PCR products. Results were expressed as the ratio between the estimated
number of molecules in the target and reference genes in each sample.
Genotyping enJS56A1 proviruses. The presence of the codon encoding an
arginine or tryptophan residue in enJS56A1 (and enJS56A1-like proviruses) at
position 21 in Gag was assessed by PCR. Genomic DNA samples collected from
various breeds of domestic sheep (Texel, n  2; Merino, n  1), wild sheep (O.
dalli, n  1; O. canadensis, n  1; O. ammon, n  1), and the Mediterranean
Mouﬂon (Ovis orientalis musimon, n  1) were ampliﬁed by PCR using a forward
primer complementary to the genomic 5-ﬂanking region of the enJS56A1 or
enJSRV-20 provirus and a reverse primer complementary to their gag gene as
previously described (2). PCR products then were cloned into a pCR4-TOPO
FIG. 1. Schematic representation of the plasmids employed in this study. All of the mutants/chimeras used in this study were derived from
expression plasmids encoding the full-length enJSRV-26 and enJSRV-18 proviruses (top). Numbers indicate amino acid residues of Env.
Premature termination codons are indicated with vertical lines and asterisks. LTR, long terminal repeat; CMV, cytomegalovirus.
7120 ARMEZZANI ET AL. J. VIROL.
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176vector (Invitrogen), and 40 individual clones for each PCR product were com-
pletely sequenced.
FISH. Fluorescent in situ hybridization (FISH) analysis was carried out essen-
tially as already described (9). Brieﬂy, sheep peripheral blood cells were cultured
at 37°C in RPMI 1640 medium (Invitrogen) supplemented with 15% fetal bovine
serum, 1.5% concanavalin A (Sigma), and penicillin-streptomycin (Invitrogen).
Cells then were synchronized with 300 g/ml thymidine (Sigma) and, after 18 h,
washed and resuspended in medium containing 15 g/ml bromodeoxyuridine
(Sigma) and 30 g/ml Hoechst 33258 (Invitrogen). Cells then were incubated for
6 h at 37°C (the last hour in the presence of 0.1 g/ml colcemid; Sigma) and then
treated with a hypotonic solution and washed three times with methanol-acetic
anhydride. Cell suspensions then were plated onto slides, incubated overnight at
50°C, and stained for 10 min with 25 g/ml Hoechst 33258. Slides were further
probed with biotin-labeled bacterial artiﬁcial chromosome (BAC) clones con-
taining the appropriate provirus. Hybridization, chromosome staining, signal
detection, and image processing were performed as already described (9) in at
least 30 metaphases for each probe. Chromosome identiﬁcation was carried out
using the R-banding karyotype by adding ﬂuorescein avidin DCS and biotinyl-
ated anti-avidin (Vectors Laboratories), as recommended by the manufacturer.
Chromosome identiﬁcation and band nomenclature followed the International
System for Chromosome Nomenclature of Domestic Bovids (10).
RESULTS
The 5 portion of the enJSRV-26 env is the main determi-
nant of JLR escape. The ﬁrst aim of this study was to identify
the molecular determinants of enJSRV-26 that are necessary
to escape JLR. At the nucleotide level, enJSRV-26 is 98%
identical to enJSRV-18 along the entire genome. enJSRV-18 is
another insertionally polymorphic provirus present in the
sheep genome. Interestingly, enJSRV-26 and enJSRV-18 Gag
and Env are 100 and 99.3% identical, respectively. However,
enJSRV-26 and enJSRV-18 display different phenotypes in the
presence of enJS56A1. enJSRV-18 is restricted by the trans-
dominant enJS56A1 (like the exogenous JSRV), whereas en-
JSRV-26 escapes JLR (2) (Fig. 2A). Because the major differ-
ences between enJSRV-26 and enJSRV-18 are found in env,
we reasoned that this region contains the main determinants
for JLR escape. The enJSRV-26 and enJSRV-18 env genes
differ for only 10 nucleotides, resulting in six synonymous and
four nonsynonymous mutations.
To identify the determinants of JLR escape, we generated a
series of chimeras between enJSRV-18 and enJSRV-26 (Fig.
1) and carried out interference assays with the transdominant
enJS56A1 (Fig. 2). As shown in Fig. 2B, the release of enJS26-
Env18 viral particles was restricted in the presence of
enJS56A1, while enJS18-Env26 escaped JLR. Furthermore,
chimeras enJS18-5Env26 and enJS26-3Env18 also were able
to escape JLR, while enJS56A1 was able to inhibit enJS26-
5Env18 and enJS18-3Env26 viral particle release (Fig. 2C
and D). Collectively, these results indicated that the 5 end of
enJSRV-26 env contains the main determinants of JLR escape.
Amino acid residue D6 in the enJSRV-26 Env is the main
determinant of JLR escape. We investigated whether the en-
JSRV-26 Env protein per se or cis-acting regions within the env
gene were involved in JLR escape. We derived enJSRV-26 and
enJSRV-18 mutants containing two premature termination
codons in Env (enJSRV-26Env and enJSRV-18Env) to pre-
vent its expression while maintaining the intact full-length viral
genome. As expected, we found that enJSRV-26Env was able
to escape JLR when the enJSRV-26 Env was provided in trans,
whereas it was restricted in the presence of the enJSRV-18 Env
(Fig. 3A). On the other hand, enJSRV18Env was restricted
by enJS56A1 in the presence of the enJSRV-18 Env but es-
caped JLR when coexpressed with the enJSRV-26 Env (Fig.
3B). These data conﬁrmed that the enJSRV-26 Env protein per
se is necessary to escape JLR.
The N-terminal region of the retroviral Env includes the
signal peptide. The SPs of enJSRV-26 and enJSRV-18 Env
differ in only three amino acid residues (Fig. 3C). However, the
SP of enJSRV-7 and enJSRV-15 (two enJSRV loci that, like
enJSRV-18, are restricted by enJS56A1) differ by only a single
FIG. 2. enJSRV-26 env 5 end contains the determinants necessary to escape JLR. Shown are Western blots of concentrated supernatants
(virus) and cell extracts (cells) of 293T cells transfected with the plasmids indicated in each panel. Membranes were incubated with antibodies
against the major capsid protein of JSRV (CA) or -tubulin as a loading control. Levels of CA associated with viral particles released in the
supernatants were quantiﬁed by chemiﬂuorescence using ImageQuant TL software (Molecular Dynamics). Graphs represent data obtained from
three independent experiments. The values obtained by each chimera expressed in the absence of enJS56A1 (black bars) were arbitrarily set as
100%. Error bars indicate standard errors; statistically signiﬁcant differences are indicated with one (P 	 0.05) or two (P 	 0.01) asterisks.
(A) Interference assays with wild-type enJSRV-26 and enJSRV-18. (B, C, and D) Interference assays using various enJSRV-26/enJSRV-18
chimeras as indicated in each panel. Only those chimeras containing the 5 end of the env gene of enJSRV-26 are able to elude enJS56A1
restriction.
VOL. 85, 2011 ESCAPING JSRV LATE RESTRICTION 7121
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177amino acid residue (residue 6) from the SP of enJSRV-26 (2).
The alanine (A) residue in position 6 is well conserved in the
SP of JSRV and all the insertionally polymorphic enJSRVs,
with the exception of enJSRV-26, where it is replaced by an
aspartic acid (D) residue (Fig. 3C). Thus, we hypothesized that
the D6 residue plays a critical role in the ability of enJSRV-26
to escape JLR. To this end, we derived the full-length single
mutants enJSRV26-EnvD6A and enJSRV18-EnvA6D. As
shown in Fig. 3D, the D6A mutation conferred susceptibility to
JLR to enJSRV-26, while the reciprocal mutation (A6D) al-
lowed enJSRV-18 to escape enJS56A1-induced restriction.
Similar results were obtained for the exogenous JSRV, where
the A6D mutation allowed JSRV to escape JLR (Fig. 3E).
These data show conclusively that a single amino acid substi-
tution in the SP of the Env glycoprotein allows enJSRV-26 to
escape JLR.
SPs of the enJSRV-26 and enJSRV-18 Env localize in dif-
ferent cellular compartments. We investigated whether the
SP of the enJSRV-26 Env possessed a different biological
activity from that of SPs of enJSRV-18 and enJS56A1. We
and others have shown that the SPs of sheep betaretrovi-
ruses are Rev-like multifunctional proteins that localize in
the nucleoli and favor full-length viral RNA nuclear export
and enhance Gag synthesis and viral particle release (8, 17).
We have shown above that the A6D substitution allows
enJSRV-26 to escape JLR. This residue lays within a pre-
dicted nuclear localization signal (NLS) and an arginine-
rich RNA binding motif (ARM) of the SP (Fig. 3C). Thus,
we investigated whether the A6D substitution affected the
intracellular localization of the enJSRV-26 SP.
By confocal microscopy, we observed that both the en-
JSRV-18 and enJSRV-26 SPs localize in the cytoplasm and in
the nucleus of transfected cells (Fig. 4). The enJSRV-18 SP
colocalized with nucleolar markers, such as ﬁbrillarin, as we
previously observed for the JSRV SP (8). On the other hand,
the enJSRV-26 SP displayed a diffuse nuclear staining pattern
FIG. 3. Amino acid residue D6 in the enJSRV-26 Env plays a major role in JLR escape. (A, B, D, and E) Western blots of concentrated
supernatants (virus) and cell extracts (cells) of 293T cells transfected with the plasmids indicated in each panel. Membranes were incubated with
antibodies against the major capsid protein (CA) of JSRV or -tubulin as a loading control. Levels of CA associated with viral particles released
in the supernatants were quantiﬁed by chemiﬂuorescence using ImageQuant TL software (Molecular Dynamics). Graphs represent data obtained
from three independent experiments. The values obtained by each mutant expressed in the absence of enJS56A1 (black bars) were arbitrarily set
as 100%. Error bars indicate standard errors; statistically signiﬁcant differences are indicated with one (P 	 0.05) or two (P 	 0.01) asterisks. Env
expression was controlled by incubating membranes with antibodies against the transmembrane (TM) domain of JSRV. (C) Graphic represen-
tation of the alignment of the amino acid sequences of the signal peptides of four insertionally polymorphic enJSRV proviruses and the exogenous
JSRV. Lines represent identical residues in the sequences, while letters indicate differences in the amino acid residues. Numbering corresponds
to amino acid residues in Env. ARM, arginine-rich motif; NLS, nuclear localization signal; NES, nuclear export signal.
7122 ARMEZZANI ET AL. J. VIROL.
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178with no accumulation in the nucleoli. The relative number of
cells expressing the enJSRV-18 SP with nucleolar localization
was about 80-fold higher than those expressing the enJSRV-26
SP (data not shown). We also determined that the enJSRV-26
SP did not relocalize in the nucleoli in the presence of
enJS56A1, indicating that its defect was not rescued by the
functional SP of enJS56A1 (data not shown). We performed
these assays in both COS and 293T cells, obtaining essentially
the same results (data not shown).
The phenotype of enJSRV-26 can be attributed to a relative
lack of function of its SP. We investigated whether the altered
localization of the enJSRV-26 SP was correlated with its al-
tered function and JLR escape. We cotransfected 293T cells
with expression plasmids for the enJSRV-26Env mutant and
the SPs of enJSRV-26 (pSP26-HA) or enJSRV-18 (pSP18-
HA), and we used Western blotting to analyze the amount of
virus produced in the presence or absence of enJS56A1 (Fig.
5A). We found that enJSRV-26Env was able to escape JLR
if the enJSRV-26 SP was provided in trans (Fig. 5A, lanes 6 and
7), while it was impaired in the presence of the enJSRV-18 SP
(Fig. 5A, lanes 8 and 9). enJSRV-26Env also was able to
escape enJS56A1 restriction when expressed by itself (Fig. 5A,
lanes 4 and 5). Accordingly, we also noticed that the release of
viral particles from enJSRV26Env was much more strongly
enhanced by the enJSRV-18 SP than by the enJSRV-26 SP
(Fig. 5A, lanes 4, 6, and 8). Similar results were obtained with
the enJSRV-18Env mutant (data not shown).
Note that in a previous study we showed that enJS56A1 also
expresses a defective Env glycoprotein (2). Betaretroviruses
assemble in the pericentriolar area, and their Env facilitate
intracellular Gag trafﬁcking and viral particle release (3, 33).
Thus, interference assays involving enJSRV-26Env can be
more difﬁcult to interpret in the absence of functional Env.
However, the data described above overall suggest that the
A6D mutation in the enJSRV-26 Env impairs at least some of
the functions played by its SP, resulting in JLR escape. To test
this hypothesis, we used a Rev-RRE-dependent HIV-1 Gag-
Pol expression vector (pNLgagSty330; termed pHIV1-RRE in
this study) (16, 21) and derived constructs where the HIV-1
RRE was replaced with the signal peptide responsive elements
(SPREs) of enJS56A1 (pHIV-SPRE56), enJSRV-18 (pHIV-
SPRE18), and enJSRV-26 (pHIV-SPRE26). These constructs
where cotransfected with either pSP18-HA, pSP26-HA, or
pSP56-HA (encoding the enJSRV-18, enJSRV-26, and
enJS56A1 SPs, respectively), and the release of HIV particles
in the supernatants was measured by ELISA (Fig. 5B). We
observed that in the presence or absence of the enJSRV-26 SP,
the levels of Gag in the supernatants of cells transfected with
pHIV-SPRE56, pHIV-SPRE18, or pHIV-SPRE26 did not
change, while they increased substantially in the presence of
the SP of either enJSRV-18 or enJS56A1 (Fig. 5B).
Collectively, the data presented so far suggested that the
ability of enJSRV-26 to escape JLR was due to the relative lack
of function of its SP. To experimentally prove this point, we
derived a mutant of the enJSRV-18 Env expression plasmid in
which the SP was replaced with the heterologous SP of the
human preprotrypsin protein (penJS18Env-PPT). Interest-
ingly, we found that enJSRV-18Env escaped JLR when
enJS18Env-PPT was provided in trans (Fig. 5C). These data
suggest that JLR escape is due to a lack of function, rather
than a gain of function, of the SP of the enJSRV-26 Env.
enJS56A1 Env plays a key role in enJSRV-26 JLR escape.
The data obtained so far suggested that the SP of the trans-
dominant enJS56A1 is able to enhance Gag expression as well
as enJSRV-26 viral particle release. Thus, our next aim was to
assess whether the expression of the enJS56A1 Env SP was a
requirement for JLR escape. To this end, we generated an
enJS56A1 mutant (enJS56A1-4CTE) in which the Env glyco-
protein (including its SP) was replaced by four repeats of the
M-PMV CTE. Gag expression of enJS56A1-4CTE therefore is
SP independent, but it relies on the M-PMV CTE, which
functions in cis (6). As expected, we found that enJSRV-26
viral particle release was blocked by enJS56A1-4CTE, indicat-
ing that the expression of the enJS56A1 Env is necessary for
enJSRV-26 to escape JLR (Fig. 6A, lanes 1, 6, and 7).
Taken together, the results obtained suggested that the
enJS56A1 and enJSRV-26 SPRE compete for the only func-
tional SP within the cell (i.e., the enJS56A1 SP). Consequently,
we hypothesized that by overexpressing enJS56A1, the intra-
cellular levels of enJS56A1 SP would favor the synthesis of the
transdominant Gag to levels sufﬁcient to block enJSRV-26. To
test this point, we cotransfected 293T cells with different ratios
of the enJSRV-26 and enJS56A1 expression plasmids and as-
sessed viral particle release by Western blotting (Fig. 6B). We
found that enJSRV-26 was able to escape JLR when the ratio
FIG. 4. Signal peptide (SP) of enJSRV-26 does not localize in the
nucleoli. The intracellular localization of the signal peptide of en-
JSRV-18 and enJSRV-26 is shown. COS cells were transfected with
expression plasmids for the SPs of enJSRV-18 or enJSRV-26 (tagged
with the HA epitope), ﬁxed 24 h posttransfection, and incubated with
anti-HA (top) and ﬁbrillarin (middle) antibodies. Nuclei are shown in
blue. Both SPs display nuclear localization, but only the enJSRV-18 SP
shows a strong colocalization with nucleolar markers such as ﬁbrillarin.
Bars correspond to 10 m.
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179of the transfected expression plasmids was 1 to 1 (Fig. 6B, lane
4), while it was blocked when the ratio was 1 to 2 (Fig. 6B, lane
5), suggesting that enJS56A1 can inherently block enJSRV-26
viral particle release. To conﬁrm these data, we performed
cotransfection assays with expression plasmids for enJSRV-26
and either wild-type enJS56A1 or an enJS56A1 mutant deleted
of gag (enJS56A1Gag) (Fig. 6C). As expected, we found that
the levels of enJSRV-26 viral particles were higher in the
FIG. 5. Signal peptide of enJSRV-26 does not function as a posttranscriptional regulator of viral gene expression and is essential to escape JLR. (A
and C) Western blots of concentrated supernatants (virus) and cell extracts (cells) of 293T cells transfected with the plasmids indicated in each panel.
Membranes were incubated with antibodies against the JSRV major capsid protein (CA), the HA or FLAG epitopes (to detect SPs or Env, respectively),
or -tubulin as a loading control. Levels of CA associated with viral particles released in the supernatants were quantiﬁed by chemiﬂuorescence using
ImageQuant TL software (Molecular Dynamics). Graphs represent data obtained from three independent experiments. The values obtained by
enJSRV-26 or related mutants in the absence of enJS56A1 (black bars) were arbitrarily set as 100%. Error bars indicate standard errors; statistically
signiﬁcant differences are indicated with one (P 	 0.05) or two (P 	 0.01) asterisks. (B) HIV Gag ELISAs were performed on supernatants of 293T cells
transfected with HIV-1 Gag-Pol expression plasmids (pHIV-SPRE26, pHIV-SPRE18, and pHIV-SPRE56) in the presence or absence of expression
plasmids for the enJSRV-26, enJSRV-18, and enJS56A1 SPs (SP26-HA, SP18-HA, and SP56-HA). Controls included supernatants of cells transfected
with the HIV-1 Gag-Pol expression plasmid containing HIV-1 RRE (pHIV1-RRE) in the presence or absence of the HIV-1 Rev (pRev).
FIG. 6. enJS56A1 Env expression is critical to escape JLR. (A and B) Western blots of concentrated supernatants (virus) and cell extracts (cells) of
293T cells transfected with the plasmids indicated in each panel. Membranes were incubated with antibodies against the JSRV major capsid protein (CA)
and -tubulin as a loading control. Note that enJS56A1-4CTE lacks the viral Env and is able to block enJSRV-26. Levels of CA associated with viral
particles released in the supernatants were quantiﬁed by chemiﬂuorescence using ImageQuant TL software (Molecular Dynamics). Graphs represent
data obtained from three independent experiments. The values obtained by enJSRV-26 were arbitrarily set as 100%. Error bars indicate standard errors;
statistically signiﬁcant differences are indicated with one (P 	 0.05) or two (P 	 0.01) asterisks. (C) Western blot analysis of concentrated supernatants
of 293T cells transfected with the indicated plasmids at 3, 6, 12, and 24 h posttransfection. The bottom panel represents the quantiﬁcation of blots by
chemiﬂuorescence as described for panels A and B. Values are expressed as arbitrary pixel units derived from three independent experiments.
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180presence of enJS56A1Gag than with the full-length
enJS56A1. These data suggest that enJS56A1 is intrinsically
able to interfere with enJSRV-26, and that JLR is directly
related to the relative ratio between transdominant and func-
tional Gag. By using interference assays, we also established
that the enJSRV-26 SP does not possess any dominant-nega-
tive role and does not affect, by itself, enJS56A1 Gag synthesis
(data not shown).
enJS56A1 is ampliﬁed within the genome of domestic sheep.
It is difﬁcult to correlate the data obtained in in vitro exper-
iments with events that in nature lead to the selection of
transdominant proviruses and viruses escaping JLR. Our
results suggest that the relative ratio between defective
transdominant and functional Gag could determine the ef-
ﬁciency of JLR. The sheep genome has an overwhelming
majority of enJSRV loci with functional Gag. However, in a
previous study, we noticed that the BAC clones containing
enJS56A1 were overrepresented in the sheep genomic BAC
library used to clone the known enJSRV loci (2). Indeed,
22% of BAC positive for enJSRV sequences contained the
enJS56A1 provirus, whereas the expected frequency was
3.7% (2). The overrepresentation of particular clones could
be due to artifacts related to the construction, and the
screening of the library but also could be due to the ampli-
ﬁcation of the genomic region containing enJS56A1. Here,
using locus-speciﬁc primers, we determined the relative
gene dosage of the transdominant enJS56A1 in genomic
DNA of wild sheep within the genus Ovis (O. dalli, n  1; O.
canadensis, n  2; O. ammon, n  4; O. vignei, n  1), the
Mediterranean Mouﬂon (Ovis orientalis musimon, n  4),
and different breeds of domestic sheep (Dorset, n  1;
Suffolk, n  1; Texel, n  10; Jacob, n  2; Red Maasai, n 
2; Merino, n  3; Xalda, n  2; Rambouillet, n  1; Soay,
n  3; Norway, n  2; Finsheep, n  3). DNA from animals
within the genera Budorcas (B. taxicolor, n  2) and Pseu-
dois (P. nayaur, n  1) was used as additional negative
controls. In addition, we estimated the relative gene dosage
of enJSRV-6 (ﬁxed in the Ovis genus), the insertionally
polymorphic enJSRV-18 (present in most but not all domes-
tic sheep), and the ovine SOX9 gene as additional controls.
We expressed the data as the ratio between the estimated
number of molecules of target genes and the -Actin gene,
which was used as a reference gene (Fig. 7A).
As expected, the dosage of the SOX9 gene did not change
signiﬁcantly across domestic and wild sheep. The modern en-
JSRV-18 provirus also showed low variations between the sam-
ples tested, whereas enJSRV-6 (which integrated before the
divergence of the genera Ovis and Capra) displayed modest
variations in some wild and domestic sheep (Fig. 7A). In con-
trast, the transdominant enJS56A1 revealed major differences
between the samples analyzed, with clear indications of
genomic ampliﬁcation in some domestic sheep breeds (Fig.
7A). FISH analysis on metaphase chromosomes derived from
domestic sheep (Fig. 7B) showed that at least one of the copies
of the transdominant enJS56A1 provirus (enJSRV-20) maps
exactly to the same chromosomal location as enJS56A1 in
chromosome 6 (6q13).
In a previous study, we speculated that enJSRV-20 arose by
a process of recombination/gene conversion with enJS56A1
(2). enJSRV-20 and enJS56A1 can be distinguished by minor
nucleotide sequence differences (23 nucleotides along the en-
tire genome) and by the 5 ﬂanking region (the env sequences
of an enJSRV provirus for enJSRV-20), but they share iden-
tical 3-ﬂanking regions. However, this study suggests that ge-
nome ampliﬁcation has driven the ampliﬁcation of enJS56A1-
like proviruses with identical genomic ﬂanking regions in any
given animal.
Previously, we also showed that the W21 amino acid residue
in Gag of enJS56A1 (and enJSRV-20) became ﬁxed during
sheep domestication. Considering that the present study
showed the presence of multiple copies of enJS56A1, we
sought to determine the relative frequency of the codon for the
Gag R/W21 residue in the proviruses harbored in the genome
of representative wild and domestic sheep. To this end, we
ampliﬁed the 5 gag region of enJS56A1-like proviruses (in-
cluding enJSRV-20) from genomic DNA of wild sheep (O.
dalli, n  1; O. canadensis, n  1; O. ammon, n  1), the
Mediterranean Mouﬂon (O. orientalis musimon, n  1), and
two different breeds of domestic sheep (Texel, n  2; Merino,
n  1). We then cloned the PCR products obtained and se-
quenced at least 40 individual clones for each sample. We
detected the codon corresponding to the Gag R21 residue in
100% of the PCR clones derived from the ampliﬁcation of
DNA collected from O. dalli and O. canadensis, which are the
species phylogenetically more distant from the domestic sheep
among those analyzed in this study, and for which we had no
evidence of genomic ampliﬁcation (Fig. 7C) (2). In species
phylogenetically closer to domestic sheep (O. ammon and O.
orientalis), 73 to 90% of the PCR clones sequenced contained
the codon corresponding to W21 in Gag. On the other hand,
100% of the clones ampliﬁed from domestic sheep (Texel and
Merino breeds) contained the codon corresponding to W21 in
Gag. These data conﬁrm that enJS56A1-like transdominant
proviruses became ﬁxed in the host genome around sheep
domestication.
DISCUSSION
In this study, we revealed the molecular mechanisms un-
derlying the ability of the recently integrated enJSRV-26
provirus to elude the late restriction induced by the defec-
tive and transdominant enJS56A1. We demonstrated that a
single point mutation in the SP of the enJSRV-26 Env allows
this virus to escape enJS56A1. Signal peptides mediate the
targeting and translocation of membrane and secretory pro-
teins to the endoplasmic reticulum (20, 41). Generally, they
are 15 to 25 amino acid residues long and contain the cleav-
age site for the cellular signal peptidase which, in turn,
releases the signal peptide from the rest of the protein (40).
Signal peptides usually are degraded by the signal peptide
peptidase. However, in some cases signal peptide sequences
display other important biological functions. For instance, it
has been shown that the mouse mammary tumor virus
(MMTV) possesses an SP that is identical for both the Rem
regulatory protein (another HIV Rev-like protein) and the
envelope glycoprotein (7, 22–24). The MMTV SP requires
processing by the cellular signal peptidase and retrotranslo-
cation for nuclear function (7).
The signal peptides of JSRV and related enJSRVs are un-
usually long (80 amino acid residues) compared to those of
VOL. 85, 2011 ESCAPING JSRV LATE RESTRICTION 7125
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181other retroviruses. We and others have shown that the JSRV
SP is a multifunctional protein that favors full-length viral
RNA nuclear export and enhances Gag synthesis and viral
particle release (8, 17). Conversely, in this study, we demon-
strated that enJSRV-26 SP function is impaired due to a single
point mutation. Interestingly, the A6D substitution lies within
two predicted regions of the enJSRV-26 SP, the NLS and the
ARM domains, which are important for SP intracellular local-
ization and function (8, 17). Our results showed that the en-
JSRV-26 SP is excluded from the nucleolus, though it still can
enter the nucleus, where it may passively diffuse given the small
size of this protein. Interestingly, the staining pattern of the
enJSRV-26 SP observed by confocal microscopy resembled
what we previously obtained with a JSRV SP mutant deleted of
its NLS (8). The HIV-1 Rev is targeted to the nucleolus, and
this localization is crucial for mRNA trafﬁcking and viral rep-
lication (19). Indeed, our data have shown that, unlike JSRV/
enJSRV SPs, the enJSRV-26 SP function is impaired, and this
defect allows this virus to elude enJS56A1 restriction. Our
study supports a model in which enJS56A1 and enJSRV-26
SPREs compete for the only functional SP (i.e., the enJS56A1
SP), resulting in an increased synthesis of enJSRV-26 and
reduced levels of enJS56A1 Gag proteins (Fig. 8). Using a
Rev-RRE-dependent HIV-1 Gag-Pol vector, we have shown
data suggesting that SPREs of enJS56A1 and enJSRV-26 re-
spond equally well to the SP of enJS56A1. Indeed, we dem-
onstrated that JLR escape depends on the stoichiometry be-
tween enJS56A1 and enJSRV-26 Gag, which in turn is
regulated by the SPs of these proviruses.
By studying the evolutionary history of the enJSRV provi-
ruses, we found that enJS56A1 possessed the wild-type R res-
idue at position 21 in Gag when it ﬁrst entered the host ge-
nome. Only subsequently did the transdominant enJS56A1
genotype harboring W21 appear in the host genome, and it
became ﬁxed around the time of sheep domestication. With
domestication, a relatively large number of animals suddenly
FIG. 7. enJS56A1 is ampliﬁed in the domestic sheep genome. (A) Graph representing qPCR used to estimate the gene dosage, in wild and
domestic sheep, of the transdominant proviruses enJSRV-6, enJSRV-18, and SOX9. Each bar represents an individual animal, and each letter
represents a different species/breed. Gray boxes indicate assays that could not be performed due to the exhaustion of sample DNA. The absence
of a bar indicates no ampliﬁcation of the corresponding enJSRV locus. Samples tested included genomic DNA collected from B. taxicolor (a), P.
nayaur (b), O. dalli (c), O. canadensis (d), O. ammon (e), O. vignei (f), O. orientalis (g), and various breeds of domestic sheep (O. aries), such as
Soay (h), Norway (i), Dorset (j), Suffolk (k), Texel (l), Jacob (m), Red Maasai (n), Finsheep (o), Merino (p), Xalda (q), and Rambouillet (r).
(B) Fluorescent in situ hybridization of metaphase R-banded chromosomes derived from a Merino sheep (mixed breed). Fluorescent probes were
derived from BAC clones containing the enJSRV-20, enJS56A1, or enJSRV-6 proviruses as described in Materials and Methods. The green
ﬂuorescent signals, indicated by arrows, are speciﬁc for the two transdominant proviruses (both located on chromosome 6 at band 6q13) and the
enJSRV-6 locus (situated on chromosome 1 at band 1q41). Ideograms of Ovis aries chromosomes with R-banding patterns also are shown.
(C) Relative frequency of the wild-type arginine (R) or the transdominant tryptophan (W) Gag residue at position 21 of the enJS56A1-like
proviruses. The 5 region of gag of enJS56A1 and enJSRV-20 was ampliﬁed by PCR from genomic DNA collected from the species indicated in
the panel. Note that letters in parentheses (c, d, e, etc.) refer to the code used for panel A. PCR products were cloned into the pCR4-TOPO vector
(Invitrogen), and 40 individual clones for each PCR product were sequenced to determine the relative presence of an arginine or trypthophan
residue at position 21 in Gag.
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182were kept in restricted spaces, and this likely facilitated the
spread of infectious agents more easily than before. Under
these circumstances, it is feasible to hypothesize that sheep
with transdominant proviruses had a selective advantage.
In our previous study, we speculated that a second trans-
dominant provirus, enJSRV-20, arose by processes of recom-
bination and/or gene conversion with enJS56A1. The results
obtained in this study suggest that the chromosomal location
containing enJS56A1 has been ampliﬁed several times, espe-
cially in some breeds of domestic sheep. Thus, sheep domes-
tication has contributed to the selection and ampliﬁcation of
transdominant proviruses.
The interplay between host and pathogen is a dynamic pro-
cess. The host has evolved sophisticated mechanisms to block
infection by pathogens, which in turn have developed counter-
measures to escape host defenses. The endogenous betaretro-
viruses of sheep represent a unique model to study virus-host
coevolution during long evolutionary periods. Sheep, like
koalas, harbor several copies of intact and insertionally poly-
morphic endogenous proviruses (2, 27, 36). The presence of
enJSRV-26, in particular, a provirus that we estimated inte-
grated in its host within the last 200 years and escapes restric-
tion by enJS56A1, suggests that betaretroviruses still are in-
vading the sheep genome. The presence of multiple copies of
transdominant enJSRV proviruses in modern sheep breeds
therefore may be another mechanism adopted by the host to
counteract retrovirus infection.
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